KR20110083442A - Organic light device and organic light compound for the same - Google Patents

Organic light device and organic light compound for the same Download PDF

Info

Publication number
KR20110083442A
KR20110083442A KR1020100006378A KR20100006378A KR20110083442A KR 20110083442 A KR20110083442 A KR 20110083442A KR 1020100006378 A KR1020100006378 A KR 1020100006378A KR 20100006378 A KR20100006378 A KR 20100006378A KR 20110083442 A KR20110083442 A KR 20110083442A
Authority
KR
South Korea
Prior art keywords
group
compound
synthesis
synthesis example
substituted
Prior art date
Application number
KR1020100006378A
Other languages
Korean (ko)
Other versions
KR101324782B1 (en
Inventor
김복영
안중복
진성민
이재성
안도환
강지승
박노길
한근희
시상만
이대균
Original Assignee
(주)씨에스엘쏠라
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)씨에스엘쏠라 filed Critical (주)씨에스엘쏠라
Publication of KR20110083442A publication Critical patent/KR20110083442A/en
Application granted granted Critical
Publication of KR101324782B1 publication Critical patent/KR101324782B1/en

Links

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D517/00Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/0805Compounds with Si-C or Si-Si linkages comprising only Si, C or H atoms
    • C07F7/0807Compounds with Si-C or Si-Si linkages comprising only Si, C or H atoms comprising Si as a ring atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Abstract

PURPOSE: An organic light device and an organic light compound for the same are provided to obtain excellent generation efficiency when applied to a light device and light compound for solar power generation, thereby enabling the use as OLED materials. CONSTITUTION: An organic light device comprises first and second electrodes and a monolayered organic film. The monolayered organic film is formed between the first electrode and the second electrode. A derivative is independently hydrogen, substituted or unsubstituted C6-C50 aryl group, substituted or unsubstituted C2-C50 heteroaryl group, substituted or unsubstituted C2-C50 cycloalkyl group, substituted or unsubstituted C2-C50 heterocycloalkyl group, or substituted or unsubstituted saturated or unsaturated hydrocarbon.

Description

유기 광소자 및 이를 위한 유기 광합물{ORGANIC LIGHT DEVICE AND ORGANIC LIGHT COMPOUND FOR THE SAME}ORGANIC LIGHT DEVICE AND ORGANIC LIGHT COMPOUND FOR THE SAME}

본 발명은 유기 광소자 및 이에 사용되는 유기 광화합물에 관한 것으로서,The present invention relates to an organic optical device and an organic optical compound used therein,

보다 상세하게는 우수한 발광효율, 발광 휘도, 색순도 및 발광 수명을 구현할 수 있는 유기 발광 소자와 이에 사용되는 유기 발광 화합물 또는 태양광 발전용 광소자 및 이에 사용되는 광화합물에 관한 것이다.
More particularly, the present invention relates to an organic light emitting device capable of realizing excellent luminous efficiency, luminous brightness, color purity, and luminous lifetime, an organic light emitting compound or an optical device for photovoltaic power generation, and an optical compound used therefor.

정보화시대로 급속히 진입하면서 전자 정보 기기와 인간의 인터페이스 역할을 하는 디스플레이(Display)의 중요성이 더욱 커지고 있다. 특히 언제 어디서나 편리하게 사용할 수 있고, 현장감 있게 생생한 화면을 보여 줄 수 있는 디스플레이를 개발하기 위한 노력이 절실히 필요하게 되었다. 더 나아가서 디스플레이를 유리 기판 대신에 플라스틱과 같은 유연한 기판 위에 제작하여 더 얇고, 더 가볍고, 깨지지 않는 플렉서블 디스플레이(flexible display)를 개발하는 연구가 활발하게 진행되고 있다. 유기발광다이오드(OLED) 디스플레이는 이와 같은 응용에 가장 적합한 차세대 평판디스플레이 기술로 큰 주목을 받고 있다.As the information age rapidly enters, the importance of a display, which serves as an interface between the electronic information device and the human being, is increasing. In particular, there is an urgent need to develop a display that can be conveniently used anytime and anywhere, and provides a vivid screen with a sense of reality. Further research is being conducted to develop thinner, lighter, unbreakable flexible displays by fabricating displays on flexible substrates such as plastic instead of glass substrates. Organic light emitting diode (OLED) displays are attracting great attention as next generation flat panel display technologies that are best suited for such applications.

유기반도체에서의 전기발광 현상은 1963년 Pope, Kallmann, Magnate에 의해 안트라센 결정에서 처음으로 발견되었고[M. Pope, H. P. Kallmamm and P. Magnae, J. Chem. Phys. 38, 2042 (1963)], 이어서 1965년에 W. Helfrich [W. Helfrich and W. G. Schneider, Phys. Rev. Lett. 14, 229(1965)] 등의 연구가 이어졌다. 그런데 고순도의 안트라센 결정은 전기전도도가 10-20 s/cm 이하의 절연체이므로 수백볼트 이상의 높은 전압을 가해야 전자와 정공이 주입되고 발광효율이 아주 낮았다. 그리고 반응성이 높은 알칼리 금속을 전극으로 사용한 실용적인 측면에서는 큰 문제가 있었다. 이후 1982년에 Vincett 등은 진공 증착 방법으로 비결정질의 안트라센 박막을 형성하고 유기 발광다이오드를 제작하는데 성공하였다. 이 소자의 발광효율은 약 0.05% 수준으로 아주 낮았으나, 이 방법은 현재까지 대표적인 OLED 제작 방법으로 사용되고 있다.
Electroluminescence in organic semiconductors was first discovered in anthracene crystals in 1963 by Pope, Kallmann and Magnate [M. Pope, HP Kallmamm and P. Magnae, J. Chem. Phys. 38 , 2042 (1963), followed by W. Helfrich [W. Helfrich and WG Schneider, Phys. Rev. Lett. 14 , 229 (1965)]. However, the high purity anthracene crystal is an insulator with an electric conductivity of 10 -20 s / cm or less. Therefore, electrons and holes are injected and light emission efficiency is very low when a high voltage of several hundred volts is applied. In addition, there was a big problem in terms of practical use of highly reactive alkali metals as electrodes. Since 1982, Vincett et al. Succeeded in forming an amorphous anthracene thin film and fabricating an organic light emitting diode by vacuum deposition. The luminous efficiency of this device was very low at about 0.05%, but this method has been used as a typical OLED manufacturing method to date.

1987년 Kodak사의 Tang등이 발광층과 전하 수송층으로 각각 Alq3 와 TPD라는 이중 층 저분자 유기물 박막을 형성하여 효율과 안정성이 개선된 녹색의 발광 현상을 발견한 이후로 저분자 OLED 디스플레이의 개발이 급속도로 빠르게 이루어졌다. 이러한 소자 구조에서는 정공 수송 물질과 전자 수송 물질의 전자 에너지 준위의 차이에 의해 전자와 정공이 diamine/Alq3 계면에 축척되어 전자-정공의 재결함 확률이 높아진다. 그 결과 이 소자는 10V 이하의 구동 전압에서 1000 cd/m2 이상의 휘도와 1.5 lm/W 수준의 높은 발광 효율을 나타냈다. 이 결과는 유기박막 발광다이오드를 이용하여 고휘도, 고효율 디스플레이를 개발할 수 있는 가능성을 제시하기 때문에 큰 주목을 끌어서 전 세계적으로 OLED 연구를 활성화하는데 큰 역할을 했다.
In 1987 the light-emitting layer and a charge transport layer, such as Kodak's Tang each Alq 3 The development of low molecular OLED displays has been rapid since the formation of green light emitting phenomena with improved efficiency and stability by forming a double-layer low molecular organic thin film called and TPD. In this device structure, electrons and holes accumulate at the diamine / Alq 3 interface due to the difference in the electron energy levels of the hole transporting material and the electron transporting material, thereby increasing the probability of electron-hole recombination. As a result, the device showed a luminance of 1000 cd / m 2 or higher and a high luminous efficiency of 1.5 lm / W at a driving voltage of 10V or lower. This result shows the possibility of developing a high-brightness, high-efficiency display using an organic thin-film light emitting diode, so it played a big role in activating OLED research worldwide.

1980년대 후반 저분자 OLED 소자의 구조는 양극(ITO), 정공수송층 (Hole Transfer Layer, HTL) 발광층 (Emission Layer, EML), 음극(Mg:Ag)의 간단한 구조에서 출발하였다. 이후 형광소자의 경우는 CuPc같은 정공주입층(Hole Injedtion Layer, HIL)이 도입되었고, Cathode와 전자주입층 재료로 Al:Li이 개발되고 LiF 같은 재료가 개발되면서 구조가 복잡해지게 되었다. 이에 따라서 전기광학적인 특성도 효율과 구동전압이 혁신적으로 개선이 이루어지게 되었다.
In the late 1980s, the structure of the low molecular OLED device started with a simple structure of an anode (ITO), a hole transfer layer (HTL) emission layer (EML), and a cathode (Mg: Ag). Later, in the case of a fluorescent device, a hole injection layer (HIL) such as CuPc was introduced, and the structure became complicated as Al: Li was developed as a cathode and an electron injection layer material, and a material such as LiF was developed. Accordingly, the efficiency and driving voltage of the electro-optical characteristics have been improved.

발광 소자(light emitting device)는 자발광형 소자로 시야각이 넓으며 콘트라스트가 우수할 뿐만 아니라 응답시간이 빠르다는 장점을 가진다. 상기 발광 소자는 발광층(emitting layer)에 무기 화합물을 사용하는 무기 발광 소자와 유기 화합물을 사용하는 유기 광소자(Organic Light Emitting Deveice : OLED)로 구분된다. 유기 광소자는 무기 발광 소자에 비하여 높은 휘도, 낮은 구동전압, 짧은 응답속도 등의 물성이 우수하고 다색화가 가능하다는 점에서 많은 연구의 대상이 된다.상기 유기 광소자는 일반적으로 애노드/유기 발광층/캐소드의 적층구조를 가지며, 애노드/정공주입층/정공수송층/발광층/전자수송층/전자주입층/캐소드 또는 애노드/정공주입층/정공수송층/발광층/정공저지층/전자수송층/전자주입층/캐소드 등과 같은 다양한 구조를 가질 수 있다.
The light emitting device is a self-luminous device, and has a wide viewing angle, excellent contrast, and fast response time. The light emitting device is classified into an inorganic light emitting device using an inorganic compound as an emitting layer and an organic light emitting device using an organic compound. Compared with inorganic light emitting devices, organic photoelectric devices have been studied in many ways in that they have excellent physical properties such as high luminance, low driving voltage, and short response speed, and are capable of multicoloring. The organic optical devices are generally used as anodes, organic light emitting layers, and cathodes. It has a laminated structure, such as anode / hole injection layer / hole transport layer / light emitting layer / electron transport layer / electron injection layer / cathode or anode / hole injection layer / hole transport layer / light emitting layer / hole blocking layer / electron transport layer / electron injection layer / cathode It can have various structures.

한편, 발광 효율이 높고 작동 수명이 긴 유기 광소자가 구현되기 위해서 고성능의 유기 광화합물이 중요시된다.On the other hand, high-performance organic optical compounds are important in order to implement organic optical devices having high luminous efficiency and long operating life.

대형화되고 저소비전력이 요구되는 패널을 제조하기 위하여, 상기 유기 광화합물들은 발광 효율, 발광 휘도 등이 추가적으로 개선되어야 하며 특히 수명 특성이 개선되어야 한다. In order to manufacture a panel having a large size and low power consumption, the organic photochemical compounds must further improve luminous efficiency, luminous luminance, and the like, and especially life characteristics.

아울러 화석연료의 대체 에너지 개발이 절실한 현실에서 이러한 유기 발광 소자 및 유기 발광 화합물은 발상의 전환을 통하여 태양광 발전을 위한 유기 광소자 및 광화합물에 적용될 수 있다.
In addition, the development of alternative energy of fossil fuel is urgently needed, such organic light emitting devices and organic light emitting compounds can be applied to organic photoelectric devices and photo compounds for photovoltaic power generation through the conversion of ideas.

본 발명이 이루고자 하는 첫 번째 기술적 과제는 발광 효율, 발광 휘도, 색순도 및 발광 수명이 향상된 유기 광소자를 제공하는 것이다.The first technical problem to be achieved by the present invention is to provide an organic optical device having improved luminous efficiency, luminous brightness, color purity and luminous lifetime.

본 발명이 이루고자 하는 두 번째 기술적 과제는 새로운 유기 광화합물을 제공하는 것이다.The second technical problem to be achieved by the present invention is to provide a new organic photochemical compound.

아울러 본 발명은 이를 유기 발광 소자 및 유기 발광 화합물, 또는 태양광 발전을 위한 유기 광소자 및 광화합물을 제공하는 것을 목적으로 한다.
In addition, an object of the present invention is to provide an organic light emitting device and an organic light emitting compound, or an organic optical device and a photo compound for photovoltaic power generation.

본 발명의 제 1태양에 따른 유기 광소자는, 제1전극; 제2전극; 및 상기 제1전극과 상기 제2전극 사이에 적어도 한 층의 유기막을 포함하는 유기 광소자로서, 상기 유기막이 하기 화학식 A의 유기 광화합물을 포함한다:An organic optical device according to the first aspect of the present invention, the first electrode; A second electrode; And at least one organic film between the first electrode and the second electrode, wherein the organic film comprises an organic photo compound of formula A:

<화학식 A><Formula A>

Figure pat00001

Figure pat00001

상기 식에서 A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 및 C2는 서로 독립적 또는 유관하게, 수소, 치환 또는 비치환된 C6-C50아릴기, 치환 또는 비치환된 C2-C50헤테로아릴기, 치환 또는 비치환된 C2-C50사이클로알킬기, 치환 또는 비치환된 C2-C50헤테로사이클로알킬기, 또는 치환 또는 비치환된 포화 또는 불포화 탄화수소이고,Wherein A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 and C2 are each independently or related to hydrogen, a substituted or unsubstituted C6-C50 aryl group, a substituted or unsubstituted C2-C50 hetero An aryl group, a substituted or unsubstituted C2-C50 cycloalkyl group, a substituted or unsubstituted C2-C50 heterocycloalkyl group, or a substituted or unsubstituted saturated or unsaturated hydrocarbon,

X1, X2, X3, X4는 각각 0(zero), Si, S, Se, O, C 또는 N이고,X1, X2, X3, X4 are each 0 (zero), Si, S, Se, O, C or N,

X1과 X2 중 어느 하나가 0(zero)이면 다른 하나는 0(zero)이 아니며, If one of X1 and X2 is zero, the other is not zero.

X3과 X4중 어느 하나가 0(zero)이면 다른 하나는 0(zero)이 아니고,If one of X3 and X4 is zero, the other is not zero.

X1, X2, X3 또는 X4가 0(zero)이면 이에 상응하는 C2, C1, A1d 또는 A1c가 0(zero)이고,If X1, X2, X3 or X4 is zero, the corresponding C2, C1, A1d or A1c is zero

X1 및 X2이 포함된 고리는 공명 또는 비공명구조이다.Rings containing X1 and X2 are either resonance or non-resonant.

상기 본 발명의 또 다른 과제를 이루기 위하여, 상기 화학식 A로 표시되는 유기 광화합물을 제공한다.
In order to achieve another object of the present invention, there is provided an organic photo compound represented by the formula (A).

본 발명에 따른 유기 광소자는 높은 발광 효율, 높은 발광 휘도, 높은 색순도 및 현저히 향상된 발광 수명을 제공하며,The organic optical device according to the present invention provides high luminous efficiency, high luminous brightness, high color purity and significantly improved luminous lifetime,

아울러 본 발명은 이를 유기 발광 소자 및 유기 발광 화합물, 또는 태양광 발전을 위한 유기 광소자 및 광화합물을 제공한다.
In addition, the present invention provides an organic light emitting device and an organic light emitting compound, or an organic optical device and a photo compound for photovoltaic power generation.

이하 실시예 등을 참고하여 본 발명을 상세히 설명하도록 한다.
Hereinafter, the present invention will be described in detail with reference to Examples.

본 발명은 다양한 변경을 가할 수 있고 여러 가지 형태를 가질 수 있는 바, 구현예(態樣, aspect)(또는 실시예)들을 본문에 상세하게 설명하고자 한다. 그러나 이는 본 발명을 특정한 개시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술범위에 포함되는 모든 변경, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다. The present invention may be modified in various ways and may have various forms, and thus embodiments (or embodiments) will be described in detail in the text. However, this is not intended to limit the present invention to the specific form disclosed, it should be understood to include all modifications, equivalents, and substitutes included in the spirit and scope of the present invention.

본 명세서에서 사용한 용어는 단지 특정한 구현예(태양, 態樣, aspect)(또는 실시예)를 설명하기 위해 사용된 것으로, 본 발명을 한정하려는 의도가 아니다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 본 출원에서, ~포함하다~ 또는 ~이루어진다~ 등의 용어는 명세서 상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부분품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부분품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다.The terminology used herein is for the purpose of describing particular embodiments (suns, aspects, and embodiments) (or embodiments) only and is not intended to be limiting of the invention. Singular expressions include plural expressions unless the context clearly indicates otherwise. In this application, the terms “comprises” or “consists” are intended to indicate that there is a feature, number, step, action, component, part, or combination thereof described on the specification, but one or more other features. It is to be understood that the present invention does not exclude the possibility of the presence or the addition of numbers, steps, operations, components, parts, or combinations thereof.

다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미를 가지고 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥 상 가지는 의미와 일치하는 의미를 가지는 것으로 해석되어야 하며, 본 출원에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.
Unless defined otherwise, all terms used herein, including technical or scientific terms, have the same meaning as commonly understood by one of ordinary skill in the art. Terms such as those defined in the commonly used dictionaries should be construed as having meanings consistent with the meanings in the context of the related art and shall not be construed in ideal or excessively formal meanings unless expressly defined in this application. Do not.

본 명세서에서 유기 광화합물은 유기 광소자에 사용되는 화합물이라는 의미로서 반드시 발광이 가능한 화합물로 그 범위가 한정되지 않으며, 그 적용 범위도 유기 발광층에 한정되지 않고, 전하 주입층 및 전하 수송층 등 유기 광소자를 구성하는 어느 층에나 모두 사용될 수 있다.In the present specification, an organic photochemical compound is a compound used in an organic optical device, and is not necessarily limited to a compound capable of emitting light, and its application range is not limited to an organic light emitting layer, and an organic photonic compound such as a charge injection layer and a charge transport layer It can be used in any layer that constitutes the ruler.

또 본 명세서에서 '광화합물' 및 '광소자'라는 용어는 사전적인 또는 관습적인 정의와 무관하게 본 발명이 유기 발광 소자 및 태양광 발전을 위한 소자에 모두 적용되는 경우를 고려하여, 이를 포괄하고자 선정한 용어이다.
In the present specification, the terms "photochemical compound" and "optical device" are intended to be encompassed in consideration of the case where the present invention is applied to both an organic light emitting device and a device for photovoltaic power generation regardless of a dictionary or customary definition. The selected term.

본 발명의 제 1태양에 따르는 유기 광소자는, 제1전극; 제2전극; 및 상기 제1전극과 상기 제2전극 사이에 적어도 한 층의 유기막을 포함하는 유기 광소자로서, 상기 유기막이 하기 화학식 A의 유기 광화합물을 포함한다:
An organic optical device according to the first aspect of the present invention, the first electrode; A second electrode; And at least one organic film between the first electrode and the second electrode, wherein the organic film comprises an organic photo compound of formula A:

<화학식 A><Formula A>

Figure pat00002
Figure pat00002

상기 유도체에 대한 화학식에서 A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 및 C2는 서로 독립적 또는 유관하게, 수소(중수소를 포함한다), 치환 또는 비치환된 C6-C50아릴기, 치환 또는 비치환된 C2-C50헤테로아릴기, 치환 또는 비치환된 C2-C50사이클로알킬기, 치환 또는 비치환된 C2-C50헤테로사이클로알킬기, 또는 치환 또는 비치환된 포화 또는 불포화 탄화수소이고,In the formula for the derivative, A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 and C2 are each independently or related to hydrogen, including deuterium, a substituted or unsubstituted C6-C50 aryl group. , A substituted or unsubstituted C2-C50 heteroaryl group, a substituted or unsubstituted C2-C50 cycloalkyl group, a substituted or unsubstituted C2-C50 heterocycloalkyl group, or a substituted or unsubstituted saturated or unsaturated hydrocarbon,

X1, X2, X3, X4는 각각 0(zero), Si, S, Se, O, C 또는 N이고,X1, X2, X3, X4 are each 0 (zero), Si, S, Se, O, C or N,

X1과 X2 중 어느 하나가 0(zero)이면 다른 하나는 0(zero)이 아니며, If one of X1 and X2 is zero, the other is not zero.

X3과 X4중 어느 하나가 0(zero)이면 다른 하나는 0(zero)이 아니고,If one of X3 and X4 is zero, the other is not zero.

X1, X2, X3 또는 X4가 0(zero)이면 이에 상응하는 C2, C1, A1d 또는 A1c가 0(zero)이고,If X1, X2, X3 or X4 is zero, the corresponding C2, C1, A1d or A1c is zero

X1 및 X2이 포함된 고리는 공명 또는 비공명구조이다.
Rings containing X1 and X2 are either resonance or non-resonant.

본 발명의 발명자는 상기 화학식 A로 표시되는 화합물의 치환기에서 A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 및 C2와 X1, X2, X3 및 X4를 선택 특정한, 다양한 유도체를 개발하여 전자수송층(ETM), 발광층(EML), 정공수송층(HTM) 등, 제1전극과 상기 제2전극 사이의 각종 유기막으로 사용될 수 있는 유기 광화합물 및 이를 이용한 유기 광소자를 개발하고, The inventors of the present invention have developed a variety of specific derivatives, in which A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 and C2 and X1, X2, X3 and X4 are selected from the substituents of the compound represented by Formula A. To develop an organic optical compound that can be used as various organic films between the first electrode and the second electrode, such as an electron transport layer (ETM), an emission layer (EML), a hole transport layer (HTM), and an organic optical device using the same

유기발광소자로 활용될 경우 효율 증가와 구동 전압의 감소와 같은 성능의 개선 및 OLED 재료로서의 능력을 극대화시킬 수 있고, 특히 발광 수명이 현저히 향상됨을 발견하였으며,When used as an organic light emitting device, it has been found that performance improvement such as increased efficiency and driving voltage can be improved, and the ability as an OLED material can be maximized, and in particular, the light emission life is significantly improved.

이를 태양광 발전을 위한 광소자 및 광화합물 분야에 응용 적용할 경우 우수한 발전 효율을 얻을 수 있을 것으로 기대된다.If this is applied to photovoltaic devices and photochemical fields for photovoltaic power generation, it is expected to obtain excellent power generation efficiency.

이하에서는 화학식 A로 표시되는 화합물을 유기 발광 소자와 관련하여 설명할 것이나, 이에 의하여 본 발명이 제한 해석 되어서는 안 된다.
Hereinafter, the compound represented by Formula A will be described with reference to the organic light emitting device, but the present invention should not be construed as a limitation.

상기 화학식 A로 표시되는 화합물은 유기 광소자 중 제1전극과 제2전극 사이에 개재된 유기막을 이루는 물질로 적합하다. 상기 화학식 A로 표시되는 화합물은 유기 발광 소자의 유기막, 특히 정공수송층, 정공주입층 또는 발광층에 사용되기 적합하며 호스트 재료뿐만 아니라 도판트 재료로서도 사용된다. 상기 화학식 A로 표시되는 화합물은 청색 내지 녹색인 색상을 제공하며 백색 발광 소자에 사용하기에 적합하다.The compound represented by Chemical Formula A is suitable as a material forming an organic film interposed between the first electrode and the second electrode of the organic optical device. The compound represented by the formula (A) is suitable for use in an organic film, particularly a hole transport layer, a hole injection layer or a light emitting layer of an organic light emitting device, and is used as a dopant material as well as a host material. The compound represented by Formula A provides a color of blue to green and is suitable for use in a white light emitting device.

A1a와 A1b, A1a와 A1c, A1b와 A1d, B1과 C1, B2와 C2 및 A2a와 A2b의 일부는 유관하게 작용기를 구성할 수 있으며,A1a and A1b, A1a and A1c, A1b and A1d, B1 and C1, B2 and C2, and some of A2a and A2b may be related groups,

이 작용기는 치환 또는 비치환된 C2-C50사이클로알킬기, 치환 또는 비치환된 C2-C50헤테로사이클로알킬기, 치환 또는 비치환된 C6-C50아릴기, 또는 치환 또는 비치환된 C2-C50헤테로아릴기이고,This functional group is a substituted or unsubstituted C2-C50 cycloalkyl group, a substituted or unsubstituted C2-C50 heterocycloalkyl group, a substituted or unsubstituted C6-C50 aryl group, or a substituted or unsubstituted C2-C50 heteroaryl group ,

또 상기 A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 및 C2 중 하나 이상이 페닐기인 것이 바람직하다.Moreover, it is preferable that at least one of said A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 and C2 is a phenyl group.

상기 아릴기는 방향족 고리 시스템을 갖는 1가 그룹으로서, 2 이상의 고리 시스템을 포함할 수 있으며, 상기 2이상의 고리 시스템은 서로 결합 또는 융합된 형태로 존재할 수 있다. 상기 헤테로아릴기는 상기 아릴기 중 하나 이상의 탄소가 N, O, S, P, Si 및 Se로 이루어진 군으로부터 선택된 하나 이상으로 치환된 그룹을 가리킨다. The aryl group is a monovalent group having an aromatic ring system, and may include two or more ring systems, and the two or more ring systems may exist in a bonded or fused form with each other. The heteroaryl group refers to a group in which at least one carbon of the aryl group is substituted with at least one selected from the group consisting of N, O, S, P, Si, and Se.

한편, 사이클로알킬기는 고리 시스템을 갖는 알킬기를 가리키며, 상기 헤테로사이클로알킬기는 상기 사이클로알킬기 중 하나 이상의 탄소가 N, O, S, P, Si 및 Se로 이루어진 군으로부터 선택된 하나 이상으로 치환된 그룹을 가리킨다. Meanwhile, a cycloalkyl group refers to an alkyl group having a ring system, and the heterocycloalkyl group refers to a group in which at least one carbon of the cycloalkyl group is substituted with at least one selected from the group consisting of N, O, S, P, Si, and Se. .

상기 아릴기 및 헤테로아릴기의 하나 이상의 수소가 치환될 경우, 이들의 치환기는 C1-C50알킬기; C1-C50알콕시기; 비치환 또는 C1-C50알킬기 또는 C1-C50알콕시기로 치환된 C6-C50아릴기; 비치환 또는 C1-C50알킬기 또는 C1-C50알콕시기로 치환된 C2-C50헤테로아릴기; 비치환 또는 C1-C50알킬기 또는 C1-C50알콕시기로 치환된 C5-C50사이클로알킬기및 비치환 또는 C1-C20알킬기 또는 C1-C20알콕시기로 치환된 C5-C50헤테로사이클로알킬기, 또는 실레인기로 표시되는 그룹으로 이루어진 군으로부터 선택된 하나 이상일 수 있다.
When one or more hydrogen of the aryl group and heteroaryl group is substituted, their substituents are C1-C50 alkyl group; C1-C50 alkoxy group; C 6 -C 50 aryl groups which are unsubstituted or substituted with C 1 -C 50 alkyl groups or C 1 -C 50 alkoxy groups; C2-C50 heteroaryl group unsubstituted or substituted with a C1-C50 alkyl group or a C1-C50 alkoxy group; C5-C50 cycloalkyl group substituted with an unsubstituted or C1-C50 alkyl group or a C1-C50 alkoxy group and a group represented by a C5-C50 heterocycloalkyl group substituted with an unsubstituted or C1-C20 alkyl group or a C1-C20 alkoxy group, or a silane group It may be one or more selected from the group consisting of.

보다 구체적으로, A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 및 C2는 서로 독립적으로 또는 유관하게, 수소, 페닐기, 톨일기, 비페닐기, 펜타레닐기, 인데닐기, 나프틸기, 비페닐레닐기, 안트라세닐기, 벤조안트라세닐기, 아즈레닐기, 헵타레닐기, 아세나프틸레닐기, 페나레닐기, 메틸안트릴기, 페난트레닐기, 트리페닐레닐기, 피레닐기, 크리세닐기, 피세닐기, 페릴레닐기, 클로로페릴레닐기, 펜타페닐기, 펜타세닐기, 테트라페닐레닐기, 헥사페닐기, 헥사세닐기, 루비세닐기, 코로네닐기, 트리나프틸레닐기, 헵타페닐기, 헵타세닐기, 플루오레닐기, 피란트레닐기, 오바레닐기, 카르바졸릴기, 디벤조퓨라닐기, 디벤조티오페닐기, 티오페닐기, 인돌일기, 푸리닐기, 벤즈이미다졸일기, 퀴놀리닐기, 벤조티오페닐기, 파라티아지닐기, 피롤일기, 피라졸릴기, 이미다졸릴기, 이미다졸리닐기, 옥사졸릴기, 티아졸릴기, 트리아졸릴기, 테트라졸일기, 옥사디아졸릴기, 피리디닐기, 피리다지닐기, 피리미디닐기, 피라지닐기, 티안트레닐기(thianthrenyl), 사이클로펜틸기, 사이클로헥실기, 옥시라닐기, 피롤리디닐기, 피라졸리디닐기, 이미다졸리디닐기, 피페리디닐기, 피페라지닐기, 모르폴리닐기, 디(C6-C50아릴)아미노기, 실레인기 및 이들의 유도체로 이루어진 군으로부터 선택될 수 있다.
More specifically, A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 and C2 independently or independently of each other, hydrogen, phenyl group, tolyl group, biphenyl group, pentarenyl group, indenyl group, naphthyl group , Biphenylenyl group, anthracenyl group, benzoanthracenyl group, azurenyl group, heptarenyl group, acenaphthylenyl group, phenenalenyl group, methyl anthryl group, phenanthrenyl group, triphenylenyl group, pyrenyl group, creie Cenyl group, pisenyl group, perylenyl group, chloroperylenyl group, pentaphenyl group, pentaxenyl group, tetraphenylenyl group, hexaphenyl group, hexasenyl group, rubisenyl group, coronyl group, trinaphthylenyl group, heptaphenyl group , Heptacenyl group, fluorenyl group, pyrantrenyl group, obarenyl group, carbazolyl group, dibenzofuranyl group, dibenzothiophenyl group, thiophenyl group, indolyl group, furinyl group, benzimidazolyl group, quinolinyl group, Benzothiophenyl group, parathiazinyl group, pyrrolyl group, pyrazolyl group, imidazolyl group, Imidazolinyl, oxazolyl, thiazolyl, triazolyl, tetrazolyl, oxdiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, thianthrenyl, Cyclopentyl group, cyclohexyl group, oxiranyl group, pyrrolidinyl group, pyrazolidinyl group, imidazolidinyl group, piperidinyl group, piperazinyl group, morpholinyl group, di (C6-C50 aryl) amino group, Silane groups and derivatives thereof.

본 명세서에 있어서, 상기 "유도체"란 용어는 상기 나열한 그룹들 중 하나 이상의 수소가 전술한 바와 같은 치환기로 치환된 그룹을 가리키는 것이다.In the present specification, the term "derivative" refers to a group in which at least one hydrogen of the groups listed above is substituted with a substituent as described above.

바람직하게는, 상기 A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 및 C2는 서로 독립적으로 또는 유관하게, 수소, 페닐기, 비페닐기, 톨일기, 나프틸기, 나프탈레닐페닐기, 디메틸벤질기, 피레닐기, 페난트레닐기, 벤조[de]안트라세닐기, 벤조[a]안트라세닐기, 벤조[b]안트라세닐기, 벤조[c]안트라세닐기, 11,11 -디메틸벤조[de]안트라세닐기, 11,11 -디에틸벤조[de]안트라세닐기, 11,11 -디메틸벤조[a]안트라세닐기, 11,11 -디메틸벤조[b]안트라세닐기, 11,11 -디메틸벤조[c]안트라세닐기, 바이플루오레닐기, 6,6 ,12,12 -테트라메틸-인데노[1,2-b]플루오레닐기, N-페닐카르바졸릴기, N-에틸카르바졸릴기, 카르바졸릴기, 디벤조퓨라닐기, 디벤조티오페닐기, 이미다졸리닐기, 인돌일기, 퀴놀리닐기, 디페닐아미노기, 디비페닐아미노기, 디(tert-부틸벤질)아미노기, (톨일)(페닐)아미노기, (페닐)(비페닐)아미노기, (페닐)(나프틸)아미노기, 디(비페틸)아미노기, 디플루오레닐아미노기, 디-p-톨일아미노기, 실레인기 및 이들의 유도체로 이루어진 군으로부터 선택될 수 있다.Preferably, the A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 and C2 independently or independently of each other, hydrogen, phenyl group, biphenyl group, tolyl group, naphthyl group, naphthalenylphenyl group, Dimethylbenzyl, pyrenyl, phenanthrenyl, benzo [de] anthracenyl, benzo [a] anthracenyl, benzo [b] anthracenyl, benzo [c] anthracenyl, 11,11-dimethylbenzo [ de] anthracenyl group, 11, 11-diethyl benzo [de] anthracenyl group, 11, 11- dimethyl benzo [a] anthracenyl group, 11, 11- dimethyl benzo [b] anthracenyl group, 11, 11- Dimethylbenzo [c] anthracenyl group, bifluorenyl group, 6,6,12,12-tetramethyl-indeno [1,2-b] fluorenyl group, N-phenylcarbazolyl group, N-ethylcarr Bazolyl group, carbazolyl group, dibenzofuranyl group, dibenzothiophenyl group, imidazolinyl group, indolyl group, quinolinyl group, diphenylamino group, dibiphenylamino group, di (tert-butylbenzyl) amino group, (tolyl (Phenyl) amino group, (phenyl) (ratio Phenyl) amino group, (phenyl) (naphthyl) amino group, di (bifetyl) amino group, difluorenylamino group, di-p-tolylamino group, silane group and derivatives thereof.

보다 상세하게 본 발명의 일 구현예에 따르면, 본 발명의 유기 광소자에 사용되는 유기 광화합물은 하기 화학식 1 내지 185의 구조(본 명세서에서 '화학식'은 생략하고 숫자만 기재함)를 가질 수 있으나 이에 한정되는 것은 아니다:
In more detail, in accordance with an embodiment of the present invention, the organic photochemical compound used in the organic photoelectric device of the present invention may have a structure of the formula 1 to 185 (in the present specification, the formula is omitted, not described). But not limited to:

Figure pat00003
Figure pat00003

Figure pat00004
Figure pat00004

Figure pat00005
Figure pat00005

Figure pat00006
Figure pat00006

Figure pat00007
Figure pat00007

Figure pat00008
Figure pat00008

Figure pat00009
Figure pat00009

Figure pat00010

Figure pat00010

Figure pat00011
Figure pat00011

Figure pat00012
Figure pat00012

Figure pat00013
Figure pat00013

Figure pat00014
Figure pat00014

Figure pat00015
Figure pat00015

상기 화학식 A로 표시되는 본 발명에 따른 유기 광화합물은 통상의 합성 방법을 이용하여 합성될 수 있으며, 상기 화합물의 보다 상세한 합성 경로는 하기 합성예의 반응식 1 내지 185을 참조한다. 상기 화학식 A의 화합물은 유기 광소자의 유기막, 특히 정공수송층, 정공주입층 또는 발광층에 사용되기 적합하다. 본 발명을 따르는 유기 발광 소자의 구조는 매우 다양하다. 상기 제1전극과 제2전극 사이에 정공주입층, 정공수송층, 정공저지층, 전자저지층, 전자수송층 및 전자주입층으로 이루어진 군으로부터 선택된 하나 이상의 층을 더 포함할 수 있다.The organic photochemical compound according to the present invention represented by Chemical Formula A may be synthesized using a conventional synthesis method, and for more detailed synthesis route of the compound, see Schemes 1 to 185 of the following Synthesis Example. The compound of formula (A) is suitable for use in organic membranes of organic optical devices, in particular hole transport layers, hole injection layers or light emitting layers. The structure of the organic light emitting device according to the present invention is very diverse. One or more layers selected from the group consisting of a hole injection layer, a hole transport layer, a hole blocking layer, an electron blocking layer, an electron transport layer and an electron injection layer may be further included between the first electrode and the second electrode.

보다 구체적으로, 본 발명을 따르는 유기 발광 소자의 구현예는 More specifically, embodiments of the organic light emitting device according to the present invention

먼저, 유기 발광 소자는 제1전극/정공주입층/발광층/전자수송층/전자주입층/제2전극으로 이루어진 구조를 가질 수 있고, First, the organic light emitting device may have a structure consisting of a first electrode / hole injection layer / light emitting layer / electron transport layer / electron injection layer / second electrode,

또 유기 발광 소자는 제1전극/정공주입층/정공수송층/발광층/전자수송층/전자주입층/제2전극으로 이루어진 구조를 가질 수 있으며,In addition, the organic light emitting device may have a structure consisting of a first electrode / hole injection layer / hole transport layer / light emitting layer / electron transport layer / electron injection layer / second electrode,

나아가 유기 발광 소자는 제1전극/정공주입층/정공수송층/발광층/정공저지층/전자수송층/전자주입층/제2전극의 구조를 가질 수 있다.Furthermore, the organic light emitting device may have a structure of a first electrode / hole injection layer / hole transport layer / light emitting layer / hole blocking layer / electron transport layer / electron injection layer / second electrode.

이때, 상기 전자수송층, 발광층 또는 정공수송층 중 하나 이상은 본 발명을 따르는 화합물을 포함할 수 있다.In this case, at least one of the electron transport layer, the light emitting layer, or the hole transport layer may include a compound according to the present invention.

본 발명을 따르는 유기 광소자의 발광층은 적색, 녹색, 청색 또는 백색을 포함하는 인광 또는 형광 도펀트를 포함할 수 있다. 이 중, 상기 인광 도펀트는 Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb 및 Tm으로 이루어진 군으로부터 선택된 하나 이상의 원소를 포함하는 유기금속화합물일 수 있다. 또한, 본 발명에 따르는 화합물은 발광층에서 형광 도펀트로도 사용될 수 있다.The light emitting layer of the organic optical device according to the present invention may include a phosphorescent or fluorescent dopant including red, green, blue or white. Among these, the phosphorescent dopant may be an organometallic compound including at least one element selected from the group consisting of Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, and Tm. The compounds according to the invention can also be used as fluorescent dopants in light emitting layers.

이하, 본 발명을 따르는 유기 광소자의 제조 방법을 유기 광소자를 참조하여, 살펴보기로 한다. 먼저 기판 상부에 높은 일함수를 갖는 제1전극용 물질을 증착법 또는 스퍼터링법 등에 의해 형성하여 제1전극을 형성한다. 상기 제1전극은 애노드(Anode)일 수 있다. 여기에서 기판으로는 통상적인 유기 광소자에서 사용되는 기판을 사용하는데 기계적 강도, 열적 안정성, 투명성, 표면 평활성, 취급용이성 및 방수성이 우수한 유리 기판 또는 투명 플라스틱 기판이 바람직하다. 제1전극용 물질로는 투명하고 전도성이 우수한 산화인듐주석(ITO), 산화인듐아연(IZO), 산화주석(SnO2), 산화아연(ZnO) 등을 사용한다.Hereinafter, a method of manufacturing an organic optical device according to the present invention will be described with reference to an organic optical device. First, a first electrode material having a high work function on the substrate is formed by a deposition method or a sputtering method to form a first electrode. The first electrode may be an anode. Herein, a substrate used in a conventional organic optical device is used, and a glass substrate or a transparent plastic substrate having excellent mechanical strength, thermal stability, transparency, surface smoothness, ease of handling, and waterproofness is preferable. Indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO 2), zinc oxide (ZnO), and the like, which are transparent and have excellent conductivity, are used as the material for the first electrode.

다음으로, 상기 제1전극 상부에 진공증착법, 스핀코팅법, 캐스트법, LB법 등과 같은 다양한 방법을 이용하여 정공주입층(HIL)을 형성할 수 있다.Next, a hole injection layer HIL may be formed on the first electrode by using various methods such as vacuum deposition, spin coating, casting, and LB.

진공증착법에 의하여 정공주입층을 형성하는 경우, 그 증착 조건은 정공주입층의 재료로서 사용하는 화합물, 목적으로 하는 정공주입층의 구조 및 열적 특성 등에 따라 다르지만, 일반적으로 증착온도 100 내지 500℃, 진공도 10-5 내지 10-3 torr, 증착속도 0.01 내지 100Å/sec, 막 두께는 통상 100Å 내지 1㎛ 범위에서 적절히 선택하는 것이 바람직하다.In the case of forming the hole injection layer by vacuum deposition, the deposition conditions vary depending on the compound used as the material of the hole injection layer, the structure and thermal characteristics of the hole injection layer, and the like. It is preferable that a vacuum degree of 10 -5 to 10 -3 torr, a deposition rate of 0.01 to 100 Pa / sec, and a film thickness are appropriately selected in the range of usually 100 Pa to 1 µm.

스핀코팅법에 의하여 정공주입층을 형성하는 경우, 그 코팅 조건은 정공주입층의 재료로서 사용하는 화합물, 목적하는 하는 정공주입층의 구조 및 열적 특성에 따라 상이하지만, 약 2000rpm 내지 5000rpm의 코팅 속도, 코팅 후 용매 제거를 위한 열처리 온도는 약 80℃ 내지 200℃의 온도 범위 에서 적절히 선택하는 것이 바람직하다.In the case of forming the hole injection layer by spin coating, the coating conditions vary depending on the compound used as the material of the hole injection layer, the structure and the thermal properties of the desired hole injection layer, but the coating speed is about 2000 rpm to 5000 rpm. After the coating, the heat treatment temperature for removing the solvent is preferably selected from a temperature range of about 80 ° C to 200 ° C.

상기 정공주입층 물질은 전술한 바와 같은 화학식 A를 갖는 화합물일 수 있다. The hole injection layer material may be a compound having Formula A as described above.

또는, 예를 들어, 미국특허 제4,356,429호에 개시된 구리프탈로시아닌 등의 프탈로시아닌 화합물 또는 Advanced Material, 6, p.677(1994)에 기재되어 있는 스타버스트형 아민 유도체류인 TCTA, m-MTDATA, m-MTDAPB, 2-TNATA(4,4 ,4 -tris(N-(2-naphtyl)-N-phenylamino)triphenylamine:4,4 ,4 -트리스(N-(나프틸)-N-페닐아미노)트리페닐아민), 용해성이 있는 전도성 고분자인 Pani/DBSA (Polyaniline/Dodecylbenzenesulfonic acid:폴리아닐린/도데실벤젠술폰산) 또는 PEDOT/PSS (Poly(3,4-ethylenedioxythiophene)/Poly(4-styrenesulfonate):폴리(3,4-에틸렌디옥시티오펜)/폴리(4-스티렌술포네이트)), PANI/CSA (Polyaniline/Camphor sulfonicacid:폴리아닐린/캠퍼술폰산) 또는 PANI/PSSOr phthalocyanine compounds such as copper phthalocyanine disclosed in US Pat. No. 4,356,429 or the starburst type amine derivatives described in Advanced Material, 6, p.677 (1994), for example, TCTA, m-MTDATA, m-. MTDAPB, 2-TNATA (4,4,4-tris (N- (2-naphtyl) -N-phenylamino) triphenylamine: 4,4,4-tris (N- (naphthyl) -N-phenylamino) triphenyl Amines), Pani / DBSA (Polyaniline / Dodecylbenzenesulfonic acid: polyaniline / dodecylbenzenesulfonic acid) or PEDOT / PSS (Poly (3,4-ethylenedioxythiophene) / Poly (4-styrenesulfonate): poly (3, 4-ethylenedioxythiophene) / poly (4-styrenesulfonate)), PANI / CSA (Polyaniline / Camphor sulfonicacid: polyaniline / camphorsulfonic acid) or PANI / PSS

(Polyaniline)/Poly(4-styrenesulfonate):폴리아닐린)/폴리(4-스티렌술포네이트)) 등과 같은 공지된 정공주입 물질을 사용할 수 있다.
Known hole injection materials such as (Polyaniline) / Poly (4-styrenesulfonate): polyaniline) / poly (4-styrenesulfonate)) and the like can be used.

상기 정공주입층의 두께는 약 100Å 내지 10000Å, 바람직하게는 100Å 내지 1000Å일 수 있다. 상기 정공주입층의 두께가 100Å 미만인 경우, 정공주입 특성이 저하될 수 있으며, 상기 정공주입층의 두께가 10000Å를 초과하는 경우, 구동전압이 상승할 수 있기 때문이다.The hole injection layer may have a thickness of about 100 kPa to 10000 kPa, preferably 100 kPa to 1000 kPa. This is because when the thickness of the hole injection layer is less than 100 kV, the hole injection characteristic may be lowered, and when the thickness of the hole injection layer exceeds 10000 kV, the driving voltage may increase.

다르게는, 상기 정공주입층은 진공기상증착법에 의해 형성할 수 있다. 구체적인 증착조건은 사용하는 화합물에 따라 다르지만, 일반적인 정공주입층의 형성과 거의 동일한 조건범위 중에서 선택된다. 예를 들어 DNTPD(N,N-bis-[4-(di-m-tolylamino)phenyl]-N,N -diphenylbiphenyl-4,4 -diamine) 등이 사용될 수 있다.Alternatively, the hole injection layer may be formed by vacuum vapor deposition. Although specific deposition conditions depend on the compound used, they are selected from the range of conditions substantially the same as the formation of a general hole injection layer. For example, DNTPD (N, N-bis- [4- (di-m-tolylamino) phenyl] -N, N-diphenylbiphenyl-4,4-diamine) may be used.

다음으로 상기 정공주입층 상부에 진공증착법, 스핀코팅법, 캐스트법, LB법 등과 같은 다양한 방법을 이용하여 정공수송층(HTL)을 형성할 수 있다. 진공증착법 및 스핀팅법에 의하여 정공수송층을 형성하는 경우, 그 증착조건 및 코팅조건은 사용하는 화합물에 따라 다르지만, 일반적으로 정공주입층의 형성과 거의 동일한 조건범위 중에서 선택된다.Next, a hole transport layer (HTL) may be formed on the hole injection layer by using various methods such as vacuum deposition, spin coating, cast, and LB. When the hole transport layer is formed by the vacuum deposition method or the spinning method, the deposition conditions and the coating conditions vary depending on the compound used, but are generally selected from a range of conditions almost the same as that of the formation of the hole injection layer.

상기 정공수송층 물질은 전술한 바와 같은 화학식 A의 화합물을 포함할 수 있다. 또는, 예를 들어, N-페닐카르바졸, 폴리비닐카르바졸 등의 카르바졸 유도체, N,N'-비스(3-메틸페닐)-N,N'-디페닐-[1,1-비페닐]-4,4'-디아민(TPD), N,N'-디(나프탈렌-1-일)-N,N'-디페닐 벤지딘(α-NPD) 등의 방향족 축합환을 가지는 통상적인 아민 유도체 등과 같은 공지된 정공수송 물질을 사용할 수 있다.상기 정공수송층의 두께는 약 50Å 내지 1000Å, 바람직하게는 100Å 내지 600Å일 수 있다. 상기 정공수송층의 두께가 50Å 미만인 경우, 정공수송 특성이 저하될 수 있으며, 상기 정공수송층의 두께가 1000Å를 초과하는 경우, 구동전압이 상승할 수 있기 때문이다.The hole transport layer material may include a compound of formula A as described above. Or, for example, carbazole derivatives, such as N-phenylcarbazole and polyvinylcarbazole, N, N'-bis (3-methylphenyl) -N, N'- diphenyl- [1,1-biphenyl] Conventional amine derivatives having aromatic condensed rings such as -4,4'-diamine (TPD), N, N'-di (naphthalen-1-yl) -N, N'-diphenyl benzidine (? -NPD), and the like The same well-known hole transport material may be used. The hole transport layer may have a thickness of about 50 kPa to 1000 kPa, preferably 100 kPa to 600 kPa. This is because when the thickness of the hole transport layer is less than 50 kV, hole transport characteristics may be degraded, and when the thickness of the hole transport layer exceeds 1000 kW, the driving voltage may increase.

다음으로 상기 정공수송층 상부에 진공증착법, 스핀코팅법, 캐스트법, LB법 등과 같은 방법을 이용하여 발광층(EML)을 형성할 수 있다. 진공증착법 및 스핀코팅법에 의해 발광층을 형성하는 경우, 그 증착조건은 사용하는 화합물에 따라 다르지만, 일반적으로 정공주입층의 형성과 거의 동일한 조건범위 중에서 선택된다.Next, the light emitting layer EML may be formed on the hole transport layer by using a vacuum deposition method, a spin coating method, a cast method, an LB method, or the like. When the light emitting layer is formed by the vacuum deposition method or the spin coating method, the deposition conditions vary depending on the compound used, but are generally selected from the ranges of conditions substantially the same as those of forming the hole injection layer.

상기 발광층은 전술한 바와 같이 본 발명을 따르는 화학식 A의 화합물을 포함할 수 있다. 이 때, 화학식 A의 화합물은 적합한 공지의 호스트 재료와 함께 사용될 수 있거나, 공지의 도펀트 재료와 함께 사용될 수 있다.The light emitting layer may include a compound of formula A according to the present invention as described above. At this time, the compound of formula A may be used with a suitable known host material or may be used with a known dopant material.

상기 화학식 A의 화합물을 단독으로 사용하는 것도 가능하다. 호스트 재료의 경우, 예를 들면, Alq3(tris(8-hydroxy-quinolatealuminium) 또는 CBP(4,4'-N,N'-디카바졸-비페닐), 또는 PVK(폴리(n-비닐카바졸)) 등을 사용할 수 있다.
It is also possible to use the compound of formula A alone. For host materials, for example, Alq3 (tris (8-hydroxy-quinolatealuminium) or CBP (4,4'-N, N'-dicarbazole-biphenyl), or PVK (poly (n-vinylcarbazole) ) Can be used.

도펀트 재료의 경우, 형광 도펀트로서는 이데미츠사(Idemitsu사)에서 구입 가능한 IDE102, IDE105 및 하야시바라사에서 구입 가능한 C545T 등을 사용할 수 있으며, 인광 도펀트로서는 적색 인광 도펀트 PtOEP, UDC사의 RD61, 녹색 인광 도판트 Ir(PPy)3(PPy=2-phenylpyridine), 청색 인광 도펀트인 F2Irpic, UDC사의 적색 인광 도펀트 RD 61 등을 사용할 수 있다. MQD(N-methylquinacridone), 쿠마린(Coumarine)유도체 등도 사용할 수 있다.In the case of the dopant material, IDE102, IDE105, and C545T, available from Hayashibara Corp., can be used as fluorescent dopants, and red phosphorescent dopants PtOEP, RD61 from UDC, green phosphorescent dopants Ir, etc. can be used. (PPy) 3 (PPy = 2-phenylpyridine), F2Irpic which is a blue phosphorescent dopant, red phosphorescent dopant RD 61 by UDC, etc. can be used. MQD (N-methylquinacridone), coumarin (Coumarine) derivative, etc. can also be used.

도핑 농도는 특별히 제한 되지 않으나 통상적으로 호스트100 중량부를 기준으로 하여 상기 도펀트의 함량은 0.01 ~ 15 중량부이다.상기 발광층의 두께는 약 100Å 내지 1000Å, 바람직하게는 200Å 내지 600Å일 수 있다.The doping concentration is not particularly limited, but the content of the dopant is generally 0.01 to 15 parts by weight based on 100 parts by weight of the host. The thickness of the light emitting layer may be about 100 kPa to 1000 kPa, preferably 200 kPa to 600 kPa.

상기 발광층의 두께가 100Å 미만인 경우, 발광 특성이 저하될 수 있으며, 상기 발광층의 두께가 1000Å를 초과하는 경우, 구동전압이 상승할 수 있기 때문이다.This is because, when the thickness of the light emitting layer is less than 100 kW, the light emission characteristics may be reduced, and when the thickness of the light emitting layer exceeds 1000 kW, the driving voltage may increase.

발광층에 발광 화합물이 인광 도펀트와 함께 사용할 경우에는 삼중항 여기자 또는 정공이 전자수송층으로 확산되는 현상을 방지하기 위하여, 상기 발광층 상부에 진공증착법, 스핀코팅법, 캐스트법, LB법 등과 같은 방법을 이용하여 정공저지층(HBL)을 형성할 수 있다. 진공증착법 및 스핀코팅법에 의해 정공저지층을 형성하는 경우, 그 조건은 사용하는 화합물에 따라 다르지만, 일반적으로 정공주입층의 형성과 거의 동일한 조건범위 중에서 선택된다. 사용가능한 공지의 정공저지재료, 예를 들면 옥사디아졸 유도체나 트리아졸 유도체, 페난트롤린 유도체, BCP 등을 들 수 있다.When a light emitting compound is used with a phosphorescent dopant in the light emitting layer, a method such as vacuum deposition, spin coating, cast method, LB method, etc. is used on the light emitting layer to prevent the triplet excitons or holes from diffusing into the electron transport layer. The hole blocking layer HBL can be formed. In the case of forming the hole blocking layer by vacuum deposition or spin coating, the conditions vary depending on the compound used, but are generally selected from the ranges of conditions almost the same as that of forming the hole injection layer. Known hole blocking materials that can be used include, for example, oxadiazole derivatives, triazole derivatives, phenanthroline derivatives, and BCP.

상기 정공저지층의 두께는 약 50Å 내지 1000Å, 바람직하게는 100Å 내지 300Å일 수 있다. 상기 정공저지층의 두께가 50Å 미만인 경우, 정공저지 특성이 저하될 수 있으며, 상기 정공저지층의 두께가 1000Å를 초과하는 경우, 구동전압이 상승할 수 있기 때문이다.상기 정공저지층이 생략될 경우 도 1b에 도시된 구조를 가지는 유기발광 소자가 얻어진다.The hole blocking layer may have a thickness of about 50 kPa to 1000 kPa, preferably 100 kPa to 300 kPa. This is because when the thickness of the hole blocking layer is less than 50 kV, the hole blocking property may be deteriorated, and when the thickness of the hole blocking layer is more than 1000 kV, the driving voltage may increase. The hole blocking layer may be omitted. In this case, an organic light emitting device having the structure shown in FIG. 1B is obtained.

다음으로 전자수송층(ETL)을 진공증착법, 또는 스핀코팅법, 캐스트법 등의 다양한 방법을 이용하여 형성한다.Next, the electron transport layer (ETL) is formed using various methods such as vacuum deposition, spin coating, and casting.

진공증착법 및 스핀코팅법에 의해 전자수송층을 형성하는 경우, 그 조건은 사용하는 화합물에 따라 다르지만, 일반적으로 정공주입층의 형성과 거의 동일한 조건범위 중에서 선택된다. 상기 전자수송층 재료는 전자주입전극(Cathode)로부터 주입된 전자를 안정하게 수송하는 기능을 하는 것으로서 퀴놀린 유도체, 특히 트리스(8-퀴놀리노레이트)알루미늄(Alq3), TAZ, Balq, PBD등과 같은 공지의 재료를 사용할 수도 있다.
When the electron transport layer is formed by the vacuum deposition method or the spin coating method, the conditions vary depending on the compound used, but are generally selected from the ranges of conditions almost the same as that of the formation of the hole injection layer. The electron transport layer material functions to stably transport electrons injected from an electron injection electrode (Cathode), and a quinoline derivative, particularly tris (8-quinolinorate) aluminum (Alq3), TAZ, Balq, PBD and the like are known. Materials may also be used.

상기 전자수송층의 두께는 약 100Å 내지 1000Å, 바람직하게는 200Å 내지 500Å일 수 있다. 상기 전자수송층의 두께가 100Å 미만인 경우, 전자수송 특성이 저하될 수 있으며, 상기 전자수송층의 두께가 1000Å를 초과하는 경우, 구동전압이 상승할 수 있기 때문이다.The electron transport layer may have a thickness of about 100 kPa to 1000 kPa, preferably 200 kPa to 500 kPa. This is because when the thickness of the electron transport layer is less than 100 kV, the electron transport characteristic may be degraded, and when the thickness of the electron transport layer exceeds 1000 kW, the driving voltage may increase.

또한 전자수송층 상부에 음극으로부터 전자의 주입을 용이하게 하는 기능을 가지는 물질인 전자주입층(EIL)이 적층될 수 있으며 이는 특별히 재료를 제한하지 않는다.In addition, an electron injection layer (EIL), which is a material having a function of facilitating injection of electrons from the cathode, may be stacked on the electron transport layer, which does not particularly limit the material.

전자 주입층으로서는 LiF, NaCl, CsF, Li2O, BaO 등과 같은 전자주입층 형성 재료로서 공지된 임의의 물질을 이용할 수 있다. 상기 전자주입층의 증착조건은 사용하는 화합물에 따라 다르지만, 일반적으로 정공주입층의 형성과 거의 동일한 조건범위 중에서 선택된다.As the electron injection layer, any material known as an electron injection layer forming material such as LiF, NaCl, CsF, Li 2 O, BaO or the like can be used. The deposition conditions of the electron injection layer vary depending on the compound used, but are generally selected from the range of conditions almost the same as the formation of the hole injection layer.

상기 전자주입층의 두께는 약 1Å 내지 100Å, 바람직하게는 5Å 내지 50Å일 수 있다. 상기 전자주입층의 두께가 1Å 미만인 경우, 전자주입 특성이 저하될 수 있으며, 상기 전자주입층의 두께가 100Å를 초과하는 경우, 구동전압이 상승할 수 있기 때문이다.The electron injection layer may have a thickness of about 1 kPa to 100 kPa, preferably 5 kPa to 50 kPa. This is because, when the thickness of the electron injection layer is less than 1 kW, the electron injection characteristic may be deteriorated, and when the thickness of the electron injection layer exceeds 100 kW, the driving voltage may increase.

마지막으로 전자주입층 상부에 진공증착법이나 스퍼터링법 등의 방법을 이용하여 제2전극을 형성할 수 있다.Finally, the second electrode may be formed on the electron injection layer by using a vacuum deposition method or a sputtering method.

상기 제2전극은 캐소드(Cathode)로 사용될 수 있다. 상기 제2전극 형성용 금속으로는 낮은 일함수를 가지는 금속, 합금, 전기전도성 화합물 및 이들의 혼합물을 사용할 수 있다. 구체적인 예로서는 리튬(Li), 마그네슘(Mg), 알루미늄(Al), 알루미늄-리튬(Al-Li), 칼슘(Ca), 마그네슘-인듐(Mg-In), 마그네슘-은(Mg-Ag)등을 들 수 있다. 또한 전면 발광소자를 얻기 위하여 ITO, IZO를 사용한 투과형 캐소드를 사용할 수도 있다.The second electrode may be used as a cathode. As the metal for forming the second electrode, a metal, an alloy, an electrically conductive compound having a low work function, and a mixture thereof may be used. Specific examples thereof include lithium (Li), magnesium (Mg), aluminum (Al), aluminum-lithium (Al-Li), calcium (Ca), magnesium-indium (Mg-In), magnesium- . Also, a transmissive cathode using ITO or IZO may be used to obtain a front light emitting element.

본 발명의 다른 구현예에 따르는 유기 전계 발광 화합물은 상기 화학식 A로 표현될 수 있으며, 보다 구체적으로는 상기 화학식 1 내지 185로 표현될 수 있다. 상기 화합물들에 대한 구체적인 내용은 상술한 유기 발과 소자에 대하여 설명한 부분과 동일하다.
The organic electroluminescent compound according to another embodiment of the present invention may be represented by Chemical Formula A, and more specifically, may be represented by Chemical Formulas 1 to 185. Details of the compounds are the same as those described for the above-mentioned organic feet and devices.

이하에서, 본 발명의 합성예 및 실시예를 구체적으로 예시하지만, 본 발명이 하기의 합성예 및 실시예로 한정되는 것은 아니다. 이하의 합성예에서 중간체 화합물은 최종 생성물의 번호에 일련번호를 추가하는 방식으로 표기한다. 예를 들어, 화합물 1은 화합물 [1] 로 상기 화합물의 중간체 화합물은 [1-1] 등으로 표기한다. 본 명세서에서 화학물의 번호는 화학식의 번호로서 표기한다. 예를 들어, 화학식 1로 표시되는 화합물은 화합물 1로 표기한다.
Hereinafter, the synthesis examples and examples of the present invention will be specifically illustrated, but the present invention is not limited to the following synthesis examples and examples. In the following synthesis, the intermediate compound is indicated by adding the serial number to the number of the final product. For example, compound 1 is represented by compound [1], and the intermediate compound of the said compound is described by [1-1] etc. In the present specification, the chemical number is indicated as the chemical formula number. For example, the compound represented by the formula (1) is represented by compound 1.

[합성 예 1] 화합물 [1]의 합성Synthesis Example 1 Synthesis of Compound [1]

Figure pat00016
Figure pat00016

2L 라운드 플라스크에 무수프탈산 50.0g(0.337mol)과 알루미늄클로라이드 112g(0.843mol)을 디클로로메탄 500mL로 교반한다. 1,1-디메틸-1H-실롤 37.0g(0.337mol)을 디클로로메탄 300mL로 녹여 상기의 상온에서 반응액에 적가시킨다. 상온에서 6시간 동안 교반 후 반응액을 정제수 2L에 붓는다. 유기층을 분리하고 포화 소금물 1L로 세척한다. 유기층을 분리하여 무수황산 마그네슘으로 건조 후 여과한다. 여과액을 감압 농축하고 디클로로메탄과 노말-헥산으로 재결정화하여 흰색 고체의 중간체 화합물 [1-1] 51.0g(59%)을 수득하였다.In a 2 L round flask, 50.0 g (0.337 mol) of phthalic anhydride and 112 g (0.843 mol) of aluminum chloride are stirred with 500 mL of dichloromethane. 37.0 g (0.337 mol) of 1,1-dimethyl-1H-silol is dissolved in 300 mL of dichloromethane and added dropwise to the reaction solution at room temperature. After stirring for 6 hours at room temperature, the reaction solution is poured into 2L of purified water. The organic layer is separated and washed with 1 L of saturated brine. The organic layer is separated, dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure and recrystallized with dichloromethane and normal-hexane to give 51.0 g (59%) of the intermediate compound [1-1] as a white solid.

플라스크에 중간체 화합물 [1-1] 50.0g(0.194mol)을 투입하고 폴리인산 300mL로 150℃에서 3시간 동안 교반한다. 반응액을 정제수 3L에 부어 고체화 시킨다. 노란색 고체를 메탄올로 세척하여 중간체 화합물 [1-2] 42.0g (90%)을 수득하였다.50.0 g (0.194 mol) of the intermediate compound [1-1] were added to the flask, and stirred with 300 mL of polyphosphoric acid at 150 ° C. for 3 hours. The reaction solution is poured into 3L of purified water and solidified. The yellow solid was washed with methanol to yield 42.0 g (90%) of the intermediate compound [1-2] .

플라스크에 중간체 화합물 [1-2] 10.0g(41.61mmol)을 무수 테트라히드로퓨란 200mL로 녹이고 0℃에서 리튬알루미늄히드라이드 7.9g(0.208mol) 을 나누어서 천천히 첨가시킨다. 온도를 올려 12시간 동안 환류 교반하고 상온으로 냉각한다. 반응액을 천천히 에탄올에 부어 고체화시킨다. 고체를 여과하고 디클로로메탄과 메탄올로 재결정화하여 흰색고체의 목적화합물[1] 6.5g (74%)을 수득하였다.10.0 g (41.61 mmol) of the intermediate compound [1-2] were dissolved in 200 mL of anhydrous tetrahydrofuran, and 7.9 g (0.208 mol) of lithium aluminum hydride was added slowly at 0 ° C. in a flask. The temperature was raised to reflux for 12 hours and cooled to room temperature. The reaction solution is poured slowly into ethanol to solidify. The solid was filtered and recrystallized with dichloromethane and methanol to give 6.5g (74%) of the target compound [1] as a white solid.

1H NMR (300 MHz, CDCl3):δ 0.65(s, 6H), 5.54(d, 1H), 7.00(d, 1H), 7.60(m, 3H), 7.85(s, 1H), 7.99(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.65 (s, 6H), 5.54 (d, 1H), 7.00 (d, 1H), 7.60 (m, 3H), 7.85 (s, 1H), 7.99 (m , 2H)

MS/FAB : 210(M+)MS / FAB: 210 (M + )

[합성 예 2] 화합물 [2]의 합성Synthesis Example 2 Synthesis of Compound [2]

Figure pat00017
Figure pat00017

플라스크에 브로모벤젠 8.17g(52.01mmol)을 무수 테트라히드로퓨란 100mL로 녹인다. 78℃에서 노말 부틸리튬(2.5몰)용액 20.8mL(52.01mmol)를 천천히 적가 시킨다. 동온도에서 중간체 화합물 [1-2] 5.0g(20.80mol)을 투입하고 상온까지 8시간동안 온도를 올린다. 반응액을 포화암모늄 수용액에 200mL에 붓는다. 유기층을 분리하고 포화 소금물로 세척한다. 유기층을 분리하여 무수황산 마그네슘으로 건조하여 여과한다. 500mL 플라스크에 여과액을 감압 농축한 후 아세트산 200mL로 교반시킨다. 치아인산나트륨 1수화물 22.0g(0.208mol) 과 요오드화칼륨 17.3g(0.104mol)을 첨가하여 12시간 동안 환류교반한다. 상온으로 냉각하고 생성된 고체를 여과한다. 메탄올 100mL로 세척하여 흰색 고체의 목적화합물 [2] 3.9g(51%)을 수득하였다.Dissolve 8.17 g (52.01 mmol) of bromobenzene in 100 mL of anhydrous tetrahydrofuran in a flask. 20.8 mL (52.01 mmol) of normal butyllithium (2.5 mol) solution was slowly added dropwise at 78 ° C. At the same temperature, 5.0 g (20.80 mol) of an intermediate compound [1-2] were added, and the temperature was raised to room temperature for 8 hours. Pour the reaction solution into 200 mL of saturated aqueous ammonium solution. The organic layer is separated and washed with saturated brine. The organic layer is separated, dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure in a 500 mL flask and stirred with 200 mL of acetic acid. 22.0 g (0.208 mol) of sodium phosphate monohydrate and 17.3 g (0.104 mol) of potassium iodide were added and stirred under reflux for 12 hours. Cool to room temperature and filter the resulting solid. Washing with 100 mL of methanol gave 3.9 g (51%) of the title compound [2] as a white solid.

1H NMR (300 MHz, CDCl3):δ 0.64(s, 6H), 5.51(d, 1H), 7.00~7.10(m, 3H), 7.40~7.60(m, 10H), 8.45(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.64 (s, 6H), 5.51 (d, 1H), 7.00 ~ 7.10 (m, 3H), 7.40 ~ 7.60 (m, 10H), 8.45 (m, 2H)

MS/FAB : 362(M+)MS / FAB: 362 (M + )

[합성 예 3] 화합물 [3]의 합성Synthesis Example 3 Synthesis of Compound [3]

Figure pat00018
Figure pat00018

합성예 1, 2 와 동일한 방법으로 1,1-디메틸-1H-실롤, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 목적화합물 [3]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , target compound [3] was obtained using 1,1-dimethyl-1H-silol, naphtho [2,3-c] furan-1,3-dione and bromobenzene. .

1H NMR (300 MHz, CDCl3):δ 0.61(s, 6H), 5.49(d, 1H), 6.99~7.09(m, 3H), 7.39~7.59(m, 10H), 8.05(m, 2H), 8.35(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.61 (s, 6H), 5.49 (d, 1H), 6.99 ~ 7.09 (m, 3H), 7.39 ~ 7.59 (m, 10H), 8.05 (m, 2H) , 8.35 (s, 2H)

MS/FAB : 412(M+)MS / FAB: 412 (M + )

[합성 예 4] 화합물 [4]의 합성Synthesis Example 4 Synthesis of Compound [4]

Figure pat00019
Figure pat00019

합성예 1, 2 와 동일한 방법으로 1,1-디메틸-1H-실롤, 나프토[1,2-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 목적화합물 [4]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , 1,1-dimethyl-1H-silol, naphtho [1,2-c] furan-1,3-dione, and bromobenzene were used to obtain the target compound [4] . .

1H NMR (300 MHz, CDCl3):δ 0.61(s, 6H), 5.55(d, 1H), 6.98~7.05(m, 3H), 7.39~7.55(m, 8H), 7.75~7.95(m, 4H), 8.05(m, 1H), 8.80(m, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.61 (s, 6H), 5.55 (d, 1H), 6.98 ~ 7.05 (m, 3H), 7.39 ~ 7.55 (m, 8H), 7.75 ~ 7.95 (m, 4H), 8.05 (m, 1 H), 8.80 (m, 1 H)

MS/FAB : 412(M+)MS / FAB: 412 (M + )

[합성 예 5] 화합물 [5]의 합성Synthesis Example 5 Synthesis of Compound [5]

Figure pat00020
Figure pat00020

합성예 1, 2 와 동일한 방법으로 1,1-디메틸-1H-실롤, 퓨로[3,4-b]피라진-5,7-디온, 브로모벤젠을 사용하여 목적화합물 [5]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , 1,1-dimethyl-1H-silol, puro [3,4-b] pyrazine-5,7-dione, and bromobenzene were used to obtain the target compound [5] .

1H NMR (300 MHz, CDCl3):δ 0.65(s, 6H), 5.50(d, 1H), 6.99(d, 1H), 7.40~7.59(m, 10H), 8.50(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.65 (s, 6H), 5.50 (d, 1H), 6.99 (d, 1H), 7.40 ~ 7.59 (m, 10H), 8.50 (m, 2H)

MS/FAB : 364(M+)MS / FAB: 364 (M + )

[합성 예 6] 화합물 [6]의 합성Synthesis Example 6 Synthesis of Compound [6]

Figure pat00021
Figure pat00021

합성예 1과동일한방법으로1,1-디메틸-1H-벤조[b]실롤, 무수푸탈산을 사용하여 목적화합물 [6]을수득하였다. Synthesis Example 1 , the desired compound [6] was obtained by using 1,1-dimethyl-1H-benzo [b] silol and futal anhydride in the same manner.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 6H), 7.35(m, 1H), 7.50~7.60(m, 4H), 7.95~8.05(m, 4H), 8.41(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 6H), 7.35 (m, 1H), 7.50 ~ 7.60 (m, 4H), 7.95 ~ 8.05 (m, 4H), 8.41 (s, 1H)

MS/FAB : 260(M+)MS / FAB: 260 (M + )

[합성 예 7] 화합물 [7]의 합성Synthesis Example 7 Synthesis of Compound [7]

Figure pat00022
Figure pat00022

합성예 1, 2 와동일한방법으로1,1-디메틸-1H-벤조[b]실롤, 무수푸탈산, 브로모벤젠을 사용하여 목적화합물 [7]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , target compound [7] was obtained using 1,1-dimethyl-1H-benzo [b] silol, phthalic anhydride, and bromobenzene.

1H NMR (300 MHz, CDCl3):δ 0.65(s, 6H), 7.30~7.55(m, 15H), 7.90(m, 1H), 8.49(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.65 (s, 6H), 7.30 ~ 7.55 (m, 15H), 7.90 (m, 1H), 8.49 (m, 2H)

MS/FAB : 412(M+)MS / FAB: 412 (M + )

[합성 예 8] 화합물 [8]의 합성Synthesis Example 8 Synthesis of Compound [8]

Figure pat00023
Figure pat00023

합성예 1, 2 와동일한방법으로1,1-디메틸-1H-벤조[b]실롤, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 목적화합물 [8]을수득하였다. Synthesis Example 1 1,1-dimethyl-benzo -1H- the second vortex same way [b] silole, using naphtho [2,3-c] furan-1,3-dione, bromobenzene desired compound [8 ] Obtained.

1H NMR (300 MHz, CDCl3):δ 0.63(s, 6H), 7.31~7.63(m, 15H), 7.90(m, 3H), 8.30(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.63 (s, 6H), 7.31 ~ 7.63 (m, 15H), 7.90 (m, 3H), 8.30 (s, 2H)

MS/FAB : 462(M+)MS / FAB: 462 (M + )

[합성 예 9] 화합물 [9]의 합성Synthesis Example 9 Synthesis of Compound [9]

Figure pat00024
Figure pat00024

합성예 1, 2 와동일한방법으로1,1-디메틸-1H-벤조[b]실롤, 나프토[1,2-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 목적화합물 [9]을수득하였다. Synthesis Example 1, the same way 1,1-dimethyl-2 vortex -1H- benzo [b] silole, using naphtho [1,2-c] furan-1,3-dione, bromobenzene target compound [10 ] Obtained.

1H NMR (300 MHz, CDCl3):δ 0.65(s, 6H), 7.30~7.61(m, 13H), 7.70~7.85(m, 5H), 8.05(m, 1H), 8.80(m, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.65 (s, 6H), 7.30 ~ 7.61 (m, 13H), 7.70 ~ 7.85 (m, 5H), 8.05 (m, 1H), 8.80 (m, 1H)

MS/FAB : 462(M+)MS / FAB: 462 (M + )

[합성 예 10] 화합물 [10]의 합성Synthesis Example 10 Synthesis of Compound [10]

Figure pat00025
Figure pat00025

합성예 1, 2 와동일한방법으로1,1-디메틸-1H-벤조[b]실롤, 퓨로[3,4-b]피라진-5,7-디온, 브로모벤젠을 사용하여 목적화합물 [10]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , 1,1-dimethyl-1H-benzo [b] silol, puro [3,4-b] pyrazine-5,7-dione, and bromobenzene were used as target compounds [10] Obtained.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 6H), 7.31~7.60(m, 13H), 7.89(m, 1H), 8.70(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 6H), 7.31 ~ 7.60 (m, 13H), 7.89 (m, 1H), 8.70 (m, 2H)

MS/FAB : 414(M+)MS / FAB: 414 (M + )

[합성 예 11] 화합물 [11]의 합성Synthesis Example 11 Synthesis of Compound [11]

Figure pat00026
Figure pat00026

합성예 1 과동일한방법으로5,5,10,10-테트라메틸-5,10-디히드로실란트렌, 무수말레인산을 사용하여 목적화합물 [11]을수득하였다. In the same manner as in Synthesis Example 1 , target compound [11] was obtained using 5,5,10,10-tetramethyl-5,10-dihydrosilanelene and maleic anhydride.

1H NMR (300 MHz, CDCl3):δ 0.65(s, 12H), 7.45~7.60(m, 6H), 7.95~8.05(m, 4H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.65 (s, 12H), 7.45 ~ 7.60 (m, 6H), 7.95 ~ 8.05 (m, 4H)

MS/FAB : 318(M+)MS / FAB: 318 (M + )

[합성 예 12] 화합물 [12]의 합성Synthesis Example 12 Synthesis of Compound [12]

Figure pat00027
Figure pat00027

합성예 1 과동일한방법으로5,5,10,10-테트라메틸-5,10-디히드로실란트렌, 무수푸탈산을 사용하여 목적화합물 [12]을수득하였다. In the same manner as in Synthesis Example 1 , the target compound [12] was obtained using 5,5,10,10-tetramethyl-5,10-dihydrosilanelene and fuphthalic anhydride.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 7.35~7.60(m, 6H), 7.90(m, 2H), 8.25~8.35(m, 4H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 7.35 ~ 7.60 (m, 6H), 7.90 (m, 2H), 8.25 ~ 8.35 (m, 4H)

MS/FAB : 368(M+)MS / FAB: 368 (M + )

[합성 예 13] 화합물 [13]의 합성Synthesis Example 13 Synthesis of Compound [13]

Figure pat00028
Figure pat00028

합성예 1, 2 와동일한방법으로5,5,10,10-테트라메틸-5,10-디히드로실란트렌, 무수푸탈산, 브로모벤젠을 사용하여 목적화합물 [13]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , the target compound [13] was obtained using 5,5,10,10-tetramethyl-5,10-dihydrosilanelene, anhydrous phthalic anhydride and bromobenzene.

1H NMR (300 MHz, CDCl3):δ 0.65(s, 12H), 7.35~7.59(m, 16H), 7.91(m, 2H), 8.25(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.65 (s, 12H), 7.35 ~ 7.59 (m, 16H), 7.91 (m, 2H), 8.25 (s, 2H)

MS/FAB : 520(M+)MS / FAB: 520 (M + )

[합성 예 14] 화합물 [14]의 합성Synthesis Example 14 Synthesis of Compound [14]

Figure pat00029
Figure pat00029

합성예 1, 2 와동일한방법으로5,5,10,10-테트라메틸-5,10-디히드로실란트렌, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 목적화합물 [14]을수득하였다.5,5,10,10-tetramethyl-5,10-dihydrosilanetrene, naphtho [2,3-c] furan-1,3-dione and bromobenzene in the same manner as in Synthesis Examples 1 and 2 Was used to obtain the target compound [14] .

1H NMR (300 MHz, CDCl3):δ 0.64(s, 12H), 7.36~7.59(m, 16H), 7.90(m, 2H), 8.28~8.32(m, 4H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.64 (s, 12H), 7.36 ~ 7.59 (m, 16H), 7.90 (m, 2H), 8.28 ~ 8.32 (m, 4H)

MS/FAB : 570(M+)MS / FAB: 570 (M + )

[합성 예 15] 화합물 [15]의 합성Synthesis Example 15 Synthesis of Compound [15]

Figure pat00030
Figure pat00030

합성예 1, 2 와동일한방법으로5,5,10,10-테트라메틸-5,10-디히드로실란트렌, 나프토[1,2-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 목적화합물 [15]을수득하였다.5,5,10,10-tetramethyl-5,10-dihydrosilanetrene, naphtho [1,2-c] furan-1,3-dione and bromobenzene in the same manner as in Synthesis Examples 1 and 2 Was used to obtain the target compound [15] .

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 7.35~7.57(m, 15H), 7.85~7.91(m, 3H), 8.15(m, 1H), 8.30(s, 2H), 8.81(m, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 7.35 ~ 7.57 (m, 15H), 7.85 ~ 7.91 (m, 3H), 8.15 (m, 1H), 8.30 (s, 2H) , 8.81 (m, 1 H)

MS/FAB : 570(M+)MS / FAB: 570 (M + )

[합성 예 16] 화합물 [16]의 합성Synthesis Example 16 Synthesis of Compound [16]

Figure pat00031
Figure pat00031

합성예 1, 2 와동일한방법으로5,5,10,10-테트라메틸-5,10-디히드로실란트렌, 퓨로[3,4-b]피리딘-5,7-디온, 브로모벤젠을 사용하여 목적화합물 [16]을수득하였다.5,5,10,10-tetramethyl-5,10-dihydrosilanerene, furo [3,4-b] pyridine-5,7-dione and bromobenzene were used in the same manner as in Synthesis Examples 1 and 2. The desired compound [16] was obtained.

1H NMR (300 MHz, CDCl3):δ 0.65(s, 12H), 7.40~7.61(m, 15H), 8.05(s, 2H), 8.30(m, 1H), 8.79(m, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.65 (s, 12H), 7.40 ~ 7.61 (m, 15H), 8.05 (s, 2H), 8.30 (m, 1H), 8.79 (m, 1H)

MS/FAB : 521(M+)MS / FAB: 521 (M + )

[합성 예 17] 화합물 [17]의 합성Synthesis Example 17 Synthesis of Compound [17]

Figure pat00032
Figure pat00032

합성예 1, 2 와동일한방법으로5,5,10,10-테트라메틸-5,10-디히드로실란트렌, 퓨로[3,4-b]피라진-5,7-디온, 브로모벤젠을 사용하여 목적화합물 [17]을수득하였다.5,5,10,10-tetramethyl-5,10-dihydrosilanetrene, puro [3,4-b] pyrazine-5,7-dione and bromobenzene were used in the same manner as in Synthesis Examples 1 and 2. The target compound [17] was obtained.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 7.39~7.60(m, 14H), 8.00(s, 2H), 8.69(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 7.39 ~ 7.60 (m, 14H), 8.00 (s, 2H), 8.69 (d, 2H)

MS/FAB : 522(M+)MS / FAB: 522 (M + )

[합성 예 18] 화합물 [18]의 합성Synthesis Example 18 Synthesis of Compound [18]

Figure pat00033
Figure pat00033

합성예 1 과 동일한 방법으로 5,5,10,10-테트라메틸-5,10-디히드로실란트렌 과 무수푸탈산을 사용하여 제조한 중간체 화합물[18-1] 50g (0.120mol), 활성화된 아연 78.5g(1.20mol), 수산화 나트륨 48.0g(1.20mol)을 투입하고 디에틸렌글리콜 1.0L 가하여 150℃ 에서 12시간 동안 교반시킨다. 상온으로 냉각시키고 규조토를 사용하여 반응액을 여과한다. 여과액을 정제수 5L 에 붓고 진한 염산으로 산성화시킨다. 생성된 흰색 고체를 여과하여 중간체 화합물 [18-2] 35.3g (73%)을 수득하였다.50 g (0.120 mol) of an intermediate compound [18-1] prepared by using 5,5,10,10-tetramethyl-5,10-dihydrosilanelene and anhydrous phthalic anhydride in the same manner as in Synthesis Example 1 78.5 g (1.20 mol) of zinc and 48.0 g (1.20 mol) of sodium hydroxide were added thereto, and 1.0 L of diethylene glycol was added thereto, followed by stirring at 150 ° C. for 12 hours. Cool to room temperature and filter the reaction solution using diatomaceous earth. The filtrate is poured into 5 L of purified water and acidified with concentrated hydrochloric acid. The resulting white solid was filtered to give 35.3 g (73%) of an intermediate compound [18-2] .

플라스크에 중간체 화합물 [18-2] 35g(86.93mmol)을 투입하고 메탄술폰산 300mL로 상온에서 5시간 동안 교반한다. 반응액을 정제수 3L에 부어 고체화 시킨다. 주황색 고체를 메탄올로 세척하여 중간체 화합물 [18-3] 29.0g (87%)을 수득하였다.35 g (86.93 mmol) of the intermediate compound [18-2] were added to the flask and stirred with 300 mL of methanesulfonic acid at room temperature for 5 hours. The reaction solution is poured into 3L of purified water and solidified. The orange solid was washed with methanol to yield 29.0 g (87%) of the intermediate compound [18-3] .

플라스크에 2-브로모나프탈렌 38.9g(0.188mol)과 마그네슘 4.57g(0.188mol)을 투입하고 무수 테트라히드로퓨란 500mL로 환류교반하여 녹인다. 상온으로 냉각하여 중간체 화합물 [18-3] 29g(75.39mol)을 투입하고 다시 12시간 동안 환류교반시킨다. 반응액을 상온으로 냉각하고 1몰 염산 수용액에 반응액을 붓는다. 유기층을 분리하고 포화 소금물로 세척한다. 유기층 분리하여 무수황산 마그네슘으로 건조하여 여과한다. 여과액을 감압 농축하여 얻은 노란색 고체를 디클로로메탄과 메탄올로 재결정화 하여 노란색 고체의 중간체 화합물 [18-4] 35g (94%)을 수득하였다.38.9 g (0.188 mol) of 2-bromonaphthalene and 4.57 g (0.188 mol) of magnesium are added to the flask, and the mixture is stirred under reflux with 500 mL of anhydrous tetrahydrofuran to dissolve. After cooling to room temperature, 29 g (75.39 mol) of an intermediate compound [18-3] were added, followed by stirring under reflux for 12 hours. Cool the reaction solution to room temperature and pour the reaction solution into 1 mol aqueous hydrochloric acid. The organic layer is separated and washed with saturated brine. The organic layer is separated, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the yellow solid obtained was recrystallized from dichloromethane and methanol to obtain 35 g (94%) of an intermediate compound [18-4] as a yellow solid.

플라스크에 중간체 화합물 [18-4] 35g(70.74mmol)을 N,N-디메틸포름아미드 1L 로 교반한다. 상온에서 N-브로모숙시니미드 13.85g(77.81mmol)을 첨가하여 8시간 교반한다. 반응액에 메탄올을 가하여 생성된 노란색 고체를 여과한다. 고체를 진공 건조하여 중간체 화합물 [18-5] 38g (94%)을 수득하였다.In a flask, 35 g (70.74 mmol) of an intermediate compound [18-4] are stirred with 1 L of N, N-dimethylformamide. 13.85 g (77.81 mmol) of N-bromosuccinimide is added at room temperature, followed by stirring for 8 hours. Methanol is added to the reaction solution, and the resulting yellow solid is filtered. The solid was dried in vacuo to yield 38 g (94%) of the intermediate compound [18-5] .

플라스크에 중간체화합물 [18-5] 38g(66.24mmol)을 무수테트라히드로퓨란 1L 로 녹이고 -78℃의 알곤 분위기에서 노말부틸리튬(2.5몰) 31.8mL(79.48mmol)을 천천히 적가시킨다. 동온도에서 트리메틸보레이트 mL(mmol)을 적가시키고 상온으로 8시간 동안 올린다. 상온에서 1노르말 염산 수용액 1L에 반응액을 붓는다. 유기층을 분리하고 포화 소금물로 세척한다. 유기층 분리하여 무수황산 마그네슘으로 건조하여 여과한다. 여과액을 감압 농축하여 얻은 노란색 고체를 디클로로메탄과 헥산으로 재결정화 하여 미색 고체의 중간체 화합물 [18-6] 30g (84%)을 수득하였다.38 g (66.24 mmol) of the intermediate compound [18-5] were dissolved in 1 L of anhydrous tetrahydrofuran, and 31.8 mL (79.48 mmol) of normal butyllithium (2.5 mol) was slowly added dropwise in an argon atmosphere at -78 ° C. Trimethyl borate mL (mmol) was added dropwise at the same temperature and raised to room temperature for 8 hours. Pour the reaction solution into 1 L of 1N aqueous hydrochloric acid solution at room temperature. The organic layer is separated and washed with saturated brine. The organic layer is separated, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the yellow solid obtained was recrystallized from dichloromethane and hexane to give 30 g (84%) of an intermediate compound [18-6] as an off-white solid.

250mL 둥근바닥플라스크에 중간체 화합물[18-6] 5.0g(9.28mmol), 1-(3-브로모페닐)나프탈렌 2.63g (9.28mmol), 테트라키스(트리페닐포스핀)팔라듐 214mg(0.186mmol), 2몰-탄산나트륨수용액 10mL, 1,4-디옥산 100mL를 가한 후 질소 분위기에서 10시간 동안 환류교반한다. 상온에서 메탄올을 가하여 결정화 시킨다. 고체를 여과하고 디클로로메탄과 메탄올로 재결정화하여 미색고체의 목적화합물 [18] 3.7g(57%)을 수득하였다.Intermediate compound [18-6] 5.0 g (9.28 mmol), 1- (3-bromophenyl) naphthalene 2.63 g (9.28 mmol), tetrakis (triphenylphosphine) palladium 214 mg (0.186 mmol) in a 250 mL round bottom flask 10 mL of 2 mol-sodium carbonate solution and 100 mL of 1,4-dioxane are added thereto, followed by stirring under reflux for 10 hours in a nitrogen atmosphere. Methanol is added at room temperature to crystallize. The solid was filtered and recrystallized from dichloromethane and methanol to obtain 3.7 g (57%) of the title compound [18] as an off-white solid.

1H NMR (300 MHz, CDCl3):δ 0.64(s, 12H), 7.35~7.75(m, 17H), 7.90~8.05(m, 7H), 8.15(m, 2H), 8.40~8.50(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.64 (s, 12H), 7.35 ~ 7.75 (m, 17H), 7.90 ~ 8.05 (m, 7H), 8.15 (m, 2H), 8.40 ~ 8.50 (m, 2H)

MS/FAB : 697(M+)MS / FAB: 697 (M + )

[합성 예 19] 화합물 [19]의 합성Synthesis Example 19 Synthesis of Compound [19]

Figure pat00034
Figure pat00034

합성예 1, 2 와동일한방법으로5,5,10,10-테트라메틸-5,10-디히드로실란트렌, 4-브로모푸탈산 무수물, 브로모벤젠을 사용하여 제조한 중간체 화합물 [19-1] 5.0g (8.34mmol) 과 페닐보론산을 사용하여 합성예 18 에따라 목적화합물 [19] 3.1g(62%)을 제조하였다.Intermediate compound prepared using 5,5,10,10-tetramethyl-5,10-dihydrosilanelene, 4-bromophthalic anhydride and bromobenzene in the same manner as in Synthesis Examples 1 and 2 [19-1 ] 3.1g (62%) of the title compound [19] was prepared according to Synthesis Example 18 using 5.0 g (8.34 mmol) and phenylboronic acid.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 7.40~7.65(m, 20H), 8.00(d, 1H), 8.10(s, 1H), 8.30(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 7.40 ~ 7.65 (m, 20H), 8.00 (d, 1H), 8.10 (s, 1H), 8.30 (s, 2H)

MS/FAB : 596(M+)MS / FAB: 596 (M + )

[합성 예 20] 화합물 [20]의 합성Synthesis Example 20 Synthesis of Compound [20]

Figure pat00035
Figure pat00035

합성예 1, 2 와동일한방법으로5,5,10,10-테트라메틸-5,10-디히드로실란트렌, 4-브로모푸탈산 무수물, 브로모벤젠을 사용하여 제조한 중간체 화합물 [19-1] 5.8g (8.34mmol) 과 페닐보론산을 사용하여 합성예 18 에따라 목적화합물 [20] 3.5g(56%)을 제조하였다.Intermediate compound prepared using 5,5,10,10-tetramethyl-5,10-dihydrosilanelene, 4-bromophthalic anhydride and bromobenzene in the same manner as in Synthesis Examples 1 and 2 [19-1 ] 3.5g (56%) of the target compound [20] was prepared according to Synthesis Example 18 using 5.8 g (8.34 mmol) and phenylboronic acid.

1H NMR (300 MHz, CDCl3):δ 0.65(s, 12H), 7.45~7.62(m, 14H), 7.95~8.10(m, 11H), 8.25(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.65 (s, 12H), 7.45 ~ 7.62 (m, 14H), 7.95 ~ 8.10 (m, 11H), 8.25 (s, 2H)

MS/FAB : 746(M+)MS / FAB: 746 (M + )

[합성 예 21] 화합물 [21]의 합성Synthesis Example 21 Synthesis of Compound [21]

Figure pat00036
Figure pat00036

합성예 1, 2 와동일한방법으로5,5,10,10-테트라메틸-5,10-디히드로실란트렌, 4-브로모푸탈산 무수물, 브로모벤젠을 사용하여 제조한 중간체 화합물 [21-1] 5.0g (6.42mmol) 과 페닐보론산, 2-나프탈렌 보론산을 사용하여 합성예 18 에따라 목적화합물 [21] 2.1g(40%)을 제조하였다.Intermediate compound prepared using 5,5,10,10-tetramethyl-5,10-dihydrosilanelene, 4-bromophthalic anhydride, bromobenzene in the same manner as in Synthesis Examples 1 and 2 [21-1 ] of the desired compound [21] 2.1g (40%) was prepared in accordance with 5.0g (6.42mmol) and phenylboronic acid, synthesized in example 18 using 2-naphthaleneboronic acid.

1H NMR (300 MHz, CDCl3):δ 0.64(s, 12H), 7.35~7.75(m, 19H), 7.85~8.10(m, 13H), 8.25(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.64 (s, 12H), 7.35 ~ 7.75 (m, 19H), 7.85 ~ 8.10 (m, 13H), 8.25 (m, 2H)

MS/FAB : 823(M+)MS / FAB: 823 (M + )

[합성 예 22] 화합물 [22]의 합성Synthesis Example 22 Synthesis of Compound [22]

Figure pat00037
Figure pat00037

100mL 둥근바닥플라스크에 중간체화합물 [19-1] 5.0g(7.14mmol), 디페닐아민 1.45g(8.57mmol), 톨루엔 50mL 를 투입하고 질소분위기에서 팔라듐아세테이트(II) 16mg (0.071mmol), 터트부톡시드나트륨1.03g (10.71mmol), 더트부틸포스핀(50% 톨루엔 용액) 0.07mL (0.0.142mmol)을 첨가하여 10시간동안 환류교반 시킨다. 반응액을 상온으로 냉각시켜 메탄올을 적가한다. 생성된 고체를 여과한다. 상온에서 진공건조하여 미색고체의 목적화합물 [22] 2.9g(51%)을 수득하였다.5.0 g (7.14 mmol) of the intermediate compound [19-1], 1.45 g (8.57 mmol) of diphenylamine, and 50 mL of toluene were added to a 100 mL round bottom flask, and 16 mg (0.071 mmol) of palladium acetate (II) and tert-butoxide were added in a nitrogen atmosphere. Sodium seed 1.03 g (10.71 mmol) and dirt butyl phosphine (50% toluene solution) 0.07 mL (0.0.142 mmol) was added and the mixture was stirred under reflux for 10 hours. The reaction solution is cooled to room temperature and methanol is added dropwise. The resulting solid is filtered. Vacuum drying at room temperature gave 2.9 g (51%) of the title compound [22] as an off-white solid.

1H NMR (300 MHz, CDCl3):δ 0.65(s, 12H), 7.01~7.25(m, 12H), 7.44~7.75(m, 13H), 7.95(m, 2H), 8.25(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.65 (s, 12H), 7.01 ~ 7.25 (m, 12H), 7.44 ~ 7.75 (m, 13H), 7.95 (m, 2H), 8.25 (m, 2H)

MS/FAB : 787(M+)MS / FAB: 787 (M + )

[합성 예 23] 화합물 [23]의 합성Synthesis Example 23 Synthesis of Compound [23]

Figure pat00038
Figure pat00038

합성예 22 와 동일한 방법으로 중간체화합물 [21-1] 5.0g(6.42mmol), 디페닐아민 2.39g(14.12mmol)을 사용하여 목적화합물 [23] 3.5g(57%)을 수득하였다. In the same manner as in Synthesis Example 22 , 3.5 g (57%) of the target compound [23] was obtained using 5.0 g (6.42 mmol) of an intermediate compound [21-1] and 2.39 g (14.12 mmol) of diphenylamine.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 7.03~7.35(m, 25H), 7.55~7.96(m, 11H), 8.28(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 7.03 ~ 7.35 (m, 25H), 7.55 ~ 7.96 (m, 11H), 8.28 (s, 2H)

MS/FAB : 955(M+)MS / FAB: 955 (M + )

[합성 예 24] 화합물 [24]의 합성Synthesis Example 24 Synthesis of Compound [24]

Figure pat00039
Figure pat00039

합성예 18 과 동일한 방법으로 중간체화합물 [18-6] 5.0g(9.28mmol), 2-(3-브로모페닐)-1-페닐-1H-벤조[d]이미다졸3.24g(9.28mmol)을 사용하여 목적화합물 [24] 3.0g(42%)을 수득하였다.3.24 g (9.28 mmol) of intermediate compound [18-6] 5.0 g (9.28 mmol) and 2- (3-bromophenyl) -1-phenyl-1H-benzo [d] imidazole were prepared in the same manner as in Synthesis example 18 . To give 3.0 g (42%) of the title compound [24] .

1H NMR (300 MHz, CDCl3):δ 0.65(s, 12H), 7.20~7.71(m, 21H), 7.90~8.01(m, 5H), 8.25~8.30(m, 3H), 8.49(m, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.65 (s, 12H), 7.20 to 7.71 (m, 21H), 7.90 to 8.01 (m, 5H), 8.25 to 8.30 (m, 3H), 8.49 (m, 1H)

MS/FAB : 762(M+)MS / FAB: 762 (M + )

[합성 예 25] 화합물 [25]의 합성Synthesis Example 25 Synthesis of Compound [25]

Figure pat00040
Figure pat00040

합성예 18 과 동일한 방법으로 중간체화합물 [18-6] 5.0g(9.28mmol), 4-브로모피리딘을 사용하여 목적화합물 [25] 를제조하였다. In the same manner as in Synthesis Example 18 , 5.0 g (9.28 mmol) of the intermediate compound [18-6] and 4-bromopyridine were used to produce the target compound [25] .

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 7.35~7.75(m, 10H), 7.95~8.05(m, 7H), 8.30(m, 2H), 8.70(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 7.35 ~ 7.75 (m, 10H), 7.95 ~ 8.05 (m, 7H), 8.30 (m, 2H), 8.70 (m, 2H)

MS/FAB : 571(M+)MS / FAB: 571 (M + )

[합성 예 26] 화합물 [26]의 합성Synthesis Example 26 Synthesis of Compound [26]

Figure pat00041
Figure pat00041

합성예 18 과 동일한 방법으로 중간체화합물 [18-6] 5.0g(9.28mmol), 6-브로모-2,2'-비피리딘을 사용하여 목적화합물 [26] 를제조하였다. In the same manner as in Synthesis Example 18 , 5.0 g (9.28 mmol) of the intermediate compound [18-6] and 6-bromo-2,2'-bipyridine were used to prepare the target compound [26] .

1H NMR (300 MHz, CDCl3):δ 0.64(s, 12H), 7.01~7.10(m, 2H), 7.34~7.71(m, 12H), 7.90~8.00(m, 5H), 8.28(m, 2H), 8.50(m, 1H), 8.85(m, 1H), 8.99(m, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.64 (s, 12H), 7.01-7.10 (m, 2H), 7.34-7.71 (m, 12H), 7.90-8.00 (m, 5H), 8.28 (m, 2H), 8.50 (m, 1H), 8.85 (m, 1H), 8.99 (m, 1H)

MS/FAB : 648(M+)MS / FAB: 648 (M + )

[합성 예 27] 화합물 [27]의 합성Synthesis Example 27 Synthesis of Compound [27]

Figure pat00042
Figure pat00042

합성예 18 과 동일한 방법으로 중간체화합물 [18-6] 5.0g(9.28mmol), 2-브로모퀴놀린을 사용하여 목적화합물 [27] 를제조하였다. In the same manner as in Synthesis Example 18 , 5.0 g (9.28 mmol) of an intermediate compound [18-6] and 2-bromoquinoline were used to prepare the target compound [27] .

1H NMR (300 MHz, CDCl3):δ 0.67(s, 12H), 7.30~7.50(m, 5H), 7.51~7.60(m, 6H), 7.70~8.10(m, 10H), 8.28(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.67 (s, 12H), 7.30 ~ 7.50 (m, 5H), 7.51 ~ 7.60 (m, 6H), 7.70 ~ 8.10 (m, 10H), 8.28 (m, 2H)

MS/FAB : 621(M+)MS / FAB: 621 (M + )

[합성 예 28] 화합물 [28]의 합성Synthesis Example 28 Synthesis of Compound [28]

Figure pat00043
Figure pat00043

합성예 1 과동일한방법으로5,5-디메틸-5H-디벤조[b,d]실롤, 무수말레인산을 사용하여 목적화합물 [28]을제조하였다. In the same manner as in Synthesis Example 1 , target compound [28] was prepared using 5,5-dimethyl-5H-dibenzo [b, d] silol and maleic anhydride.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 6H), 7.35~7.62(m, 5H), 7.79(m, 1H), 8.00~8.05(m, 3H), 8.39(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 6H), 7.35 ~ 7.62 (m, 5H), 7.79 (m, 1H), 8.00 ~ 8.05 (m, 3H), 8.39 (s, 1H)

MS/FAB : 260(M+)MS / FAB: 260 (M + )

[합성 예 29] 화합물 [29]의 합성Synthesis Example 29 Synthesis of Compound [29]

Figure pat00044
Figure pat00044

합성예 1 과동일한방법으로5,5-디메틸-5H-디벤조[b,d]실롤, 푸탈산무수물을 사용하여 목적화합물 [29]을제조하였다. In the same manner as in Synthesis Example 1 , the target compound [29] was prepared using 5,5-dimethyl-5H-dibenzo [b, d] silol and futal anhydride.

1H NMR (300 MHz, CDCl3):δ 0.65(s, 6H), 7.29~7.61(m, 5H), 7.88~7.95(m, 3H), 8.21~8.30(m, 4H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.65 (s, 6H), 7.29 ~ 7.61 (m, 5H), 7.88 ~ 7.95 (m, 3H), 8.21 ~ 8.30 (m, 4H)

MS/FAB : 310(M+)MS / FAB: 310 (M + )

[합성 예 30] 화합물 [30]의 합성Synthesis Example 30 Synthesis of Compound [30]

Figure pat00045
Figure pat00045

합성예 1, 2 와 동일한 방법으로 5,5-디메틸-5H-디벤조[b,d]실롤, 푸탈산무수물, 브로모벤젠을 사용하여 목적화합물 [30]을제조하였다. In the same manner as in Synthesis Examples 1 and 2 , 5,5-dimethyl-5H-dibenzo [b, d] silol, butyric anhydride, and bromobenzene were used to produce the target compound [30] .

1H NMR (300 MHz, CDCl3):δ 0.64(s, 6H), 7.31~7.63(m, 15H), 7.90(m, 3H), 8.25(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.64 (s, 6H), 7.31 ~ 7.63 (m, 15H), 7.90 (m, 3H), 8.25 (m, 2H)

MS/FAB : 462(M+)MS / FAB: 462 (M + )

[합성 예 31] 화합물 [31]의 합성Synthesis Example 31 Synthesis of Compound [31]

Figure pat00046
Figure pat00046

합성예1 , 2와동일한방법으로5,5-디메닐-5H-디벤조[b,d]실롤, 퓨로[3,4-b]피라진-5,7-디온, 브로모벤젠을 사용하여 노란색 고체의 목적화합물 [31]을수득하였다. Synthesis Example 1 , 2 in the same manner as 5,5-dimenyl-5H-dibenzo [b, d] silol, puro [3,4-b] pyrazine-5,7-dione, bromobenzene The target compound [31] was obtained as a solid.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 6H), 7.33~7.52(m, 12H), 7.61(t, 1H), 7.99(s, 1H), 8.01(s, 1H), 8.74(s, 2H), 8.12~8.18(m, 3H), 8.45(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 6H), 7.33 ~ 7.52 (m, 12H), 7.61 (t, 1H), 7.99 (s, 1H), 8.01 (s, 1H), 8.74 (s, 2H), 8.12-8.18 (m, 3H), 8.45 (d, 1H)

MS/FAB : 464(M+)MS / FAB: 464 (M + )

[합성 예 32] 화합물 [32]의 합성Synthesis Example 32 Synthesis of Compound [32]

Figure pat00047
Figure pat00047

합성예1과동일한방법으로1,1,4,4-테트라메틸-1,4-디히드로실롤[3,2-b]실롤, 무수푸탈산을 사용하여 노란색 고체의 목적화합물 [32]을수득하였다. Synthesis Example 1 Obtained the desired compound as a yellow solid [1] using 1,1,4,4-tetramethyl-1,4-dihydrosilol [3,2-b] silol and fuphthalic anhydride in the same manner as in Synthesis example 1 It was.

1H NMR (300 MHz, CDCl3):δ 0.14(s, 6H), 0.66(s, 6H), 5.20(d, 1H), 6.50(d, 1H), 7.59~7.60(m, 3H), 7.83(s, 1H), 8.00~8.01(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.14 (s, 6H), 0.66 (s, 6H), 5.20 (d, 1H), 6.50 (d, 1H), 7.59 ~ 7.60 (m, 3H), 7.83 (s, 1H), 8.00-8.01 (m, 2H)

MS/FAB : 292(M+)MS / FAB: 292 (M + )

[합성 예 33] 화합물 [33]의 합성Synthesis Example 33 Synthesis of Compound [33]

Figure pat00048
Figure pat00048

합성예1과동일한방법으로1,1,4,4-테트라메틸-1,4-디히드로실롤[3,2-b]실롤, 나프토[2,3-c]퓨란-1,3-디온을 사용하여 노란색 고체의 목적화합물 [33]을수득하였다. Synthesis Example 1 1,1,4,4-tetramethyl-1,4-dihydrosilol [3,2-b] silol and naphtho [2,3-c] furan-1,3-dione in the same manner as in Synthesis example 1 Was obtained to obtain the target compound [33] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 0.14(s, 6H), 0.66(s, 6H), 5.20(d, 1H), 6.50(d, 1H), 7.39~7.40(m, 2H), 7.90~8.00(m, 4H), 8.30(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.14 (s, 6H), 0.66 (s, 6H), 5.20 (d, 1H), 6.50 (d, 1H), 7.39 ~ 7.40 (m, 2H), 7.90 ~ 8.00 (m, 4H), 8.30 (s, 2H)

MS/FAB : 342(M+)MS / FAB: 342 (M + )

[합성 예 34] 화합물 [34]의 합성Synthesis Example 34 Synthesis of Compound [34]

Figure pat00049
Figure pat00049

합성예1 , 2와 동일한 방법으로 1,1,4,4-테트라메틸-1,4-디히드로실롤[3,2-b]실롤, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색 고체의 목적화합물 [34]을수득하였다.1,1,4,4-tetramethyl-1,4-dihydrosilol [3,2-b] silol and naphtho [2,3-c] furan-1,3 in the same manner as in Synthesis Examples 1 and 2 -Dione and bromobenzene were used to obtain the target compound [34] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 0.14(s, 6H), 0.66(s, 6H), 5.20(d, 1H), 6.50(d, 1H), 7.15~7.16(m, 2H), 7.40~7.52(m, 10H), 7.89~7.90(m, 2H), 8.30(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.14 (s, 6H), 0.66 (s, 6H), 5.20 (d, 1H), 6.50 (d, 1H), 7.15 ~ 7.16 (m, 2H), 7.40 ~ 7.52 (m, 10H), 7.89-7.90 (m, 2H), 8.30 (s, 2H)

MS/FAB : 494(M+)MS / FAB: 494 (M + )

[합성 예 35] 화합물 [35]의 합성Synthesis Example 35 Synthesis of Compound [35]

Figure pat00050
Figure pat00050

합성예1과 동일한 방법으로 화합물[35-1], 무수푸탈산을 사용하여 노란색 고체의 목적화합물 [35]을수득하였다. In the same manner as in Synthesis Example 1 , compound [35-1] and the desired compound [35] as a yellow solid were obtained using futal anhydride.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 5.30(d, 1H), 6.90(d, 1H), 7.50(s, 1H), 7.59~7.60(m, 3H), 8.00~8.01(m, 3H), 8.44(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 5.30 (d, 1H), 6.90 (d, 1H), 7.50 (s, 1H), 7.59 ~ 7.60 (m, 3H), 8.00 ~ 8.01 (m, 3H), 8.44 (s, 1H)

MS/FAB : 342(M+)MS / FAB: 342 (M + )

[합성 예 36] 화합물 [36]의 합성Synthesis Example 36 Synthesis of Compound [36]

Figure pat00051
Figure pat00051

합성예1과 동일한 방법으로 화합물[35-1], 나프토[2,3-c]퓨란-1,3-디온을 사용하여 노란색 고체의 목적화합물 [36]을수득하였다. In the same manner as in Synthesis Example 1 , compound [35-1] and naphtho [2,3-c] furan-1,3-dione were used to obtain the target compound [36] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 5.30(d, 1H), 6.90(d, 1H), 7.39~7.40(m, 2H), 7.50(s, 1H), 7.60(s, 1H), 7.90~7.91(m, 2H), 8.23~8.25(m, 2H), 8.31(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 5.30 (d, 1H), 6.90 (d, 1H), 7.39 ~ 7.40 (m, 2H), 7.50 (s, 1H), 7.60 (s, 1H), 7.90-7.91 (m, 2H), 8.23-8.25 (m, 2H), 8.31 (s, 2H)

MS/FAB : 392(M+)MS / FAB: 392 (M + )

[합성 예 37] 화합물 [37]의 합성Synthesis Example 37 Synthesis of Compound [37]

Figure pat00052
Figure pat00052

합성예1 , 2와 동일한 방법으로 화합물[35-1], 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색 고체의 목적화합물 [37]을수득하였다. Using the compound [35-1] , naphtho [2,3-c] furan-1,3-dione and bromobenzene in the same manner as in Synthesis Examples 1 and 2 , the target compound [37] as a yellow solid was obtained. .

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 5.30(d, 1H), 6.90(d, 1H), 7.39~7.41(m, 4H), 7.50~7.52(m, 9H), 7.60(s, 1H), 7.91~7.92(m, 2H), 8.23(s, 1H), 8.25(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 5.30 (d, 1H), 6.90 (d, 1H), 7.39 ~ 7.41 (m, 4H), 7.50 ~ 7.52 (m, 9H) , 7.60 (s, 1H), 7.91 ~ 7.92 (m, 2H), 8.23 (s, 1H), 8.25 (s, 1H)

MS/FAB : 544(M+)MS / FAB: 544 (M + )

[합성 예 38] 화합물 [38]의 합성Synthesis Example 38 Synthesis of Compound [38]

Figure pat00053
Figure pat00053

합성예1과 동일한 방법으로 화합물[38-1], 무수말레인산을 사용하여 노란색 고체의 목적화합물 [38]을수득하였다. In the same manner as in Synthesis Example 1 , compound [38-1] and maleic anhydride were used to obtain the target compound [38] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 7.33(t, 1H), 7.52~7.61(m, 4H), 7.89~7.92(m, 3H), 8.00~8.01(m, 3H), 8.44(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 7.33 (t, 1H), 7.52 ~ 7.61 (m, 4H), 7.89 ~ 7.92 (m, 3H), 8.00 ~ 8.01 (m, 3H), 8.44 (s, 1H)

MS/FAB : 392(M+)MS / FAB: 392 (M + )

[합성 예 39] 화합물 [39]의 합성Synthesis Example 39 Synthesis of Compound [39]

Figure pat00054
Figure pat00054

합성예1과 동일한 방법으로 화합물[38-1], 무수푸탈산, 을 사용하여 노란색 고체의 목적화합물 [39]을수득하였다. In the same manner as in Synthesis Example 1 , the title compound [39] was obtained as a yellow solid using compound [38-1] , butyric anhydride.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 7.33~7.39(m, 3H), 7.52(d, 1H), 7.61(t, 1H), 7.89~7.92(m, 5H), 8.23~8.25(m, 2H), 8.31(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 7.33 ~ 7.39 (m, 3H), 7.52 (d, 1H), 7.61 (t, 1H), 7.89 ~ 7.92 (m, 5H) , 8.23-8.25 (m, 2H), 8.31 (s, 2H)

MS/FAB : 442(M+)MS / FAB: 442 (M + )

[합성 예 40] 화합물 [40]의 합성Synthesis Example 40 Synthesis of Compound [40]

Figure pat00055
Figure pat00055

합성예1 , 2와 동일한 방법으로 화합물[38-1], 무수푸탈산, 브로모벤젠을 사용하여 노란색 고체의 목적화합물 [40]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , compound [38-1] , objective acid [40] of a yellow solid was obtained using broth benzene.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 7.33~7.41(m, 5H), 7.41~7.61(m, 10H), 7.89~7.92(m, 5H), 8.23(s, 1H), 8.25(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 7.33 ~ 7.41 (m, 5H), 7.41 ~ 7.61 (m, 10H), 7.89 ~ 7.92 (m, 5H), 8.23 (s, 1H), 8.25 (s, 1H)

MS/FAB : 594(M+)MS / FAB: 594 (M + )

[합성 예 41] 화합물 [41]의 합성Synthesis Example 41 Synthesis of Compound [41]

Figure pat00056
Figure pat00056

합성예1 , 2, 19와 동일한 방법으로 화합물[38-1], 무수푸탈산, 브로모벤젠, 페닐보론산을 사용하여 노란색 고체의 목적화합물 [41]을수득하였다. In the same manner as in Synthesis Examples 1 , 2, and 19 , compound [38-1] , objective acid [41] of a yellow solid was obtained using phthalic anhydride, bromobenzene, and phenylboronic acid.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 7.33~7.52(m, 17H), 7.60~7.61(m, 2H), 7.89~7.97(m, 4H), 8.13(s, 1H), 8.23(s, 1H), 8.25(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 7.33 ~ 7.52 (m, 17H), 7.60 ~ 7.61 (m, 2H), 7.89-7.97 (m, 4H), 8.13 (s, 1H), 8.23 (s, 1H), 8.25 (s, 1H)

MS/FAB : 670(M+)MS / FAB: 670 (M + )

[합성 예 42] 화합물 [42]의 합성Synthesis Example 42 Synthesis of Compound [42]

Figure pat00057
Figure pat00057

합성예1 , 2, 18와 동일한 방법으로 화합물[38-1], 무수푸탈산, 브로모벤젠, 2-브로모퀴놀린을 사용하여 노란색 고체의 목적화합물 [42]을수득하였다. In the same manner as in Synthesis Examples 1 , 2, and 18 , compound [38-1] , objective acid [42] of a yellow solid was obtained using 2-phthalomonoline and 2-bromoquinoline.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 7.33~7.41(m, 5H), 7.51~7.61(m, 7H), 7.78(t, 1H), 7.89~7.98(m, 6H), 8.06~8.10(m, 2H), 8.23(s, 1H), 8.25(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 7.33-7.41 (m, 5H), 7.51-7.61 (m, 7H), 7.78 (t, 1H), 7.89-7.98 (m, 6H), 8.06-8.10 (m, 2H), 8.23 (s, 1H), 8.25 (s, 1H)

MS/FAB : 645(M+)MS / FAB: 645 (M + )

[합성 예 43] 화합물 [43]의 합성Synthesis Example 43 Synthesis of Compound [43]

Figure pat00058
Figure pat00058

합성예1 , 2, 22와 동일한 방법으로 화합물[43-1], 5-브로모무수푸탈산, 브로모벤젠, 디페닐아민을 사용하여 노란색 고체의 목적화합물 [43]을수득하였다. In the same manner as in Synthesis Example 1 , 2, 22 , compound [43-1] , 5- bromophthalic anhydride, bromobenzene, and diphenylamine were used to obtain the target compound [43] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 7.02~7.09(m, 16H), 7.20~7.24(m, 8H), 7.41~7.52(m, 10H), 7.64(d, 1H), 7.75(d, 1H), 7.92(s, 2H), 8.23(s, 1H), 8.25(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 7.02 ~ 7.09 (m, 16H), 7.20 ~ 7.24 (m, 8H), 7.41 ~ 7.52 (m, 10H), 7.64 (d, 1H), 7.75 (d, 1H), 7.92 (s, 2H), 8.23 (s, 1H), 8.25 (s, 1H)

MS/FAB : 929(M+)MS / FAB: 929 (M + )

[합성 예 44] 화합물 [44]의 합성Synthesis Example 44 Synthesis of Compound [44]

Figure pat00059
Figure pat00059

합성예1 , 2, 19와 동일한 방법으로 화합물[38-1], 5-브로모무수푸탈산, 브로모벤젠, 2,2'-비피리딘-6-일 보론산을 사용하여 노란색 고체의 목적화합물 [44]을수득하였다. Synthesis Example 1 The purpose of the yellow solid using the compound [38-1] , 5-bromo anhydride, bromobenzene, and 2,2'-bipyridin-6-yl boronic acid in the same manner as in Synthesis Example 1 , 2, 19 Compound [44] was obtained.

1H NMR (300 MHz, CDCl3):δ 0.66(s, 12H), 7.08~7.10(m, 2H), 7.33~7.70(m, 15H), 7.89~7.92(m, 3H), 8.00(d, 1H), 8.12(d, 1H), 8.23~8.25(m, 2H), 8.53(d, 1H), 8.64(s, 1H), 8.90(d, 1H), 9.30(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.66 (s, 12H), 7.08-7.10 (m, 2H), 7.33-77.7 (m, 15H), 7.89-7.92 (m, 3H), 8.00 (d, 1H), 8.12 (d, 1H), 8.23-8.25 (m, 2H), 8.53 (d, 1H), 8.64 (s, 1H), 8.90 (d, 1H), 9.30 (d, 1H)

MS/FAB : 749(M+)MS / FAB: 749 (M + )

[합성 예 45] 화합물 [45]의 합성Synthesis Example 45 Synthesis of Compound [45]

Figure pat00060
Figure pat00060

합성예 1과동일한방법으로티오펜, 무수푸탈산을 사용하여 노란색고체의 목적화합물 [45]을수득하였다. Synthesis Example In the same manner as 1 , thiophene and phthalic anhydride were used to obtain the target compound as a yellow solid [45] .

1H NMR (300 MHz, CDCl3):δ 7.65~7.68(m, 3H), 7.76~7.78(m, 2H), 7.86(s, 1H), 8.15(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.65-7.68 (m, 3H), 7.76-7.78 (m, 2H), 7.86 (s, 1H), 8.15 (d, 2H)

MS/FAB : 184(M+)MS / FAB: 184 (M + )

[합성 예 46] 화합물 [46]의 합성Synthesis Example 46 Synthesis of Compound [46]

합성예1 , 2과동일한방법으로티오펜, 무수푸탈산, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [46]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , thiophene, phthalic anhydride and bromobenzene were used to obtain the target compound as a yellow solid [46] .

1H NMR (300 MHz, CDCl3):δ 7.42~7.55(m, 12H), 7.76~7.78(m, 2H), 8.55(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.42-7.55 (m, 12H), 7.76-7.78 (m, 2H), 8.55 (s, 2H)

MS/FAB : 336(M+)MS / FAB: 336 (M + )

[합성 예 47] 화합물 [47]의 합성Synthesis Example 47 Synthesis of Compound [47]

Figure pat00062
Figure pat00062

합성예1 , 2과동일한방법으로티오펜, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [47]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , thiophene, naphtho [2,3-c] furan-1,3-dione, and bromobenzene were used to obtain the target compound [47] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.39~7.52(m, 12H), 7.76~7.78(m, 2H), 7.92(d, 2H), 8.29(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.39-7.52 (m, 12H), 7.76-7.78 (m, 2H), 7.92 (d, 2H), 8.29 (s, 2H)

MS/FAB : 386(M+)MS / FAB: 386 (M + )

[합성 예 48] 화합물 [48]의 합성Synthesis Example 48 Synthesis of Compound [48]

Figure pat00063
Figure pat00063

합성예1 , 2과동일한방법으로티오펜, 나프토[1,2-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [48]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , thiophene, naphtho [1,2-c] furan-1,3-dione, and bromobenzene were used to obtain the target compound [48] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.41~7.52(m, 10H), 7.71~7.82(m, 6H), 8.10(d, 1H), 8.92(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.41 to 7.52 (m, 10H), 7.71 to 7.82 (m, 6H), 8.10 (d, 1H), 8.92 (d, 1H)

MS/FAB : 386(M+)MS / FAB: 386 (M + )

[합성 예 49] 화합물 [49]의 합성Synthesis Example 49 Synthesis of Compound [49]

Figure pat00064
Figure pat00064

합성예1 , 2과동일한방법으로티오펜, 퓨로[3,4-b]피라진-5,7-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [49]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , thiophene, puro [3,4-b] pyrazine-5,7-dione, and bromobenzene were used to obtain the target compound [49] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.41~7.52(m, 10H), 7.76~7.78(m, 2H), 8.73(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.41-7.52 (m, 10H), 7.76-7.78 (m, 2H), 8.73 (d, 2H)

MS/FAB : 338(M+)MS / FAB: 338 (M + )

[합성 예 50] 화합물 [50]의 합성Synthesis Example 50 Synthesis of Compound [50]

Figure pat00065
Figure pat00065

합성예1과동일한방법으로티안스렌, 무수말레인산을 사용하여 노란색고체의 목적화합물 [50]을 수득하였다. In the same manner as in Synthesis Example 1 , the target compound [50] was obtained as yellow solid using thianthrene and maleic anhydride.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 2H), 7.21(d, 2H), 7.40(s, 2H), 7.59~7.60(m, 2H), 8.01(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.00 (m, 2H), 7.21 (d, 2H), 7.40 (s, 2H), 7.59-7.60 (m, 2H), 8.01 (d, 2H)

MS/FAB : 266(M+)MS / FAB: 266 (M + )

[합성 예 51] 화합물 [51]의 합성Synthesis Example 51 Synthesis of Compound [51]

Figure pat00066
Figure pat00066

합성예1과동일한방법으로티안스렌, 무수푸탈산을 사용하여 노란색고체의 목적화합물 [51]을수득하였다. In the same manner as in Synthesis Example 1 , the target compound [51] was obtained as a yellow solid by using thianthrene and futal anhydride.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 2H), 7.21(d, 2H), 7.38~7.39(m, 2H), 7.65(s, 2H), 7.90(d, 2H), 8.30(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.00 (m, 2H), 7.21 (d, 2H), 7.38-7.39 (m, 2H), 7.65 (s, 2H), 7.90 (d, 2H) , 8.30 (s, 2H)

MS/FAB : 316(M+)MS / FAB: 316 (M + )

[합성 예 52] 화합물 [52]의 합성Synthesis Example 52 Synthesis of Compound [52]

Figure pat00067
Figure pat00067

합성예2과동일한방법으로티안스렌, 무수푸탈산, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [52]을수득하였다. In the same manner as in Synthesis Example 2 , the target compound [52] was obtained as a yellow solid using thiansrene, phthalic anhydride, and bromobenzene.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 2H), 7.21(d, 2H), 7.39~7.52(m, 12H),7.64(s, 2H), 7.90(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.00 (m, 2H), 7.21 (d, 2H), 7.39-7.52 (m, 12H), 7.74 (s, 2H), 7.90 (d, 2H)

MS/FAB : 468(M+)MS / FAB: 468 (M + )

[합성 예 53] 화합물 [53]의 합성Synthesis Example 53 Synthesis of Compound [53]

Figure pat00068
Figure pat00068

합성예2과동일한방법으로티안스렌, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [53]을수득하였다. Synthesis Example 2 The same procedure as in Synthesis Example 2 was used to obtain the target compound [53] as a yellow solid using thianthrene, naphtho [2,3-c] furan-1,3-dione, and bromobenzene.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 2H), 7.21(d, 2H), 7.39~7.52(m, 12H), 7.65(s, 2H), 7.92(d, 2H), 8.30(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.00 (m, 2H), 7.21 (d, 2H), 7.39-7.52 (m, 12H), 7.65 (s, 2H), 7.92 (d, 2H) , 8.30 (s, 2H)

MS/FAB : 518(M+)MS / FAB: 518 (M + )

[합성 예 54] 화합물 [54]의 합성Synthesis Example 54 Synthesis of Compound [54]

Figure pat00069
Figure pat00069

합성예2과동일한방법으로티안스렌, 나프토[1,2-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [54]을수득하였다.By the same method as in Example 2 using Tian seuren, naphtho [1,2-c] furan-1,3-dione, bromobenzene, to give the desired compound [54] of a yellow solid.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 2H), 7.21(d, 2H), 7.39~7.51(m, 11H), 7.64(s, 2H), 7.84~7.91(m, 3H), 8.11(d, 1H), 8.92(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.00 (m, 2H), 7.21 (d, 2H), 7.39-7.51 (m, 11H), 7.64 (s, 2H), 7.84-7.91 (m, 3H), 8.11 (d, 1H), 8.92 (d, 1H)

MS/FAB : 518(M+)MS / FAB: 518 (M + )

[합성 예 55] 화합물 [55]의 합성Synthesis Example 55 Synthesis of Compound [55]

Figure pat00070
Figure pat00070

합성예2과동일한방법으로티안스렌, 퓨로[3,4-b]피리딘-5,7-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [55]을수득하였다.Tian the seuren, furo [3,4-b] pyridine-5,7-dione, bromo target compound [55] of the yellow solid using the parent benzene In the same manner as in Synthesis Example 2 was obtained.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 2H), 7.21(d, 2H), 7.41~7.58(m, 13H), 8.35(d, 1H), 8.83(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.00 (m, 2H), 7.21 (d, 2H), 7.41-7.58 (m, 13H), 8.35 (d, 1H), 8.83 (d, 1H)

MS/FAB : 469(M+)MS / FAB: 469 (M + )

[합성 예 56] 화합물 [56]의 합성Synthesis Example 56 Synthesis of Compound [56]

Figure pat00071
Figure pat00071

합성예2과동일한방법으로티안스렌, 퓨로[3,4-b]피라진-5,7-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [56]을수득하였다.By the same method as in Example 2 using Tian seuren, furo [3,4-b] pyrazine-5,7-dione, bromobenzene, to give the desired compound [56] of a yellow solid.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 2H), 7.21(d, 2H), 7.41~7.52(m, 12H), 8.73(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.00 (m, 2H), 7.21 (d, 2H), 7.41-7.52 (m, 12H), 8.73 (d, 2H)

MS/FAB : 470(M+)MS / FAB: 470 (M + )

[합성 예 57] 화합물 [57]의 합성Synthesis Example 57 Synthesis of Compound [57]

Figure pat00072
Figure pat00072

합성예18과동일한방법으로티안스렌, 무수푸탈산, 2-브로모나프탈렌을 사용하여 합성한 중간체화합물[57-1]과 1-(3-브로모페닐)나프탈렌을 사용하여 노란색고체의 목적화합물 [57]을수득하였다. Synthesis Example 18 An intermediate compound [57-1] and 1- (3-bromophenyl) naphthalene, synthesized using thianthrene, phthalic anhydride and 2-bromonaphthalene in the same manner as the target compound of yellow solid. [57] was obtained.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 2H), 7.21(d, 2H), 7.39~7.65(m, 15H), 7.91~8.07(m, 7H), 8.41(d, 1H), 8.55(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.00 (m, 2H), 7.21 (d, 2H), 7.39-7.75 (m, 15H), 7.91-8.07 (m, 7H), 8.41 (d, 1H), 8.55 (d, 1H)

MS/FAB : 644(M+)MS / FAB: 644 (M + )

[합성 예 58] 화합물 [58]의 합성Synthesis Example 58 Synthesis of Compound [58]

Figure pat00073
Figure pat00073

합성예19과동일한방법으로티안스렌, 5-브로모무수푸탈산, 브로모벤젠을 사용하여 합성한 중간체화합물[58-1]과 페닐보론산을 사용하여 노란색고체의 목적화합물 [58]을수득하였다. Synthesis Example 19 An intermediate compound [58-1] synthesized using thiansrene, 5-bromo anhydride and bromobenzene, and a target compound of yellow solid [58] using phenylboronic acid were obtained in the same manner as in Synthesis Example 19. It was.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 2H), 7.21(d, 2H), 7.41~7.65(m, 18H), 7.97(s, 1H), 8.12(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.00 (m, 2H), 7.21 (d, 2H), 7.41-7.75 (m, 18H), 7.97 (s, 1H), 8.12 (s, 1H)

MS/FAB : 544(M+)MS / FAB: 544 (M + )

[합성 예 59] 화합물 [59]의 합성Synthesis Example 59 Synthesis of Compound [59]

Figure pat00074
Figure pat00074

합성예19과동일한방법으로티안스렌, 5-브로모무수푸탈산, 2-브로모나프탈렌을 사용하여 합성한 중간체화합물[59-1]과 나프탈렌-2-닐 보론산을 사용하여 노란색고체의 목적화합물 [59]을수득하였다. Synthesis Example 19 The objective of the yellow solid using the intermediate compound [59-1] and naphthalene-2-yl boronic acid synthesize | combined using thian srene, 5-bromo anhydride, and 2-bromonaphthalene by the same method. Compound [59] was obtained.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 2H), 7.20(d, 2H), 7.58~7.65(m, 12H), 7.72~7.73(m, 3H), 7.92~8.00(m, 10H), 8.13(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.00 (m, 2H), 7.20 (d, 2H), 7.58-7.75 (m, 12H), 7.72-7.73 (m, 3H), 7.92-8.00 ( m, 10H), 8.13 (s, 1H)

MS/FAB : 694(M+)MS / FAB: 694 (M + )

[합성 예 60] 화합물 [60]의 합성Synthesis Example 60 Synthesis of Compound [60]

Figure pat00075
Figure pat00075

합성예21과동일한방법으로 2-브로모티안스렌, 5-브로모무수푸탈산, 2-브로모나프탈렌을 사용하여 합성한 중간체화합물[60-1]과 나프탈렌-2-닐 보론산, 페닐보론산을 사용하여 노란색고체의 목적화합물 [60]을수득하였다. Synthesis Example 21 Intermediate compound [60-1] synthesized using 2-bromothiasene, 5-bromophthalic anhydride and 2-bromonaphthalene in the same manner as in Synthesis Example 21 , naphthalene-2-ylboronic acid, phenylborone An acid was used to obtain the title compound [60] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.22~7.33(m, 3H), 7.41~7.42(m, 1H), 7.51~7.65(m, 16H), 7.72~7.73(m, 3H), 7.93~8.00(m, 10H), 8.13(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.22-7.33 (m, 3H), 7.41-7.42 (m, 1H), 7.51-7.75 (m, 16H), 7.72-7.73 (m, 3H), 7.93- 8.00 (m, 10H), 8.13 (s, 1H)

MS/FAB : 770(M+)MS / FAB: 770 (M + )

[합성 예 61] 화합물 [61]의 합성Synthesis Example 61 Synthesis of Compound [61]

Figure pat00076
Figure pat00076

합성예22과동일한방법으로중간체화합물[59-1]과 디페닐아민을 사용하여 노란색고체의 목적화합물 [61]을수득하였다. In the same manner as in Synthesis Example 22 , the intermediate compound [59-1] and diphenylamine were used to obtain the title compound [61] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 10H), 7.21~7.22(m, 6H), 7.58~7.64(m, 8H), 7.73~7.75(m, 3H), 7.93~7.98(m, 6H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.00 (m, 10H), 7.21-7.22 (m, 6H), 7.58-7.74 (m, 8H), 7.73-7.75 (m, 3H), 7.93- 7.98 (m, 6 H)

MS/FAB : 735(M+)MS / FAB: 735 (M + )

[합성 예 62] 화합물 [62]의 합성Synthesis Example 62 Synthesis of Compound [62]

Figure pat00077
Figure pat00077

합성예22과동일한방법으로중간체화합물[60-1]과 디페닐아민을 사용하여 노란색고체의 목적화합물 [62]을수득하였다. In the same manner as in Synthesis Example 22 , the intermediate compound [60-1] and diphenylamine were used to obtain the title compound [62] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 6.99~7.21(m, 25H), 7.58~7.64(m, 8H), 7.73~7.75(m, 3H), 7.93~7.98(m, 6H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.21 (m, 25H), 7.58-7.74 (m, 8H), 7.73-7.75 (m, 3H), 7.93-7.98 (m, 6H)

MS/FAB : 902(M+)MS / FAB: 902 (M + )

[합성 예 63] 화합물 [63]의 합성Synthesis Example 63 Synthesis of Compound [63]

Figure pat00078
Figure pat00078

합성예18과동일한방법으로중간체화합물[57-1]과 2-(3-브로모페닐)-1-페닐-1H-벤조[d]이미다졸을 사용하여 노란색고체의 목적화합물 [63]을수득하였다. In the same manner as in Synthesis Example 18 , an intermediate compound [57-1] and 2- (3-bromophenyl) -1-phenyl-1H-benzo [d] imidazole were obtained to obtain the target compound as a yellow solid [63] . It was.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 2H), 7.21~7.22(m, 4H), 7.45~7.65(m, 17H), 7.91~8.00(m, 5H), 8.23(d, 1H), 8.54(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.00 (m, 2H), 7.21-7.22 (m, 4H), 7.45-7.75 (m, 17H), 7.91-8.00 (m, 5H), 8.23 ( d, 1H), 8.54 (d, 1H)

MS/FAB : 710(M+)MS / FAB: 710 (M + )

[합성 예 64] 화합물 [64]의 합성Synthesis Example 64 Synthesis of Compound [64]

Figure pat00079
Figure pat00079

합성예18과동일한방법으로중간체화합물[57-1]과 4-브로모피리딘을 사용하여 노란색고체의 목적화합물 [64]을수득하였다. In the same manner as in Synthesis Example 18 , the intermediate compound [57-1] and 4-bromopyridine were used to obtain the target compound [64] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 6.99~7.20(m, 2H), 7.21(d, 2H), 7.37~7.38(m, 2H), 7.58~7.73(m, 6H), 7.91~8.00(m, 7H), 8.75(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99 to 7.20 (m, 2H), 7.21 (d, 2H), 7.37 to 7.38 (m, 2H), 7.58 to 7.73 (m, 6H), 7.91 to 8.00 ( m, 7H), 8.75 (d, 2H)

MS/FAB : 519(M+)MS / FAB: 519 (M + )

[합성 예 65] 화합물 [65]의 합성Synthesis Example 65 Synthesis of Compound [65]

Figure pat00080
Figure pat00080

합성예18과동일한방법으로중간체화합물[57-1]과 6-브로모-2,2'-비피리딘을 사용하여 노란색고체의 목적화합물 [65]을수득하였다. In the same manner as in Synthesis Example 18 , an intermediate compound [57-1] and 6-bromo-2,2'-bipyridine were used to obtain the target compound [65] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 3H), 7.15~7.21(m, 3H), 7.37~7.38(m, 2H), 7.59~7.70(m, 8H), 7.91~8.0(m, 5H), 8.53(d, 1H), 8.78(d, 1H), 8.93(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99 to 7.00 (m, 3H), 7.15 to 7.21 (m, 3H), 7.37 to 7.38 (m, 2H), 7.59 to 7.70 (m, 8H), 7.91 to 8.0 (m, 5H), 8.53 (d, 1H), 8.78 (d, 1H), 8.93 (d, 1H)

MS/FAB : 596(M+)MS / FAB: 596 (M + )

[합성 예 66] 화합물 [66]의 합성Synthesis Example 66 Synthesis of Compound [66]

Figure pat00081
Figure pat00081

합성예18과동일한방법으로중간체화합물[57-1]과 2-브로모퀴놀린을 사용하여 노란색고체의 목적화합물 [66]을수득하였다. In the same manner as in Synthesis Example 18 , the intermediate compound [57-1] and 2-bromoquinoline were used to obtain the title compound [66] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 6.99~7.00(m, 2H), 7.20(d, H), 7.35~7.38(m, 3H), 7.59~7.65(m, 6H), 7.73~7.77(m, 2H), 7.91~8.05(m, 8H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.99-7.00 (m, 2H), 7.20 (d, H), 7.35-7.38 (m, 3H), 7.59-7.75 (m, 6H), 7.73-7.77 ( m, 2H), 7.91-8.05 (m, 8H)

MS/FAB : 569(M+)MS / FAB: 569 (M + )

[합성 예 67] 화합물 [67]의 합성Synthesis Example 67 Synthesis of Compound [67]

Figure pat00082
Figure pat00082

합성예1과동일한방법으로디벤조[b,d]티오펜, 무수말레인산을 사용하여 노란색고체의 목적화합물 [67]을수득하였다. In the same manner as in Synthesis Example 1 , dibenzo [b, d] thiophene and maleic anhydride were used to obtain the target compound [67] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.51~7.54(m, 2H), 7.67~7.68(m, 2H), 7.78(s, 1H), 7.86(s, 1H), 7.98(s, 1H), 8.15(d, 2H), 8.43(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.51-7.54 (m, 2H), 7.67-7.68 (m, 2H), 7.78 (s, 1H), 7.86 (s, 1H), 7.98 (s, 1H) , 8.15 (d, 2H), 8.43 (d, 1H)

MS/FAB : 234(M+)MS / FAB: 234 (M + )

[합성 예 68] 화합물 [68]의 합성Synthesis Example 68 Synthesis of Compound [68]

Figure pat00083
Figure pat00083

합성예1과동일한방법으로디벤조[b,d]티오펜, 무수푸탈산을 사용하여 노란색고체의 목적화합물 [68]을수득하였다. In the same manner as in Synthesis Example 1 , the title compound [68] was obtained using dibenzo [b, d] thiophene and phthalic anhydride.

1H NMR (300 MHz, CDCl3):δ 7.38~7.39(m, 2H), 7.50~7.52(m, 2H), 7.91~7.98(m, 5H), 8.31(s, 2H), 8.43(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.38-7.39 (m, 2H), 7.50-7.52 (m, 2H), 7.91-7.98 (m, 5H), 8.31 (s, 2H), 8.43 (d, 1H)

MS/FAB : 284(M+)MS / FAB: 284 (M + )

[합성 예 69] 화합물 [69]의 합성Synthesis Example 69 Synthesis of Compound [69]

Figure pat00084
Figure pat00084

합성예2과동일한방법으로디벤조[b,d]티오펜, 무수푸탈산, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [69]을수득하였다.Using the dibenzo [b, d] thiophene, anhydrous Fu deoxidation, bromobenzene in the same manner as in Synthesis Example 2, to give the desired compound [69] of a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.39~7.52(m, 14H), 7.91~7.98(m, 5H), 8.43(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.39-7.52 (m, 14H), 7.91-7.98 (m, 5H), 8.43 (d, 1H)

MS/FAB : 436(M+)MS / FAB: 436 (M + )

[합성 예 70] 화합물 [70]의 합성Synthesis Example 70 Synthesis of Compound [70]

Figure pat00085
Figure pat00085

합성예2과동일한방법으로디벤조[b,d]티오펜, 퓨로[3,4-b]피라진-5,7-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [70]을수득하였다. Synthesis Example 2 A yellow solid target compound [70] was obtained using dibenzo [b, d] thiophene, puro [3,4-b] pyrazine-5,7-dione and bromobenzene in the same manner as in Synthesis example 2. .

1H NMR (300 MHz, CDCl3):δ 7.41~7.52(m, 12H), 7.78(s, 1H), 7.86(s, 1H), 7.98(d, 1H), 8.43(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.41-7.52 (m, 12H), 7.78 (s, 1H), 7.86 (s, 1H), 7.98 (d, 1H), 8.43 (d, 1H)

MS/FAB : 438(M+)MS / FAB: 438 (M + )

[합성 예 71] 화합물 [71]의 합성Synthesis Example 71 Synthesis of Compound [71]

Figure pat00086
Figure pat00086

합성예 1과동일한방법으로티에노[3,2-b]티오펜, 무수푸탈산을 사용하여 노란색고체의 목적화합물 [71]을수득하였다. Synthesis Example In the same manner as 1 , thieno [3,2-b] thiophene and phthalic anhydride were used to obtain the target compound [71] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 6.97(d, 1H), 7.20(d, 1H), 7.67~7.68(m, 2H), 7.78(s, 1H), 7.85(s, 1H), 8.16(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.97 (d, 1H), 7.20 (d, 1H), 7.67-77.6 (m, 2H), 7.78 (s, 1H), 7.85 (s, 1H), 8.16 (d, 2H)

MS/FAB : 240(M+)MS / FAB: 240 (M + )

[합성 예 72] 화합물 [72]의 합성Synthesis Example 72 Synthesis of Compound [72]

Figure pat00087
Figure pat00087

합성예 1과동일한방법으로티에노[3,2-b]티오펜, 나프토[2,3-c]퓨란-1,3-디온을 사용하여 노란색고체의 목적화합물 [72]을수득하였다. Synthesis Example In the same manner as 1 , thieno [3,2-b] thiophene and naphtho [2,3-c] furan-1,3-dione were used to obtain the target compound [72] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 6.97(d, 1H), 7.20(d, 1H), 7.39~7.40(m, 2H), 7.91~7.92(m, 4H), 8.31(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.97 (d, 1H), 7.20 (d, 1H), 7.39 ~ 7.40 (m, 2H), 7.91 ~ 7.92 (m, 4H), 8.31 (s, 2H)

MS/FAB : 290(M+)MS / FAB: 290 (M + )

[합성 예 73] 화합물 [73]의 합성Synthesis Example 73 Synthesis of Compound [73]

Figure pat00088
Figure pat00088

합성예 2과동일한방법으로티에노[3,2-b]티오펜, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [73]을수득하였다. Synthesis Example 2 In the same manner, a target compound of yellow solid was obtained using thieno [3,2-b] thiophene, naphtho [2,3-c] furan-1,3-dione, and bromobenzene [73] . It was.

1H NMR (300 MHz, CDCl3):δ 6.97(d, 1H), 7.20(d, 1H), 7.40~7.52(m, 12H), 7.91(d, 2H), 8.31(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.97 (d, 1H), 7.20 (d, 1H), 7.40 ~ 7.52 (m, 12H), 7.91 (d, 2H), 8.31 (s, 2H)

MS/FAB : 442(M+)MS / FAB: 442 (M + )

[합성 예 74] 화합물 [74]의 합성Synthesis Example 74 Synthesis of Compound [74]

Figure pat00089
Figure pat00089

합성예 1과동일한방법으로벤조[1,2-b:4,5-b']디티오펜, 무수푸탈산을 사용하여 노란색고체의 목적화합물 [74]을수득하였다. Synthesis Example In the same manner as in 1 , benzo [1,2-b: 4,5-b '] dithiophene and phthalic anhydride were used to obtain the target compound [74] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.65~7.67(m, 3H), 7.78~7.86(m, 5H), 8.16(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.65-7.76 (m, 3H), 7.78-7.86 (m, 5H), 8.16 (d, 2H)

MS/FAB : 290(M+)MS / FAB: 290 (M + )

[합성 예 75] 화합물 [75]의 합성Synthesis Example 75 Synthesis of Compound [75]

Figure pat00090
Figure pat00090

합성예 1과동일한방법으로벤조[1,2-b:4,5-b']디티오펜, 나프토[2,3-c]퓨란-1,3-디온을 사용하여 노란색고체의 목적화합물 [75]을수득하였다. Synthesis Example 1 In the same manner, the title compound as a yellow solid using benzo [1,2-b: 4,5-b '] dithiophene and naphtho [2,3-c] furan-1,3-dione [75] Obtained.

1H NMR (300 MHz, CDCl3):δ 7.38~7.39(m, 2H), 7.65(d, 1H), 7.78~7.79(m, 2H), 7.86~7.91(m, 5H), 8.31(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.38-7.39 (m, 2H), 7.65 (d, 1H), 7.78-7.79 (m, 2H), 7.86-7.91 (m, 5H), 8.31 (s, 2H)

MS/FAB : 340(M+)MS / FAB: 340 (M + )

[합성 예 76] 화합물 [76]의 합성Synthesis Example 76 Synthesis of Compound [76]

Figure pat00091
Figure pat00091

합성예 2과동일한방법으로벤조[1,2-b:4,5-b']디티오펜, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [76]을수득하였다. Synthesis Example 2 The purpose of the yellow solid using benzo [1,2-b: 4,5-b '] dithiophene, naphtho [2,3-c] furan-1,3-dione and bromobenzene in the same manner Compound [76] was obtained.

1H NMR (300 MHz, CDCl3):δ 7.39~7.51(m, 12H), 7.65(d, 1H), 7.77~7.78(m, 2H), 7.86~7.91(m, 3H), 8.31(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.39 to 7.51 (m, 12H), 7.65 (d, 1H), 7.77 to 7.78 (m, 2H), 7.86 to 7.91 (m, 3H), 8.31 (s, 2H)

MS/FAB : 492(M+)MS / FAB: 492 (M + )

[합성 예 77] 화합물 [77]의 합성Synthesis Example 77 Synthesis of Compound [77]

Figure pat00092
Figure pat00092

합성예 1과동일한방법으로디벤조[1,2-b:4,5-b']디티오펜, 무수말레인산을 사용하여 노란색고체의 목적화합물 [77]을수득하였다. Synthesis Example In the same manner as 1 , dibenzo [1,2-b: 4,5-b '] dithiophene and maleic anhydride were used to obtain the title compound [77] .

1H NMR (300 MHz, CDCl3):δ 7.50~7.52(m, 2H), 7.66~7.67(m, 2H), 7.77(s, 1H), 7.78(s, 1H), 7.84(s, 1H), 7.85(s, 1H), 7.97(s, 1H), 8.16(s, 2H), 8.45(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.50-7.52 (m, 2H), 7.66-7.57 (m, 2H), 7.77 (s, 1H), 7.78 (s, 1H), 7.84 (s, 1H) , 7.85 (s, 1H), 7.97 (s, 1H), 8.16 (s, 2H), 8.45 (d, 1H)

MS/FAB : 340(M+)MS / FAB: 340 (M + )

[합성 예 78] 화합물 [78]의 합성Synthesis Example 78 Synthesis of Compound [78]

Figure pat00093
Figure pat00093

합성예 1과동일한방법으로디벤조[1,2-b:4,5-b']디티오펜, 무수푸탈산을 사용하여 노란색고체의 목적화합물 [78]을수득하였다. Synthesis Example In the same manner as 1 , dibenzo [1,2-b: 4,5-b '] dithiophene and phthalic anhydride were used to obtain the target compound [78] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.38~7.39(m, 2H), 7.50~7.52(m, 2H), 7.78(s, 1H), 7.86(s, 1H), 7.91~7.98(m, 5H), 8.31(s, 2H), 8.45(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.38-7.39 (m, 2H), 7.50-7.52 (m, 2H), 7.78 (s, 1H), 7.86 (s, 1H), 7.91-7.98 (m, 5H), 8.31 (s, 2H), 8.45 (d, 1H)

MS/FAB : 390(M+)MS / FAB: 390 (M + )

[합성 예 79] 화합물 [79]의 합성Synthesis Example 79 Synthesis of Compound [79]

Figure pat00094
Figure pat00094

합성예 2과동일한방법으로디벤조[1,2-b:4,5-b']디티오펜, 무수푸탈산, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [79]을수득하였다. Synthesis Example In the same manner as 2 , dibenzo [1,2-b: 4,5-b '] dithiophene, phthalic anhydride and bromobenzene were used to obtain the title compound [79] .

1H NMR (300 MHz, CDCl3):δ 7.38~7.51(m, 14H), 7.78(s, 1H), 7.86(s, 1H), 7.91~7.98(m, 5H), 8.45(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.38-7.51 (m, 14H), 7.78 (s, 1H), 7.86 (s, 1H), 7.91-7.98 (m, 5H), 8.45 (d, 1H)

MS/FAB : 542(M+)MS / FAB: 542 (M + )

[합성 예 80] 화합물 [80]의 합성Synthesis Example 80 Synthesis of Compound [80]

Figure pat00095
Figure pat00095

합성예 19과동일한방법으로디벤조[1,2-b:4,5-b']디티오펜, 5-브로모무수푸탈산, 브로모벤젠을 사용하여 합성한 중간체화합물[80-1]과 페닐보론산을 사용하여 노란색고체의 목적화합물 [80]을수득하였다. Synthesis Example 19 Intermediate compound [80-1] and phenylborone synthesized using dibenzo [1,2-b: 4,5-b '] dithiophene, 5-bromophthalic anhydride and bromobenzene in the same manner An acid was used to obtain the title compound [80] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.41~7.51(m, 17H), 7.61(d, 1H), 7.78(s, 1H), 7.86(s, 1H), 7.90(s, 1H), 7.90(s, 1H), 7.91(s, 1h), 7.97~7.98(m, 2H), 8.12(s, 1H), 8.45(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.41-7.51 (m, 17H), 7.61 (d, 1H), 7.78 (s, 1H), 7.86 (s, 1H), 7.90 (s, 1H), 7.90 (s, 1H), 7.91 (s, 1h), 7.97-7.98 (m, 2H), 8.12 (s, 1H), 8.45 (d, 1H)

MS/FAB : 618(M+)MS / FAB: 618 (M + )

[합성 예 81] 화합물 [81]의 합성Synthesis Example 81 Synthesis of Compound [81]

Figure pat00096
Figure pat00096

합성예 18과동일한방법으로디벤조[1,2-b:4,5-b']디티오펜, 무수푸탈산, 브로모벤젠을 사용하여 합성한 중간체화합물[81-1]과 2-브로모퀴놀린을 사용하여 노란색고체의 목적화합물 [81]을수득하였다. Synthesis Example 18 In the same manner, the intermediate compound [81-1] and 2-bromoquinoline synthesized using dibenzo [1,2-b: 4,5-b '] dithiophene, anhydrous phthalic anhydride and bromobenzene were synthesized. The desired compound [81] was obtained as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.35~7.60(m, 11H), 7.77~7.78(m, 2H), 7.86(s, 1H), 7.91~7.98(m, 6H), 8.06~8.09(m, 2H), 8.45(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.35-7.60 (m, 11H), 7.77-77.7 (m, 2H), 7.86 (s, 1H), 7.91-7.98 (m, 6H), 8.06-8.09 ( m, 2H), 8.45 (d, 1H)

MS/FAB : 593(M+)MS / FAB: 593 (M + )

[합성 예 82] 화합물 [82]의 합성Synthesis Example 82 Synthesis of Compound

Figure pat00097
Figure pat00097

합성예 19과동일한방법으로중간체화합물[80-1]과 2,2'-비피리딘-6-닐보론산을 사용하여 노란색고체의 목적화합물 [82]을수득하였다. Synthesis Example In the same manner as the 19 , the intermediate compound [80-1] and 2,2'-bipyridine-6-ylboronic acid were used to obtain the target compound of the yellow solid [82] .

1H NMR (300 MHz, CDCl3):δ 7.00(d, 1H), 7.13~7.14(m, 1H), 7.41~7.52(m, 12H), 7.63~7.70(m, 2H), 7.78(s, 1H), 7.86(s, 1H), 7.91(s, 2H), 7.98~8.00(m, 2H), 8.63(s, 1H), 8.78(d, 1H), 8.93(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.00 (d, 1H), 7.13 ~ 7.14 (m, 1H), 7.41 ~ 7.52 (m, 12H), 7.63 ~ 7.70 (m, 2H), 7.78 (s, 1H), 7.86 (s, 1H), 7.91 (s, 2H), 7.98-8.00 (m, 2H), 8.63 (s, 1H), 8.78 (d, 1H), 8.93 (d, 1H)

MS/FAB : 696(M+)MS / FAB: 696 (M + )

[합성 예 83] 화합물 [83]의 합성Synthesis Example 83 Synthesis of Compound [83]

Figure pat00098
Figure pat00098

합성예 1과동일한방법으로디티에노티오펜, 무수푸탈산을 사용하여 노란색고체의 목적화합물 [83]을수득하였다. Synthesis Example In the same manner as 1 , dithienothiophene and futal anhydride were used to obtain the target compound as a yellow solid [83] .

1H NMR (300 MHz, CDCl3):δ 7.09~7.14(m, 2H), 7.68~7.70(m, 2H), 7.82~7.85(m, 2H), 8.14~8.17(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.09 to 7.14 (m, 2H), 7.68 to 7.70 (m, 2H), 7.82 to 7.85 (m, 2H), 8.14 to 8.17 (m, 2H)

MS/FAB : 295(M+)MS / FAB: 295 (M + )

[합성 예 84] 화합물 [84]의 합성Synthesis Example 84 Synthesis of Compound

Figure pat00099
Figure pat00099

합성예1과동일한방법으로디티에노티오펜, 나프토[2,3-c]퓨란-1,3-디온을 사용하여 노란색고체의 목적화합물 [84]을수득하였다. In the same manner as in Synthesis Example 1 , dithienothiophene and naphtho [2,3-c] furan-1,3-dione were used to obtain the target compound [84] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.09~7.14(m, 2H), 7.37~7.41(m, 2H), 7.88~7.92(m, 4H), 8.27~8.30(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.09 ~ 7.14 (m, 2H), 7.37 ~ 7.41 (m, 2H), 7.88 ~ 7.92 (m, 4H), 8.27 ~ 8.30 (m, 2H)

MS/FAB : 345(M+)MS / FAB: 345 (M + )

[합성 예 85] 화합물 [85]의 합성Synthesis Example 85 Synthesis of Compound

Figure pat00100
Figure pat00100

합성예1 , 2과동일한방법으로디티에노티오펜, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [85]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , dithienothiophene, naphtho [2,3-c] furan-1,3-dione, and bromobenzene were used to obtain the target compound [85] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.11~7.15(m, 2H), 7.38~7.53(m, 12H), 7.89~7.91(m, 2H), 8.29~8.32(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.11-7.15 (m, 2H), 7.38-7.53 (m, 12H), 7.89-7.91 (m, 2H), 8.29-8.32 (m, 2H)

MS/FAB : 498(M+)MS / FAB: 498 (M + )

[합성 예 86] 화합물 [86]의 합성Synthesis Example 86 Synthesis of Compound

Figure pat00101
Figure pat00101

합성예1과동일한방법으로화합물[86-1], 무수푸탈산을 사용하여 노란색고체의 목적화합물 [86]을수득하였다. In the same manner as in Synthesis Example 1 , the title compound [86] was obtained using the compound [86-1] and futal anhydride.

1H NMR (300 MHz, CDCl3):δ 7.06~7.09(m, 2H), 7.65~7.68(m, 2H), 7.82~7.85(m, 2H), 8.15~8.19(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.06 to 7.09 (m, 2H), 7.65 to 7.68 (m, 2H), 7.82 to 7.85 (m, 2H), 8.15 to 8.19 (m, 2H)

MS/FAB : 351(M+)MS / FAB: 351 (M + )

[합성 예 87] 화합물 [87]의 합성Synthesis Example 87 Synthesis of Compound [87]

Figure pat00102
Figure pat00102

합성예1과동일한방법으로화합물[86-1], 나프토[2,3-c]퓨란-1,3-디온을 사용하여 노란색고체의 목적화합물 [87]을수득하였다. In the same manner as in Synthesis Example 1 , Compound [86-1] and naphtho [2,3-c] furan-1,3-dione were used to obtain the target compound [87] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.07~7.10(m, 2H), 7.38~7.41(m, 2H), 7.88~7.92(m, 4H), 8.29~8.32(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.07 to 7.10 (m, 2H), 7.38 to 7.41 (m, 2H), 7.88 to 7.72 (m, 4H), 8.29 to 8.32 (m, 2H)

MS/FAB : 401(M+)MS / FAB: 401 (M + )

[합성 예 88] 화합물 [88]의 합성Synthesis Example 88 Synthesis of Compound [88]

Figure pat00103
Figure pat00103

합성예1 , 2과동일한방법으로화합물[86-1], 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [88]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , compound [86-1] , naphtho [2,3-c] furan-1,3-dione, and bromobenzene were used to obtain the title compound [88] . .

1H NMR (300 MHz, CDCl3):δ 7.06~7.09(m, 2H), 7.37~7.53(m, 12H), 7.90~7.93(m, 2H), 8.30~8.33(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.06-7.09 (m, 2H), 7.37-7.53 (m, 12H), 7.90-7.83 (m, 2H), 8.30-8.33 (m, 2H)

MS/FAB : 554(M+)MS / FAB: 554 (M + )

[합성 예 89] 화합물 [89]의 합성Synthesis Example 89 Synthesis of Compound [89]

Figure pat00104
Figure pat00104

합성예1과동일한방법으로화합물[89-1], 무수푸탈산을 사용하여 노란색고체의 목적화합물 [89]을수득하였다. In the same manner as in Synthesis Example 1 , the compound [89-1] and the desired compound [89] as a yellow solid were obtained using futal anhydride.

1H NMR (300 MHz, CDCl3):δ 7.64~7.69(m, 3H), 7.77~7.87(m, 7H), 8.15~8.19(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.64-7.69 (m, 3H), 7.77-7.87 (m, 7H), 8.15-8.19 (m, 2H)

MS/FAB : 340(M+)MS / FAB: 340 (M + )

[합성 예 90] 화합물 [90]의 합성Synthesis Example 90 Synthesis of Compound

Figure pat00105
Figure pat00105

합성예1과동일한방법으로화합물[89-1], 나프토[2,3-c]퓨란-1,3-디온을 사용하여 노란색고체의 목적화합물 [90]을수득하였다. In the same manner as in Synthesis Example 1 , Compound [89-1] and naphtho [2,3-c] furan-1,3-dione were used to obtain the target compound [90] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.38~7.41(m, 2H), 7.74~7.93(m, 10H), 8.30~8.35(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.38-7.41 (m, 2H), 7.74-7.73 (m, 10H), 8.30-8.35 (m, 2H)

MS/FAB : 390(M+)MS / FAB: 390 (M + )

[합성 예 91] 화합물 [91]의 합성Synthesis Example 91 Synthesis of Compound [91]

Figure pat00106
Figure pat00106

합성예1 , 2과동일한방법으로화합물[89-1], 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [91]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , Compound [89-1] , Naphtho [2,3-c] furan-1,3-dione, and bromobenzene were used to obtain the title compound [91] . .

1H NMR (300 MHz, CDCl3):δ 7.37~7.53(m, 12H), 7.76~7.81(m, 4H), 7.84~7.94(m, 4H), 8.30~8.34(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.37 to 7.53 (m, 12H), 7.76 to 7.81 (m, 4H), 7.84 to 7.74 (m, 4H), 8.30 to 8.34 (m, 2H)

MS/FAB : 542(M+)MS / FAB: 542 (M + )

[합성 예 92] 화합물 [92]의 합성Synthesis Example 92 Synthesis of Compound

Figure pat00107
Figure pat00107

합성예1과동일한방법으로셀레노펜, 무수푸탈산을 사용하여 노란색고체의 목적화합물 [92]을수득하였다.Using Selenium nopen anhydride, Fu deoxidized in the same manner as in Synthesis Example 1, to give the desired compound [92] of a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.08~7.11(m, 2H), 7.57~7.60(m, 3H), 8.01~8.05(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.08 to 7.71 (m, 2H), 7.57 to 7.70 (m, 3H), 8.01 to 8.05 (m, 3H)

MS/FAB : 231(M+)MS / FAB: 231 (M + )

[합성 예 93] 화합물 [93]의 합성Synthesis Example 93 Synthesis of Compound [93]

Figure pat00108
Figure pat00108

합성예1 , 2과동일한방법으로셀레노펜, 무수푸탈산, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [93]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , selenofene, phthalic anhydride and bromobenzene were used to obtain the target compound as a yellow solid [93] .

1H NMR (300 MHz, CDCl3):δ 7.05~7.12(m, 4H), 7.43~7.56(m, 10H), 8.54~8.57(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.05 ~ 7.12 (m, 4H), 7.43 ~ 7.56 (m, 10H), 8.54 ~ 8.57 (m, 2H)

MS/FAB : 384(M+)MS / FAB: 384 (M + )

[합성 예 94] 화합물 [94]의 합성Synthesis Example 94 Synthesis of Compound [94]

Figure pat00109
Figure pat00109

합성예1 , 2과동일한방법으로셀레노펜, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [94]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , selenenophene, naphtho [2,3-c] furan-1,3-dione, and bromobenzene were used to obtain the title compound [94] .

1H NMR (300 MHz, CDCl3):δ 7.06~7.11(m, 4H), 7.44~7.53(m, 10H), 7.90~7.93(m, 2H), 8.29~8.32(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.06 ~ 7.11 (m, 4H), 7.44 ~ 7.53 (m, 10H), 7.90 ~ 7.93 (m, 2H), 8.29 ~ 8.32 (m, 2H)

MS/FAB : 434(M+)MS / FAB: 434 (M + )

[합성 예 95] 화합물 [95]의 합성Synthesis Example 95 Synthesis of Compound

Figure pat00110
Figure pat00110

합성예1 , 2과동일한방법으로셀레노펜, 나프토[1,2-c]퓨란-1,3-다이온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [95]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , selenofene, naphtho [1,2-c] furan-1,3-dione, and bromobenzene were used to obtain the target compound [95] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.07~7.13(m, 4H), 7.40~7.49(m, 8H), 7.78~7.84(m, 5H), 8.79~8.80(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.07 to 7.13 (m, 4H), 7.40 to 7.49 (m, 8H), 7.78 to 7.84 (m, 5H), 8.79 to 8.80 (d, 1H)

MS/FAB : 434(M+)MS / FAB: 434 (M + )

[합성 예 96] 화합물 [96]의 합성Synthesis Example 96 Synthesis of Compound

Figure pat00111
Figure pat00111

합성예1 , 2과동일한방법으로셀레노펜, 퓨로[3,4-b]피라진-5,7-다이온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [96]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , selenenophene, puro [3,4-b] pyrazine-5,7-dione, and bromobenzene were used to obtain the title compound [96] .

1H NMR (300 MHz, CDCl3):δ 7.06~7.09(m, 2H), 7.45~7.52(m, 10H), 8.68~8.70(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.06-7.09 (m, 2H), 7.45-7.52 (m, 10H), 8.68-8.70 (m, 2H)

MS/FAB : 386(M+)MS / FAB: 386 (M + )

[합성 예 97] 화합물 [97]의 합성Synthesis Example 97 Synthesis of Compound [97]

Figure pat00112
Figure pat00112

합성예1과동일한방법으로셀레안트렌, 무수말레인산을 사용하여 노란색고체의 목적화합물 [97]을수득하였다.Using the celecoxib not Trenton, maleic anhydride in the same manner as in Synthesis Example 1, to give the desired compound [97] of a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.35~7.42(m, 4H), 7.62~7.69(m, 4H), 7.99~8.02(m, H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.35-7.42 (m, 4H), 7.62-7.69 (m, 4H), 7.99-8.02 (m, H)

MS/FAB : 361(M+)MS / FAB: 361 (M + )

[합성 예 98] 화합물 [98]의 합성Synthesis Example 98 Synthesis of Compound [98]

Figure pat00113
Figure pat00113

합성예1과동일한방법으로셀레안트렌, 무수푸탈산을 사용하여 노란색고체의 목적화합물 [98]을수득하였다.Using the celecoxib not Transistor anhydride, Fu deoxidized in the same manner as in Synthesis Example 1, to give the desired compound [98] of a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.28~7.31(m, 2H), 7.42~7.47(m, 4H), 7.91~7.97(m, 4H), 8.29~8.33(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.28 to 7.31 (m, 2H), 7.42 to 7.47 (m, 4H), 7.91 to 7.97 (m, 4H), 8.29 to 8.33 (m, 2H)

MS/FAB : 411(M+)MS / FAB: 411 (M + )

[합성 예 99] 화합물 [99]의 합성Synthesis Example 99 Synthesis of Compound [99]

Figure pat00114
Figure pat00114

합성예1 , 2과동일한방법으로셀레안트렌, 무수푸탈산, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [99]을수득하였다.Using the Synthesis Example 1, 2 and celecoxib not Transistor anhydride, Fu deoxidation in the same way, bromobenzene, to give the desired compound [99] of a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.30~7.33(m, 2H), 7.41~7.54(m, 14H), 7.92~7.99(m, 4H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.30-7.73 (m, 2H), 7.41-7.54 (m, 14H), 7.92-7.99 (m, 4H)

MS/FAB : 563(M+)MS / FAB: 563 (M + )

[합성 예 100] 화합물 [100]의 합성Synthesis Example 100 Synthesis of Compound [100]

Figure pat00115
Figure pat00115

합성예1 , 2과동일한방법으로셀레안트렌, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [100]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , selenantrene, naphtho [2,3-c] furan-1,3-dione, and bromobenzene were used to obtain the target compound [100] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.29~7.33(m, 2H), 7.42~7.55(m, 14H), 7.88~7.91(m, 4H), 8.30~8.33(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.29 to 7.33 (m, 2H), 7.42 to 7.55 (m, 14H), 7.88 to 7.91 (m, 4H), 8.30 to 8.33 (m, 2H)

MS/FAB : 614(M+)
MS / FAB: 614 (M + )

[합성 예 101] 화합물 [101]의 합성Synthesis Example 101 Synthesis of Compound

Figure pat00116
Figure pat00116

합성예1, 2과동일한방법으로셀레안트렌, 나프토[1,2-c]퓨란-1,3-다이온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [101]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , selenantrene, naphtho [1,2-c] furan-1,3-dione, and bromobenzene were used to obtain the target compound [101] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.30~7.33(m, 2H), 7.40~7.55(m, 13H), 7.83~7.89(m, 4H), 8.10~8.14(m, 2H), 8.92~8.93(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.30-7.73 (m, 2H), 7.40-7.55 (m, 13H), 7.83-7.89 (m, 4H), 8.10-8.14 (m, 2H), 8.92- 8.93 (d, 1 H)

MS/FAB : 614(M+)MS / FAB: 614 (M + )

[합성 예 102] 화합물 [102]의 합성Synthesis Example 102 Synthesis of Compound [102]

Figure pat00117
Figure pat00117

합성예18과동일한방법으로셀레안트렌, 무수푸탈산 2-브로모나프탈렌을 사용하여 얻은 중간체 화합물 [102-1]과 2-(3-브로모페닐)-1-페닐-1H-벤조[d]이미다졸을 사용하여 노란색고체의 목적화합물 [102]을수득하였다. Synthesis Example 18 The intermediate compound [102-1] and 2- (3-bromophenyl) -1-phenyl-1H-benzo [d obtained using selenantrene and 2-bromonaphthalene in the same manner as in Synthesis Example ] Imidazole was used to obtain the target compound [102] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.25~7.31(m, 4H), 7.43~7.59(m, 15H), 7.70~7.74(m, 2H), 7.93~8.01(m, 7H), 8.33~8.37(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.25-7.31 (m, 4H), 7.43-7.59 (m, 15H), 7.70-7.74 (m, 2H), 7.93-8.01 (m, 7H), 8.33- 8.37 (m, 2 H)

MS/FAB : 806(M+)MS / FAB: 806 (M + )

[합성 예 103] 화합물 [103]의 합성Synthesis Example 103 Synthesis of Compound [103]

Figure pat00118
Figure pat00118

합성예18과동일한방법으로중간체화합물[102-1]과 4-브로모피리딘을 사용하여 노란색고체의 목적화합물 [103]을수득하였다. In the same manner as in Synthesis Example 18 , the intermediate compound [102-1] and 4-bromopyridine were used to obtain the target compound [103] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.28~7.31(m, 2H), 7.40~7.46(m, 4H), 7.65~7.71(m, 4H), 7.89~7.99(m, 9H), 8.74~8.77(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.28 to 7.31 (m, 2H), 7.40 to 7.46 (m, 4H), 7.65 to 7.71 (m, 4H), 7.89 to 7.99 (m, 9H), 8.74 to 8.77 (m, 2 H)

MS/FAB : 615(M+)MS / FAB: 615 (M + )

[합성 예 104] 화합물 [104]의 합성Synthesis Example 104 Synthesis of Compound

Figure pat00119
Figure pat00119

합성예18과동일한방법으로중간체화합물[102-1]과6-브로모-2,2'-비피리딘을 사용하여 노란색고체의 목적화합물 [104]을수득하였다. In the same manner as in Synthesis Example 18 , the intermediate compound [102-1] and 6-bromo-2,2'-bipyridine were used to obtain the target compound of the yellow solid [104] .

1H NMR (300 MHz, CDCl3):δ 7.08~7.12(m, 2H), 7.36~7.42(m, 6H), 7.60~7.72(m, 6H), 7.91~8.03(m, 7H), 8.52~8.54(d, 1H), 8.89~8.91(d, 1H), 9.30~9.32(d, 1H), 1 H NMR (300 MHz, CDCl 3 ): δ 7.08 ~ 7.12 (m, 2H), 7.36 ~ 7.42 (m, 6H), 7.60 ~ 7.72 (m, 6H), 7.91 ~ 8.03 (m, 7H), 8.52 ~ 8.54 (d, 1H), 8.89-9.91 (d, 1H), 9.30-9.32 (d, 1H),

MS/FAB : 692(M+)MS / FAB: 692 (M + )

[합성 예 105] 화합물 [105]의 합성Synthesis Example 105 Synthesis of Compound [105]

Figure pat00120
Figure pat00120

합성예18과동일한방법으로중간체화합물[102-1]과 2-브로모퀴놀린을 사용하여 노란색고체의 목적화합물 [105]을수득하였다. In the same manner as in Synthesis Example 18 , the intermediate compound [102-1] and 2-bromoquinoline were used to obtain the target compound [105] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.28~7.32(m, 2H), 7.36~7.43(m, 5H), 7.57~7.62(m, 4H), 7.74~7.77(m, 2H), 7.94~8.15(m, 10H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.28-7.32 (m, 2H), 7.36-7.43 (m, 5H), 7.57-7.72 (m, 4H), 7.74-7.77 (m, 2H), 7.94- 8.15 (m, 10 H)

MS/FAB : 665(M+)MS / FAB: 665 (M + )

[합성 예 106] 화합물 [106]의 합성Synthesis Example 106 Synthesis of Compound [106]

Figure pat00121
Figure pat00121

합성예1과동일한방법으로디벤조[b,d]셀레노펜, 무수말레인산을 사용하여 노란색고체의 목적화합물 [106]을수득하였다.A dibenzo [b, d] Selenium nopen, the target compound [106] of the yellow solid using the maleic anhydride in the same manner as in Synthesis Example 1 was obtained.

1H NMR (300 MHz, CDCl3):δ 7.34~7.38(m, 2H), 7.42~7.48(m, 3H), 7.74~7.79(m, 2H), 8.12~8.19(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.34 to 7.38 (m, 2H), 7.42 to 7.48 (m, 3H), 7.74 to 7.79 (m, 2H), 8.12 to 8.19 (m, 3H)

MS/FAB : 281(M+)MS / FAB: 281 (M + )

[합성 예 107] 화합물 [107]의 합성Synthesis Example 107 Synthesis of Compound [107]

Figure pat00122
Figure pat00122

합성예1과동일한방법으로디벤조[b,d]셀레노펜, 무수푸탈산을 사용하여 노란색고체의 목적화합물 [107]을수득하였다. In the same manner as in Synthesis Example 1 , dibenzo [b, d] selenophene and fuphthalic anhydride were used to obtain the target compound as a yellow solid [107] .

1H NMR (300 MHz, CDCl3):δ 7.35~7.44(m, 5H), 7.84~7.92(m, 4H), 8.16~8.21(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.35-7.44 (m, 5H), 7.84-7.72 (m, 4H), 8.16-8.21 (m, 3H)

MS/FAB : 332(M+)MS / FAB: 332 (M + )

[합성 예 108] 화합물 [108]의 합성Synthesis Example 108 Synthesis of Compound [108]

Figure pat00123
Figure pat00123

합성예1, 2과동일한방법으로디벤조[b,d]셀레노펜, 무수푸탈산, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [108]을수득하였다.A dibenzo [b, d] Selenium nopen anhydride, Fu deoxidation, bromo target compound [108] of the yellow solid using the parent benzene By the same method as in Examples 1 and 2 was obtained.

1H NMR (300 MHz, CDCl3):δ 7.36~7.52(m, 15H), 7.79~7.84(m, 3H), 8.06~8.09(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.36-7.52 (m, 15H), 7.79-7.84 (m, 3H), 8.06-8.09 (m, 2H)

MS/FAB : 484(M+)MS / FAB: 484 (M + )

[합성 예 109] 화합물 [109]의 합성Synthesis Example 109 Synthesis of Compound [109]

Figure pat00124
Figure pat00124

합성예 1, 2과동일한방법으로디벤조[b,d]셀레노펜, 퓨로[3,4-b]파이라진-5,7-다이온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [109]을수득하였다. Synthesis Example 1, 2 Subjected compound of yellow solid using dibenzo [b, d] selenophene, puro [3,4-b] pyrazine-5,7-dione, bromobenzene in the same manner as in Synthesis Examples 1 and 2. [109] ] Obtained.

1H NMR (300 MHz, CDCl3):δ 7.37~7.54(m, 12H), 7.78~7.85(m, 3H), 8.73~8.77(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.37 to 7.54 (m, 12H), 7.78 to 7.85 (m, 3H), 8.73 to 8.77 (m, 2H)

MS/FAB : 486(M+)MS / FAB: 486 (M + )

[합성 예 110] 화합물 [110]의 합성Synthesis Example 110 Synthesis of Compound [110]

Figure pat00125
Figure pat00125

합성예 1과동일한방법으로3a,6a-디하이드로셀레노펜-[3,2-b]셀레노펜, 무수푸탈산을 사용하여 노란색고체의 목적화합물 [110]을수득하였다. In the same manner as in Synthesis Example 1 , the desired compound [110] as a yellow solid was obtained using 3a, 6a-dihydroselenophene- [3,2-b] selenophene and phthalic anhydride.

1H NMR (300 MHz, CDCl3):δ 7.11~7.13(d, 1H), 7.64~7.69(m, 3H), 7.95~8.01(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.11-7.13 (d, 1H), 7.64-7.69 (m, 3H), 7.95-8.01 (m, 3H)

MS/FAB : 335(M+)MS / FAB: 335 (M + )

[합성 예 111] 화합물 [111]의 합성Synthesis Example 111 Synthesis of Compound [111]

Figure pat00126
Figure pat00126

합성예 1과동일한방법으로3a,6a-디하이드로셀레노펜-[3,2-b]셀레노펜, 나프토[2,3-c]퓨란-1,3-디온을 사용하여 노란색고체의 목적화합물 [111]을수득하였다. Synthesis Example 1 The target compound as a yellow solid using 3a, 6a-dihydroselenophene- [3,2-b] selenophene and naphtho [2,3-c] furan-1,3-dione in the same manner as in Synthesis Example 1. [111] was obtained.

1H NMR (300 MHz, CDCl3):δ 7.12~7.14(d, 1H), 7.42~7.46(m, 2H), 7.92~7.99(m, 5H), 8.31~8.36(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.12 to 7.14 (d, 1H), 7.42 to 7.46 (m, 2H), 7.92 to 7.99 (m, 5H), 8.31 to 8.36 (m, 2H)

MS/FAB : 385(M+)MS / FAB: 385 (M + )

[합성 예 112] 화합물 [112]의 합성Synthesis Example 112 Synthesis of Compound [112]

Figure pat00127
Figure pat00127

합성예 1, 2과동일한방법으로3a,6a-디하이드로셀레노펜-[3,2-b]셀레노펜, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [112]을수득하였다.3a, 6a-dihydroselenophene- [3,2-b] selenophene, naphtho [2,3-c] furan-1,3-dione and bromobenzene were used in the same manner as in Synthesis Examples 1 and 2. The desired compound [112] was obtained as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.13~7.18(d, 1H), 7.42~7.53(m, 10H), 7.81~7.87(m, 3H), 8.29~8.32(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.13-7.18 (d, 1H), 7.42-7.73 (m, 10H), 7.81-7.87 (m, 3H), 8.29-8.32 (m, 2H)

MS/FAB : 537(M+)MS / FAB: 537 (M + )

[합성 예 113] 화합물 [113]의 합성Synthesis Example 113 Synthesis of Compound [113]

Figure pat00128
Figure pat00128

합성예 1과동일한방법으로벤조디셀레노펜, 무수푸탈산을 사용하여 노란색고체의 목적화합물 [113]을수득하였다. In the same manner as in Synthesis Example 1 , the target compound [113] was obtained as a yellow solid using benzodiselenophene and phthalic anhydride.

1H NMR (300 MHz, CDCl3):δ 6.70~6.71(d, 1H), 7.18~7.19(d, 1H), 7.41~7.44(m, 2H), 7.63~7.69(m, 3H), 8.16~8.21(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.70-6.71 (d, 1H), 7.18-7.19 (d, 1H), 7.41-7.44 (m, 2H), 7.63-7.69 (m, 3H), 8.16- 8.21 (m, 3H)

MS/FAB : 385(M+)MS / FAB: 385 (M + )

[합성 예 114] 화합물 [114]의 합성Synthesis Example 114 Synthesis of Compound

Figure pat00129
Figure pat00129

합성예 1과동일한방법으로벤조디셀레노펜, 나프토[2,3-c]퓨란-1,3-디온을 사용하여 노란색고체의 목적화합물 [114]을수득하였다. In the same manner as in Synthesis Example 1 , the desired compound [114] as a yellow solid was obtained using benzodiselenophene and naphtho [2,3-c] furan-1,3-dione.

1H NMR (300 MHz, CDCl3):δ 6.69~6.70(d, 1H), 7.18~7.19(d, 1H), 7.38~7.45(m, 4H), 7.95~8.02(m, 3H), 8.17~8.23(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.69 ~ 6.70 (d, 1H), 7.18 ~ 7.19 (d, 1H), 7.38 ~ 7.45 (m, 4H), 7.95 ~ 8.02 (m, 3H), 8.17 ~ 8.23 (m, 3H)

MS/FAB : 435(M+)MS / FAB: 435 (M + )

[합성 예 115] 화합물 [115]의 합성Synthesis Example 115 Synthesis of Compound [115]

Figure pat00130
Figure pat00130

합성예 2과동일한방법으로벤조디셀레노펜, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [115]을수득하였다. In the same manner as in Synthesis Example 2 , benzodiselenophene, naphtho [2,3-c] furan-1,3-dione, and bromobenzene were used to obtain the title compound [115] .

1H NMR (300 MHz, CDCl3):δ 6.71~6.72(d, 1H), 7.19~7.20(d, 1H), 7.45~7.56(m, 14H), 7.88~7.92(m, 2H), 8.25~8.29(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.71-6.72 (d, 1H), 7.19-7.20 (d, 1H), 7.45-7.56 (m, 14H), 7.88-7.72 (m, 2H), 8.25- 8.29 (m, 2 H)

MS/FAB : 587(M+)MS / FAB: 587 (M + )

[합성 예 116] 화합물 [116]의 합성Synthesis Example 116 Synthesis of Compound

Figure pat00131
Figure pat00131

합성예 1과동일한방법으로화합물 [116-1], 무수푸탈산을 사용하여 노란색고체의 목적화합물 [116]을수득하였다. In the same manner as in Synthesis Example 1 , compound [116-1] and the target compound [116] were obtained as yellow solid using futal anhydride.

1H NMR (300 MHz, CDCl3):δ 6.69~6.70(d, 1H), 7.19~7.20(d, 1H), 7.66~7.73(m, 5H), 7.89~7.96(m, 3H), 8.33~8.36(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.69 ~ 6.70 (d, 1H), 7.19 ~ 7.20 (d, 1H), 7.66 ~ 7.73 (m, 5H), 7.89 ~ 7.96 (m, 3H), 8.33 ~ 8.36 (m, 2 H)

MS/FAB : 435(M+)MS / FAB: 435 (M + )

[합성 예 117] 화합물 [117]의 합성Synthesis Example 117 Synthesis of Compound

Figure pat00132
Figure pat00132

합성예 1과동일한방법으로화합물 [116-1], 나프토[2,3-c]퓨란-1,3-디온을 사용하여 노란색고체의 목적화합물 [117]을수득하였다. In the same manner as in Synthesis Example 1 , compound [116-1] and naphtho [2,3-c] furan-1,3-dione were used to obtain the target compound [117] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 6.68~6.70(d, 1H), 7.18~7.19(d, 1H), 7.39~7.44(m, 2H), 7.63~7.68(m, 2H), 7.88~7.94(m, 3H), 7.99~8.03(m, 2H), 8.29~8.25(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.68 ~ 6.70 (d, 1H), 7.18 ~ 7.19 (d, 1H), 7.39 ~ 7.44 (m, 2H), 7.63 ~ 7.68 (m, 2H), 7.88 ~ 7.94 (m, 3H), 7.99-8.03 (m, 2H), 8.29-8.25 (m, 3H)

MS/FAB : 485(M+)MS / FAB: 485 (M + )

[합성 예 118] 화합물 [118]의 합성Synthesis Example 118 Synthesis of Compound [118]

Figure pat00133
Figure pat00133

합성예 1, 2과동일한방법으로화합물 [116-1], 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [118]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , compound [116-1], naphtho [2,3-c] furan-1,3-dione, and bromobenzene were used to obtain the title compound [118] as a yellow solid. .

1H NMR (300 MHz, CDCl3):δ 6.69~6.70(d, 1H), 7.17~7.19(d, 1H), 7.43~7.56(m, 12H), 7.65~7.69(m, 2H), 7.85~7.91(m, 3H), 8.31~8.36(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.69 ~ 6.70 (d, 1H), 7.17 ~ 7.19 (d, 1H), 7.43 ~ 7.56 (m, 12H), 7.65 ~ 7.69 (m, 2H), 7.85 ~ 7.91 (m, 3H), 8.31-8.36 (m, 3H)

MS/FAB : 638(M+)MS / FAB: 638 (M + )

[합성 예 119] 화합물 [119]의 합성Synthesis Example 119 Synthesis of Compound [119]

Figure pat00134
Figure pat00134

합성예 1과동일한방법으로화합물 [119-1], 무수푸탈산을 사용하여 노란색고체의 목적화합물 [119]을수득하였다. In the same manner as in Synthesis Example 1 , compound [119-1] and the desired compound [119] as a yellow solid were obtained using phthalic anhydride.

1H NMR (300 MHz, CDCl3):δ 7.11~7.13(d, 1H), 7.61~7.68(m, 3H), 7.82~7.86(m, 2H), 7.99~8.04(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.11-7.13 (d, 1H), 7.61-7.68 (m, 3H), 7.82-7.86 (m, 2H), 7.99-8.04 (m, 2H)

MS/FAB : 439(M+)MS / FAB: 439 (M + )

[합성 예 120] 화합물 [120]의 합성Synthesis Example 120 Synthesis of Compound [120]

Figure pat00135
Figure pat00135

합성예 1과동일한방법으로화합물 [119-1], 나프토[2,3-c]퓨란-1,3-디온을 사용하여 노란색고체의 목적화합물 [120]을수득하였다. Synthesis Example In the same manner as 1 , compound [119-1] and naphtho [2,3-c] furan-1,3-dione were used to obtain the target compound [120] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.12~7.14(d, 1H), 7.40~7.45(m, 2H), 7.91~8.01(m, 5H), 8.30~8.34(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.12 to 7.14 (d, 1H), 7.40 to 7.45 (m, 2H), 7.91 to 8.01 (m, 5H), 8.30 to 8.34 (m, 2H)

MS/FAB : 489(M+)MS / FAB: 489 (M + )

[합성 예 121] 화합물 [121]의 합성Synthesis Example 121 Synthesis of Compound [121]

Figure pat00136
Figure pat00136

합성예 1, 2과동일한방법으로화합물 [119-1], 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [121]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , compound [119-1], naphtho [2,3-c] furan-1,3-dione, and bromobenzene were used to obtain the target compound [121] as a yellow solid. .

1H NMR (300 MHz, CDCl3):δ 7.11~7.17(m, 3H), 7.42~7.54(m, 10H), 7.82~7.89(m, 3H), 8.30~8.35(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.11 to 7.17 (m, 3H), 7.42 to 7.74 (m, 10H), 7.82 to 7.89 (m, 3H), 8.30 to 8.35 (m, 2H)

MS/FAB : 641(M+)MS / FAB: 641 (M + )

[합성 예 122] 화합물 [122]의 합성Synthesis Example 122 Synthesis of Compound [122]

Figure pat00137
Figure pat00137

합성예 1과동일한방법으로화합물 [122-1], 무수푸탈산을 사용하여 노란색고체의 목적화합물 [122]을수득하였다. Synthesis Example In the same manner as 1 , compound [122-1] and objective compound [122] of yellow solid were obtained using futal anhydride.

1H NMR (300 MHz, CDCl3):δ 7.11~7.13(d, 1H), 7.62~7.70(m, 4H), 7.96~8.02(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.11-7.13 (d, 1H), 7.62-7.70 (m, 4H), 7.96-8.02 (m, 3H)

MS/FAB : 543(M+)MS / FAB: 543 (M + )

[합성 예 123] 화합물 [123]의 합성Synthesis Example 123 Synthesis of Compound [123]

Figure pat00138
Figure pat00138

합성예 1과동일한방법으로화합물 [122-1], 나프토[2,3-c]퓨란-1,3-디온을 사용하여 노란색고체의 목적화합물 [123]을수득하였다. Synthesis Example 1 In the same manner as the compound [122-1] and naphtho [2,3-c] furan-1,3-dione to obtain the target compound [123] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 7.13~7.15(d, 1H), 7.40~7.45(m, 2H), 7.88~7.96(m, 5H), 8.29~8.33(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.13-7.15 (d, 1H), 7.40-7.45 (m, 2H), 7.88-7.96 (m, 5H), 8.29-8.33 (m, 2H)

MS/FAB : 593(M+)MS / FAB: 593 (M + )

[합성 예 124] 화합물 [124]의 합성Synthesis Example 124 Synthesis of Compound [124]

Figure pat00139
Figure pat00139

합성예 1, 2과동일한방법으로화합물 [122-1], 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색고체의 목적화합물 [124]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , Compound [122-1], Naphtho [2,3-c] furan-1,3-dione, and bromobenzene were used to obtain the title compound [124] . .

1H NMR (300 MHz, CDCl3):δ 7.11~7.17(M, 3H), 7.41~7.55(m, 10H), 7.86~7.91(m, 3H), 8.28~8.32(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.11-7.17 (M, 3H), 7.41-7.55 (m, 10H), 7.86-7.91 (m, 3H), 8.28-8.32 (m, 2H)

MS/FAB : 745(M+)MS / FAB: 745 (M + )

[합성 예 125] 화합물 [125]의 합성Synthesis Example 125 Synthesis of Compound

Figure pat00140
Figure pat00140

합성예 1와동일한방법으로1-페닐-1H-필롤, 무수푸탈산을 사용하여 목적화합물 [125]을수득하였다. Synthesis Example In the same manner as in 1, 1-phenyl-1H-pilol and futal anhydride were used to obtain the target compound [125] .

1H NMR (300 MHz, CDCl3):δ 6.92(d, 1H), 7.35~7.57(m, 10H), 8.06(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.92 (d, 1H), 7.35 ~ 7.57 (m, 10H), 8.06 (m, 2H)

MS/FAB : 243(M+)MS / FAB: 243 (M + )

[합성 예 126] 화합물 [126]의 합성Synthesis Example 126 Synthesis of Compound

Figure pat00141
Figure pat00141

합성예 1, 2 와 동일한 방법으로 1-페닐-1H-필롤, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 목적화합물 [126]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , 1-phenyl-1H-pilol, naphtho [2,3-c] furan-1,3-dione, and bromobenzene were used to obtain the target compound [126] .

1H NMR (300 MHz, CDCl3):δ 6.92(d, 1H), 7.29~7.50(m, 18H), 7.81(m, 2H), 8.11(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.92 (d, 1H), 7.29 ~ 7.50 (m, 18H), 7.81 (m, 2H), 8.11 (s, 2H)

MS/FAB : 446(M+)MS / FAB: 446 (M + )

[합성 예 127] 화합물 [127]의 합성Synthesis Example 127 Synthesis of Compound [127]

Figure pat00142
Figure pat00142

합성예 1, 2와동일한방법으로1-페닐-1H-필롤, 나프토[1,2-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 목적화합물 [127]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , the target compound [127] was obtained using 1-phenyl-1H-pilol, naphtho [1,2-c] furan-1,3-dione and bromobenzene.

1H NMR (300 MHz, CDCl3):δ 6.92(d, 1H), 7.31~7.50(m, 16H), 7.61(d, 2H), 7.72~7.78(m, 2H), 8.02(d, 1H), 8.33(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.92 (d, 1H), 7.31 ~ 7.50 (m, 16H), 7.61 (d, 2H), 7.72 ~ 7.78 (m, 2H), 8.02 (d, 1H) , 8.33 (d, 1 H)

MS/FAB : 446(M+)MS / FAB: 446 (M + )

[합성 예 128] 화합물 [128]의 합성Synthesis Example 128 Synthesis of Compound [128]

Figure pat00143
Figure pat00143

합성예 1, 2와동일한방법으로1-페닐-1H-필롤, 푸로[3,4-b]피라진-5,7-디온, 브로모벤젠을 사용하여 목적화합물 [128]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , the target compound [128] was obtained using 1-phenyl-1H-pilol, furo [3,4-b] pyrazine-5,7-dione and bromobenzene.

1H NMR (300 MHz, CDCl3):δ 6.92(d, 1H), 7.31~7.50(m, 16H), 8.35(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.92 (d, 1H), 7.31 ~ 7.50 (m, 16H), 8.35 (d, 2H)

MS/FAB : 398(M+)MS / FAB: 398 (M + )

[합성 예 129] 화합물 [129]의 합성Synthesis Example 129 Synthesis of Compound [129]

Figure pat00144
Figure pat00144

합성예 1와동일한방법으로5,10-디에틸-5,10-디하이트로페나진, 무수말레인산을 사용하여 목적화합물 [129]을수득하였다. Synthesis Example In the same manner as 1 , 5,10-diethyl-5,10-dihytropenazine and maleic anhydride were used to obtain the target compound [129] .

1H NMR (300 MHz, CDCl3):δ 1.25(m, 6H), 3.20(m, 4H), 6.58(d, 2H), 6.78(d, 2H), 7.17(m, 2H), 7.48(m, 4H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.25 (m, 6H), 3.20 (m, 4H), 6.58 (d, 2H), 6.78 (d, 2H), 7.17 (m, 2H), 7.48 (m , 4H)

MS/FAB : 288(M+)MS / FAB: 288 (M + )

[합성 예 130] 화합물 [130]의 합성Synthesis Example 130 Synthesis of Compound [130]

Figure pat00145
Figure pat00145

합성예 1와동일한방법으로5,10-디페닐-5,10-디하이드로페나진, 무수푸탈산을 사용하여 목적화합물 [130]을수득하였다. Synthesis Example In the same manner as in 1 , 5,10-diphenyl-5,10-dihydrophenazine and futal anhydride were used to obtain the target compound [130] .

1H NMR (300 MHz, CDCl3):δ 6.58(d, 2H), 6.66~6.73(m, 6H), 6.91~6.98(m, 4H), 7.10(m, 4H), 7.29(d, 2H), 7.81~7.86(m, 4H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.58 (d, 2H), 6.66 ~ 6.73 (m, 6H), 6.91 ~ 6.98 (m, 4H), 7.10 (m, 4H), 7.29 (d, 2H) , 7.81-7.86 (m, 4H)

MS/FAB : 435(M+)MS / FAB: 435 (M + )

[합성 예 131] 화합물 [131]의 합성Synthesis Example 131 Synthesis of Compound [131]

Figure pat00146
Figure pat00146

합성예 1, 2와동일한방법으로5,10-디페닐-5,10-디하이드로페나진, 무수푸탈산, 브로모벤젠을 사용하여 목적화합물 [131]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , target compound [131] was obtained using 5,10-diphenyl-5,10-dihydrophenazine, anhydrous phthalic anhydride, and bromobenzene.

1H NMR (300 MHz, CDCl3):δ 6.58(d, 2H), 6.66~6.73(m, 6H), 6.91~6.97(m, 4H), 7.10(m, 4H), 7.29~7.42(m, 12H), 7.51(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.58 (d, 2H), 6.66-6.73 (m, 6H), 6.91-6.97 (m, 4H), 7.10 (m, 4H), 7.29-7.42 (m, 12H), 7.51 (d, 2H)

MS/FAB : 587(M+)MS / FAB: 587 (M + )

[합성 예 132] 화합물 [132]의 합성Synthesis Example 132 Synthesis of Compound

Figure pat00147
Figure pat00147

합성예 1, 2와동일한방법으로5,10-디페닐-5,10-디하이드로페나진, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 목적화합물 [132]을수득하였다.5,10-diphenyl-5,10-dihydrophenazine, naphtho [2,3-c] furan-1,3-dione and bromobenzene in the same manner as in Synthesis Examples 1 and 2 [132] obtained.

1H NMR (300 MHz, CDCl3):δ 6.58(d, 2H), 6.66~6.73(m, 6H), 6.91~6.97(m, 4H), 7.10(m, 4H), 7.29~7.41(m, 12H), 7.61(d, 2H), 8.01(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.58 (d, 2H), 6.66-6.73 (m, 6H), 6.91-6.97 (m, 4H), 7.10 (m, 4H), 7.29-7.41 (m, 12H), 7.61 (d, 2H), 8.01 (s, 2H)

MS/FAB : 637(M+)MS / FAB: 637 (M + )

[합성 예 133] 화합물 [133]의 합성Synthesis Example 133 Synthesis of Compound [133]

Figure pat00148
Figure pat00148

합성예 1, 2와동일한방법으로5,10-디페닐-5,10-디하이드로페나진, 푸로[3,4-b]피라진-5,7-디온, 브로모벤젠을 사용하여 목적화합물 [133]을수득하였다.Using the Synthesis Examples 1 and 2 worked as a vortex method 5,10- diphenyl -5,10- dihydro-phenazine, furo [3,4-b] pyrazine-5,7-dione, bromobenzene object compound [ 133] .

1H NMR (300 MHz, CDCl3):δ 6.58(d, 2H), 6.66~6.74(m, 8H), 6.91(t, 2H), 7.10(m, 4H), 7.31~7.42(m, 10H), 8.33(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.58 (d, 2H), 6.66 ~ 6.74 (m, 8H), 6.91 (t, 2H), 7.10 (m, 4H), 7.31 ~ 7.42 (m, 10H) , 8.33 (d, 2 H)

MS/FAB : 589(M+)MS / FAB: 589 (M + )

[합성 예 134] 화합물 [134]의 합성Synthesis Example 134 Synthesis of Compound

Figure pat00149
Figure pat00149

합성예 1, 2와동일한방법으로5,10-디페닐-5,10-디하이드로페나진, 5-브로모무수푸탈산, 2-브로모나프탈렌을 사용하여 합성한 중간체 화합물 [134-1]과디페닐아민을사용하여합성예22와동일한방법으로목적화합물[134]을수득하였다.Intermediate compound synthesized using 5,10-diphenyl-5,10-dihydrophenazine, 5-bromophthalic anhydride and 2-bromonaphthalene in the same manner as in Synthesis Examples 1 and 2 [134-1] Using di-diphenylamine, the target compound [134] was obtained in the same manner as in Synthesis Example 22 .

1H NMR (300 MHz, CDCl3):δ 6.58(d, 2H), 6.66~6.73(m, 10H), 6.91~6.97(m, 7H), 7.03(s, 1H), 7.10(m, 8H), 7.48~7.49(m, 6H), 7.63~7.65(m, 3H), 7.82~7.90(m, 6H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.58 (d, 2H), 6.66-6.73 (m, 10H), 6.91-6.97 (m, 7H), 7.03 (s, 1H), 7.10 (m, 8H) , 7.48 ~ 7.49 (m, 6H), 7.63 ~ 7.65 (m, 3H), 7.82 ~ 7.90 (m, 6H)

MS/FAB : 854(M+)MS / FAB: 854 (M + )

[합성 예 135] 화합물 [135]의 합성Synthesis Example 135 Synthesis of Compound [135]

Figure pat00150
Figure pat00150

합성예 1, 2와동일한방법으로 2-브로모-5,10-디페닐-5,10-디하이드로페나진, 5-브로모무수푸탈산, 2-브로모나프탈렌을 사용하여 합성한 중간체 화합물 [135-1]과디페닐아민을사용하여합성예22와동일한방법으로목적화합물[135]을수득하였다.Intermediate compounds synthesized using 2-bromo-5,10-diphenyl-5,10-dihydrophenazine, 5-bromophthalic anhydride and 2-bromonaphthalene in the same manner as in Synthesis Examples 1 and 2 [135-1] The target compound [135] was obtained in the same manner as in Synthesis Example 22 using hyperdiphenylamine.

1H NMR (300 MHz, CDCl3):δ 6.52(s, 1H), 6.64(d, 1H), 6.73(d, 1H), 6.83(m, 12H), 6.91~6.97(m, 9H), 7.03(s, 1H), 7.10(m, 12H), 7.48~7.49(m, 6H), 7.63~7.65(m, 3H), 7.82~7.90(m, 6H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.52 (s, 1H), 6.64 (d, 1H), 6.73 (d, 1H), 6.83 (m, 12H), 6.91 ~ 6.97 (m, 9H), 7.03 (s, 1H), 7.10 (m, 12H), 7.48-7.49 (m, 6H), 7.63-7.75 (m, 3H), 7.82-7.90 (m, 6H)

MS/FAB : 1021(M+)MS / FAB: 1021 (M + )

[합성 예 136] 화합물 [136]의 합성Synthesis Example 136 Synthesis of Compound [136]

Figure pat00151
Figure pat00151

합성예18와동일한방법으로5,10-디페닐-5,10-디하이드로페나진, 무수푸탈산, 2-브로모나프탈렌을 사용하여 합성한 중간체 화합물 [136-1]과2-(3-브로모페닐)-1-페닐-1H-벤조[d]이미다졸을 사용하여 목적화합물 [136]을수득하였다. Synthesis Example 18 Intermediate compounds [136-1] and 2- (3- synthesized using 5,10-diphenyl-5,10-dihydrophenazine, anhydrous phthalic anhydride and 2-bromonaphthalene in the same manner as in Synthesis Example 18 The target compound [136] was obtained using bromophenyl) -1-phenyl-1H-benzo [d] imidazole.

1H NMR (300 MHz, CDCl3):δ 1 H NMR (300 MHz, CDCl 3 ): δ

MS/FAB : 829(M+)MS / FAB: 829 (M + )

[합성 예 137] 화합물 [137]의 합성Synthesis Example 137 Synthesis of Compound

Figure pat00152
Figure pat00152

합성예18와동일한방법으로중간체화합물[136-1]과4-브로모피리딘을 사용하여 목적화합물 [137]을수득하였다. In the same manner as in Synthesis Example 18, the target compound [137] was obtained using the intermediate compound [136-1] and 4-bromopyridine.

1H NMR (300 MHz, CDCl3):δ 6.58(d, 2H), 6.66~6.73(m, 6H), 6.91~6.97(m, 4H), 7.10(m, 4H), 7.29(d, 2H), 7.48~7.49(m, 3H), 7.63(d, 1H), 7.81~7.90(m, 7H), 8.25(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.58 (d, 2H), 6.66-6.73 (m, 6H), 6.91-6.97 (m, 4H), 7.10 (m, 4H), 7.29 (d, 2H) , 7.48-7.49 (m, 3H), 7.63 (d, 1H), 7.81-7.90 (m, 7H), 8.25 (d, 2H)

MS/FAB : 638(M+)MS / FAB: 638 (M + )

[합성 예 138] 화합물 [138]의 합성Synthesis Example 138 Synthesis of Compound [138]

Figure pat00153
Figure pat00153

합성예18와동일한방법으로중간체화합물[136-1]과6-브로모-2,2'-비피리딘을 사용하여 목적화합물 [138]을수득하였다. In the same manner as in Synthesis Example 18, the target compound [138] was obtained using an intermediate compound [136-1] and 6-bromo-2,2'-bipyridine.

1H NMR (300 MHz, CDCl3):δ 6.58(d, 2H), 6.66~6.73(m, 6H), 6.91~6.97(m, 4H), 7.00(d, 1H), 7.04~7.10(m, 5H), 7.29(d, 2H), 7.49~7.60(m, 6H), 7.81~7.90(m, 5H), 8.14(d, 1H), 8.26(d, 1H), 8.50(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.58 (d, 2H), 6.66-6.73 (m, 6H), 6.91-6.97 (m, 4H), 7.00 (d, 1H), 7.04-7.10 (m, 5H), 7.29 (d, 2H), 7.49 ~ 7.60 (m, 6H), 7.81 ~ 7.90 (m, 5H), 8.14 (d, 1H), 8.26 (d, 1H), 8.50 (d, 1H)

MS/FAB : 715(M+)MS / FAB: 715 (M + )

[합성 예 139] 화합물 [139]의 합성Synthesis Example 139 Synthesis of Compound

Figure pat00154
Figure pat00154

합성예18와동일한방법으로중간체화합물[136-1]과2-클로로퀴놀린을 사용하여 목적화합물 [139]을수득하였다. In the same manner as in Synthesis Example 18, the target compound [139] was obtained using an intermediate compound [136-1] and 2- chloroquinoline .

1H NMR (300 MHz, CDCl3):δ 6.58(d, 2H), 6.66~6.73(m, 6H), 6.91~6.97(m, 4H), 7.10(m, 4H), 7.25~7.29(m, 3H), 7.49~7.50(m, 4H), 7.63~7.68(m, 2H), 7.88~7.96(m, 8H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.58 (d, 2H), 6.66-6.73 (m, 6H), 6.91-6.97 (m, 4H), 7.10 (m, 4H), 7.25-7.29 (m, 3H), 7.49-7.50 (m, 4H), 7.63-7.68 (m, 2H), 7.88-7.96 (m, 8H)

MS/FAB : 688(M+)MS / FAB: 688 (M + )

[합성 예 140] 화합물 [140]의 합성Synthesis Example 140 Synthesis of Compound [140]

Figure pat00155
Figure pat00155

합성예 1와동일한방법으로10-페닐-10H-페노티아진, 무수말레인산을 사용하여 목적화합물 [140]을수득하였다. Synthesis Example In the same manner as in 1 , 10-phenyl-10H-phenothiazine and maleic anhydride were used to obtain the target compound [140] .

1H NMR (300 MHz, CDCl3):δ 6.73~6.78(m, 3H), 6.81(t, 1H), 7.01~7.07(m, 2H), 7.16~7.31(m, 5H), 7.57(d, 2H), 8.06(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.73-6.68 (m, 3H), 6.81 (t, 1H), 7.01-7.07 (m, 2H), 7.16-7.31 (m, 5H), 7.57 (d, 2H), 8.06 (m, 2H)

MS/FAB : 325(M+)MS / FAB: 325 (M + )

[합성 예 141] 화합물 [141]의 합성Synthesis Example 141 Synthesis of Compound

Figure pat00156
Figure pat00156

합성예 1와동일한방법으로10-페닐-10H-페노티아진, 무수푸탈산을 사용하여 목적화합물 [141]을수득하였다. Synthesis Example In the same manner as 1 , 10-phenyl-10H-phenothiazine and phthalic anhydride were used to obtain the target compound [141] .

1H NMR (300 MHz, CDCl3):δ 6.73(m, 2H), 6.91~6.93(m, 2H), 7.07(t, 1H), 7.16~7.31(m, 5H), 7.35(d, 2H), 7.59(s, 1H), 7.81(d, 2H), 7.98(s, 1H), 8.09(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.73 (m, 2H), 6.91 ~ 6.93 (m, 2H), 7.07 (t, 1H), 7.16 ~ 7.31 (m, 5H), 7.35 (d, 2H) , 7.59 (s, 1H), 7.81 (d, 2H), 7.98 (s, 1H), 8.09 (s, 1H)

MS/FAB : 376(M+)MS / FAB: 376 (M + )

[합성 예 142] 화합물 [142]의 합성Synthesis Example 142 Synthesis of Compound

Figure pat00157
Figure pat00157

합성예 1, 2와동일한방법으로10-페닐-10H-페노티아진, 무수푸탈산, 브로모벤젠을 사용하여 목적화합물 [142]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , 10-phenyl-10H-phenothiazine, phthalic anhydride, and bromobenzene were used to obtain the target compound [142] .

1H NMR (300 MHz, CDCl3):δ 6.73(m, 2H), 6.91~6.93(m, 2H), 7.07(t, 1H), 7.16~7.31(m, 5H), 7.35~7.41(m, 12H), 7.59(s, 1H), 7.81(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.73 (m, 2H), 6.91 to 6.63 (m, 2H), 7.07 (t, 1H), 7.16 to 7.31 (m, 5H), 7.35 to 7.41 (m, 12H), 7.59 (s, 1H), 7.81 (d, 2H)

MS/FAB : 528(M+)MS / FAB: 528 (M + )

[합성 예 143] 화합물 [143]의 합성Synthesis Example 143 Synthesis of Compound [143]

Figure pat00158
Figure pat00158

합성예18와동일한방법으로10-페닐-10H-페노티아진, 무수푸탈산, 브로모벤젠을 사용하여 합성한 중간체 화합물 [143-1]과 4-브로모피리딘을 사용하여 목적화합물 [143]을수득하였다. Synthesis Example 18 An intermediate compound [143-1] and 4-bromopyridine synthesized using 10-phenyl-10H-phenothiazine, phthalic anhydride, and bromobenzene in the same manner as in Synthesis Example 18 [143] Obtained.

1H NMR (300 MHz, CDCl3):δ 6.73(m, 2H), 6.91~6.93(m, 2H), 7.07(t, 1H), 7.16~7.31(m, 5H), 7.35~7.41(m, 7H), 7.59(s, 1H), 7.81~7.89(m, 4H), 8.29(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.73 (m, 2H), 6.91 to 6.63 (m, 2H), 7.07 (t, 1H), 7.16 to 7.31 (m, 5H), 7.35 to 7.41 (m, 7H), 7.59 (s, 1H), 7.81-7.89 (m, 4H), 8.29 (d, 2H)

MS/FAB : 529(M+)MS / FAB: 529 (M + )

[합성 예 144] 화합물 [144]의 합성Synthesis Example 144 Synthesis of Compound

Figure pat00159
Figure pat00159

합성예 1와동일한방법으로10-페닐-10H-페옥사진, 무수말레인산을 사용하여 목적화합물 [144]을수득하였다. Synthesis Example In the same manner as 1 , 10-phenyl-10H-phenoxazine and maleic anhydride were used to obtain the target compound [144] .

1H NMR (300 MHz, CDCl3):δ 6.69~6.73(m, 3H), 6.87~7.02(m, 4H), 7.10~7.14(m, 3H), 7.24~7.29(m, 2H), 7.59~7.64(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.69 ~ 6.73 (m, 3H), 6.87 ~ 7.02 (m, 4H), 7.10 ~ 7.14 (m, 3H), 7.24 ~ 7.29 (m, 2H), 7.59 ~ 7.64 (m, 3 H)

MS/FAB : 309(M+)MS / FAB: 309 (M + )

[합성 예 145] 화합물 [145]의 합성Synthesis Example 145 Synthesis of Compound

Figure pat00160
Figure pat00160

합성예 1와동일한방법으로10-페닐-10H-페옥사진, 무수푸탈산을 사용하여 목적화합물 [145]을수득하였다. Synthesis Example In the same manner as in 1 , the target compound [145] was obtained using 10-phenyl-10H-phenoxazine and phthalic anhydride.

1H NMR (300 MHz, CDCl3):δ 6.69~6.73(m, 3H), 6.87~7.05(m, 5H), 7.08(s, 1H), 7.10(m, 2H), 7.29(m, 2H), 7.81(d, 2H), 7.94(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.69 ~ 6.73 (m, 3H), 6.87 ~ 7.05 (m, 5H), 7.08 (s, 1H), 7.10 (m, 2H), 7.29 (m, 2H) , 7.81 (d, 2H), 7.94 (d, 2H)

MS/FAB : 359(M+)MS / FAB: 359 (M + )

[합성 예 146] 화합물 [146]의 합성Synthesis Example 146 Synthesis of Compound [146]

Figure pat00161
Figure pat00161

합성예 1, 2와동일한방법으로10-페닐-10H-페옥사진, 무수푸탈산, 브로모벤젠을 사용하여 목적화합물 [146]을수득하였다.Using the Synthesis Example 1, 2, 10-phenyl -10H- peok pictures, anhydrous Fu deoxidation, bromobenzene with vortex same method to give the desired compound [146].

1H NMR (300 MHz, CDCl3):δ 6.69~6.73(m, 3H), 6.87~6.91(m, 2H), 6.99~7.05(m, 3H), 7.08(s, 1H), 7.10(m, 2H), 7.29~7.42(m, 12H), 7.81(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.69 to 6.73 (m, 3H), 6.87 to 6.61 (m, 2H), 6.99 to 7.05 (m, 3H), 7.08 (s, 1H), 7.10 (m, 2H), 7.29-7.42 (m, 12H), 7.81 (d, 2H)

MS/FAB : 512(M+)MS / FAB: 512 (M + )

[합성 예 147] 화합물 [147]의 합성Synthesis Example 147 Synthesis of Compound

Figure pat00162
Figure pat00162

합성예18와동일한방법으로10-페닐-10H-페옥사진, 무수푸탈산, 브로모벤젠을 사용하여 합성한 중간체 화합물 [147-1]과 4-브로모피리미딘을 사용하여 목적화합물 [147]을수득하였다. Synthesis Example 18 An intermediate compound [147-1] synthesized using 10-phenyl-10H-phenoxazine, phthalic anhydride, and bromobenzene in the same manner as in Synthesis Example 18 , and a target compound using 4-bromopyrimidine [147] Obtained.

1H NMR (300 MHz, CDCl3):δ 6.69~6.73(m, 3H), 6.87~7.05(m, 5H), 7.08(s, 1H), 7.10(m, 2H), 7.29~7.42(m, 7H), 7.81(d, 2H), 7.99(d, 1H), 8.26(d, 1H), 8.57(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.69-6.73 (m, 3H), 6.87-7.05 (m, 5H), 7.08 (s, 1H), 7.10 (m, 2H), 7.29-7.42 (m, 7H), 7.81 (d, 2H), 7.99 (d, 1H), 8.26 (d, 1H), 8.57 (s, 1H)

MS/FAB : 514(M+)MS / FAB: 514 (M + )

[합성 예 148] 화합물 [148]의 합성Synthesis Example 148 Synthesis of Compound

Figure pat00163
Figure pat00163

합성예 1와동일한방법으로9-페닐-9H-카바졸 무수말레인산을 사용하여 목적화합물 [148]을수득하였다. Synthesis Example In the same manner as 1 , 9-phenyl-9H-carbazole maleic anhydride was used to obtain the target compound [148] .

1H NMR (300 MHz, CDCl3):δ 7.15~7.57(m, 11H), 7.84(d, 1H), 8.06(m, 2H), 8.25(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.15 to 7.57 (m, 11H), 7.84 (d, 1H), 8.06 (m, 2H), 8.25 (d, 1H)

MS/FAB : 293(M+)MS / FAB: 293 (M + )

[합성 예 149] 화합물 [149]의 합성Synthesis Example 149 Synthesis of Compound [149]

Figure pat00164
Figure pat00164

합성예 1와동일한방법으로9-페닐-9H-카바졸, 무수푸탈산을 사용하여 목적화합물 [149]을수득하였다. Synthesis Example In the same manner as in 1 , 9-phenyl-9H-carbazole and phthalic anhydride were used to obtain the target compound [149] .

1H NMR (300 MHz, CDCl3):δ 7.15~7.48(m, 9H), 7.81~7.84(m, 5H), 8.11(d, 2H), 8.25(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.15-7.48 (m, 9H), 7.81-7.84 (m, 5H), 8.11 (d, 2H), 8.25 (d, 1H)

MS/FAB : 343(M+)MS / FAB: 343 (M + )

[합성 예 150] 화합물 [150]의 합성Synthesis Example 150 Synthesis of Compound [150]

Figure pat00165
Figure pat00165

합성예 1, 2와동일한방법으로9-페닐-9H-카바졸, 무수푸탈산, 브로모벤젠을 사용하여 목적화합물 [150]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , 9-phenyl-9H-carbazole, phthalic anhydride, and bromobenzene were used to obtain the target compound [150] .

1H NMR (300 MHz, CDCl3):δ 7.15~7.48(m, 19H), 7.81~7.84(m, 5H), 8.25(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.15-7.48 (m, 19H), 7.81-7.84 (m, 5H), 8.25 (d, 1H)

MS/FAB : 496(M+)MS / FAB: 496 (M + )

[합성 예 151] 화합물 [151]의 합성Synthesis Example 151 Synthesis of Compound [151]

Figure pat00166
Figure pat00166

합성예 1, 2와동일한방법으로9-페닐-9H-카바졸, 푸로[3,4-b]피라진-5,7-디온, 브로모벤젠을 사용하여 목적화합물 [151]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , 9-phenyl-9H-carbazole, furo [3,4-b] pyrazine-5,7-dione and bromobenzene were used to obtain the target compound [151] .

1H NMR (300 MHz, CDCl3):δ 7.15~7.48(m, 19H), 7.84(d, 1H), 8.25(d, 1H), 8.54(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.15-7.48 (m, 19H), 7.84 (d, 1H), 8.25 (d, 1H), 8.54 (s, 2H)

MS/FAB : 498(M+)MS / FAB: 498 (M + )

[합성 예 152] 화합물 [152]의 합성Synthesis Example 152 Synthesis of Compound [152]

Figure pat00167
Figure pat00167

합성예 1와동일한방법으로1,5-디페닐-1,5-디하이드로피롤[2,3-f]인돌, 무수푸탈산을 사용하여 목적화합물 [152]을수득하였다. In the same manner as in Synthesis Example 1 , target compound [152] was obtained using 1,5-diphenyl-1,5-dihydropyrrole [2,3-f] indole and phthalic anhydride.

1H NMR (300 MHz, CDCl3):δ 6.62(d, 1H), 7.30~7.57(m, 17H), 8.06(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.62 (d, 1H), 7.30 ~ 7.57 (m, 17H), 8.06 (m, 2H)

MS/FAB : 409(M+)MS / FAB: 409 (M + )

[합성 예 153] 화합물 [153]의 합성Synthesis Example 153 Synthesis of Compound [153]

Figure pat00168
Figure pat00168

합성예 1와동일한방법으로1,5-디페닐-1,5-디하이드로피롤[2,3-f]인돌, 나프토[2,3-c]퓨란-1,3-디온을 사용하여 목적화합물 [153]을수득하였다. Synthesis Example 1 Using 1,5-diphenyl-1,5-dihydropyrrole [2,3-f] indole and naphtho [2,3-c] furan-1,3-dione in the same manner as in Synthesis Example 1 Compound [153] was obtained.

1H NMR (300 MHz, CDCl3):δ 6.62(d, 1H), 7.30~7.50(m, 15H), 7.81(m, 4H), 8.21(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.62 (d, 1H), 7.30 ~ 7.50 (m, 15H), 7.81 (m, 4H), 8.21 (s, 2H)

MS/FAB : 459(M+)MS / FAB: 459 (M + )

[합성 예 154] 화합물 [154]의 합성Synthesis Example 154 Synthesis of Compound [154]

Figure pat00169
Figure pat00169

합성예 1, 2와동일한방법으로1,5-디페닐-1,5-디하이드로피롤[2,3-f]인돌, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 목적화합물 [154]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , 1,5-diphenyl-1,5-dihydropyrrole [2,3-f] indole, naphtho [2,3-c] furan-1,3-dione, bro Mobenzene was used to obtain the target compound [154] .

1H NMR (300 MHz, CDCl3):δ 6.62(d, 1H), 7.30~7.50(m, 25H), 7.81(m, 2H), 8.21(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.62 (d, 1H), 7.30 ~ 7.50 (m, 25H), 7.81 (m, 2H), 8.21 (s, 2H)

MS/FAB : 611(M+)MS / FAB: 611 (M + )

[합성 예 155] 화합물 [155]의 합성Synthesis Example 155 Synthesis of Compound [155]

Figure pat00170
Figure pat00170

합성예 1와동일한방법으로5,11-디페닐-5,11-디하이드로인돌[3,2-b]카바졸, 무수말레인산을 사용하여 목적화합물 [155]을수득하였다. In the same manner as in Synthesis Example 1 , the target compound [155] was obtained using 5,11-diphenyl-5,11-dihydroindole [3,2-b] carbazole and maleic anhydride.

1H NMR (300 MHz, CDCl3):δ 7.19(t, 1H), 7.30~7.57(m, 18H), 8.02~8.06(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.19 (t, 1H), 7.30-7.57 (m, 18H), 8.02-8.06 (m, 3H)

MS/FAB : 459(M+)MS / FAB: 459 (M + )

[합성 예 156] 화합물 [156]의 합성Synthesis Example 156 Synthesis of Compound

Figure pat00171
Figure pat00171

합성예 1와동일한방법으로5,11-디페닐-5,11-디하이드로인돌[3,2-b]카바졸, 무수푸탈산을 사용하여 목적화합물 [156]을수득하였다. In the same manner as in Synthesis Example 1 , 5,11-diphenyl-5,11-dihydroindole [3,2-b] carbazole and anhydrous phthalic anhydride were used to obtain the target compound [156] .

1H NMR (300 MHz, CDCl3):δ 7.19(t, 1H), 7.29~7.53(m, 16H), 7.81(m, 4H), 8.02(d, 1H), 8.21(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.19 (t, 1H), 7.29 to 7.53 (m, 16H), 7.81 (m, 4H), 8.02 (d, 1H), 8.21 (d, 2H)

MS/FAB : 509(M+)MS / FAB: 509 (M + )

[합성 예 157] 화합물 [157]의 합성Synthesis Example 157 Synthesis of Compound

Figure pat00172
Figure pat00172

합성예 1, 2와동일한방법으로5,11-디페닐-5,11-디하이드로인돌[3,2-b]카바졸, 무수푸탈산, 브로모벤젠을 사용하여 목적화합물 [157]을수득하였다.Obtained target compound [157] using 5,11-diphenyl-5,11-dihydroindole [3,2-b] carbazole, butyric anhydride and bromobenzene in the same manner as in Synthesis Examples 1 and 2. It was.

1H NMR (300 MHz, CDCl3):δ 7.19(t, 1H), 7.29~7.53(m, 26H), 7.81(m, 4H), 8.02(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.19 (t, 1H), 7.29-7.53 (m, 26H), 7.81 (m, 4H), 8.02 (d, 1H)

MS/FAB : 661(M+)MS / FAB: 661 (M + )

[합성 예 158] 화합물 [158]의 합성Synthesis Example 158 Synthesis of Compound

Figure pat00173
Figure pat00173

합성예18와동일한방법으로5,11-디페닐-5,11-디하이드로인돌[3,2-b]카바졸, 무수푸탈산, 브로모벤젠을 사용하여 합성한 중간체 화합물 [158-1]과 2-클로로퀴롤린을 사용하여 목적화합물 [158]을수득하였다. Synthesis Example 18 Intermediate compound synthesized using 5,11-diphenyl-5,11-dihydroindole [3,2-b] carbazole, phthalic anhydride and bromobenzene in the same manner as in Synthesis Example 18 [158-1] And 2-chloroquiline were used to obtain the target compound [158] .

1H NMR (300 MHz, CDCl3):δ 7.30~7.53(m, 24H), 7.68(t, 1H), 7.81~7.88(m, 5H), 7.96~8.02(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 7.30-7.53 (m, 24H), 7.68 (t, 1H), 7.81-7.88 (m, 5H), 7.96-8.02 (m, 3H)

MS/FAB : 712(M+)MS / FAB: 712 (M + )

[합성 예 159] 화합물 [159]의 합성Synthesis Example 159 Synthesis of Compound

Figure pat00174
Figure pat00174

합성예 1와동일한방법으로1,6-디페닐-1,6-디하이드로인돌[6,5-f]인돌, 무수푸탈산을 사용하여 목적화합물 [159]을수득하였다. In the same manner as in Synthesis Example 1 , the target compound [159] was obtained using 1,6-diphenyl-1,6-dihydroindole [6,5-f] indole and phthalic anhydride.

1H NMR (300 MHz, CDCl3):δ 6.72(d, 1H), 7.30~7.57(m, 19H), 8.06(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.72 (d, 1H), 7.30 ~ 7.57 (m, 19H), 8.06 (d, 2H)

MS/FAB : 459(M+)MS / FAB: 459 (M + )

[합성 예 160] 화합물 [160]의 합성Synthesis Example 160 Synthesis of Compound

Figure pat00175
Figure pat00175

합성예 1와동일한방법으로1,6-디페닐-1,6-디하이드로인돌[6,5-f]인돌, 나프토[2,3-c]퓨란-1,3-디온을 사용하여 목적화합물 [160]을수득하였다.1,6-diphenyl-1,6-dihydroindole [6,5-f] indole and naphtho [2,3-c] furan-1,3-dione in the same manner as in Synthesis Example 1 Compound [160] was obtained.

1H NMR (300 MHz, CDCl3):δ 6.72(d, 1H), 7.29~7.50(m, 17H), 7.81(m, 4H), 8.21(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.72 (d, 1H), 7.29 ~ 7.50 (m, 17H), 7.81 (m, 4H), 8.21 (d, 2H)

MS/FAB : 509(M+)MS / FAB: 509 (M + )

[합성 예 161] 화합물 [161]의 합성Synthesis Example 161 Synthesis of Compound

Figure pat00176
Figure pat00176

합성예 1, 2와동일한방법으로1,6-디페닐-1,6-디하이드로인돌[6,5-f]인돌, 나프토[2,3-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 목적화합물 [161]을수득하였다.1,6-diphenyl-1,6-dihydroindole [6,5-f] indole, naphtho [2,3-c] furan-1,3-dione, bromine in the same manner as in Synthesis Examples 1 and 2 Parent compound was used to obtain the target compound [161] .

1H NMR (300 MHz, CDCl3):δ 6.72(d, 1H), 7.29~7.50(m, 27H), 7.81(m, 2H), 8.21(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 6.72 (d, 1H), 7.29 ~ 7.50 (m, 27H), 7.81 (m, 2H), 8.21 (d, 2H)

MS/FAB : 661(M+)MS / FAB: 661 (M + )

[합성 예 162] 화합물 [162]의 합성Synthesis Example 162 Synthesis of Compound

Figure pat00177
Figure pat00177

합성예 1과 동일한 방법으로 5,5,10,10,15,15-헥사메틸-10,15-디히드로-5H-디인데노[1,2-a:1',2'-c]플로렌, 무수말레인산을 사용하여 노란색 고체의 목적화합물 [162]을수득하였다.5,5,10,10,15,15-hexamethyl-10,15-dihydro-5H-diindeno [1,2-a: 1 ', 2'-c] ple in the same manner as in Synthesis example 1 The target compound [162] was obtained as a yellow solid using Loren and maleic anhydride.

1H NMR (300 MHz, CDCl3):δ 1.83(s, 12H), 1.89(s, 6H), 7.24~7.28(m, 2H), 7.38 ~7.44(m, 2H), 7.52~7.61(m, 5H), 7.87(d, 1H), 7.97~8.01(m, 2H), 8.09(d, 1H), 8.28(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.83 (s, 12H), 1.89 (s, 6H), 7.24 to 7.28 (m, 2H), 7.38 to 7.44 (m, 2H), 7.52 to 7.61 (m, 5H), 7.87 (d, 1H), 7.97-8.01 (m, 2H), 8.09 (d, 1H), 8.28 (s, 1H)

MS/FAB : 476(M+)MS / FAB: 476 (M + )

[합성 예 163] 화합물 [163]의 합성Synthesis Example 163 Synthesis of Compound [163]

Figure pat00178
Figure pat00178

합성예 1, 2와 동일한 방법으로 5,5,10,10,15,15-헥사메틸-10,15-디히드로-5H-디인데노[1,2-a:1',2'-c]플로렌, 무수말레인산, 브로모벤젠을 사용하여 노란색 고체의 목적화합물 [163]을수득하였다.5,5,10,10,15,15-hexamethyl-10,15-dihydro-5H-diindeno [1,2-a: 1 ', 2'-c in the same manner as in Synthesis Examples 1 and 2 ] Florence, maleic anhydride, and bromobenzene were used to obtain the target compound [163] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.83(s, 12H), 1.89(s, 6H), 7.24~7.28(m, 2H), 7.38 ~7.55(m, 10H), 7.79~7.87(m, 6H), 7.97~8.09(m, 4H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.83 (s, 12H), 1.89 (s, 6H), 7.24 to 7.28 (m, 2H), 7.38 to 7.55 (m, 10H), 7.79 to 7.87 (m, 6H), 7.97-8.09 (m, 4H)

MS/FAB : 628(M+)MS / FAB: 628 (M + )

[합성 예 164] 화합물 [164]의 합성Synthesis Example 164 Synthesis of Compound

Figure pat00179
Figure pat00179

합성예 1과 동일한 방법으로 5,5,10,10,15,15-헥사메틸-10,15-디히드로-5H-디인데노[1,2-a:1',2'-c]플로렌, 무수푸탈산을 사용하여 노란색 고체의 목적화합물 [164]을수득하였다.5,5,10,10,15,15-hexamethyl-10,15-dihydro-5H-diindeno [1,2-a: 1 ', 2'-c] ple in the same manner as in Synthesis example 1 Lauren, using anhydrous Fu deoxidation to give the target compound [164] of a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.83(s, 12H), 1.89(s, 6H), 7.24~7.28(m, 2H), 7.38 ~7.44(m, 4H), 7.55~7.61(m, 2H), 7.76(s, 1H), 7.87~7.91(m, 3H), 8.07~8.09(m, 2H), 8.28~8.32(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.83 (s, 12H), 1.89 (s, 6H), 7.24 to 7.28 (m, 2H), 7.38 to 7.44 (m, 4H), 7.55 to 7.61 (m, 2H), 7.76 (s, 1H), 7.87-7.91 (m, 3H), 8.07-8.09 (m, 2H), 8.28-8.32 (m, 2H)

MS/FAB : 526(M+)MS / FAB: 526 (M + )

[합성 예 165] 화합물 [165]의 합성Synthesis Example 165 Synthesis of Compound

Figure pat00180
Figure pat00180

합성예 1, 2와 동일한 방법으로 5,5,10,10,15,15-헥사메틸-10,15-디히드로-5H-디인데노[1,2-a:1',2'-c]플로렌, 무수푸탈산, 브로모벤젠을 사용하여 노란색 고체의 목적화합물 [165]을수득하였다.5,5,10,10,15,15-hexamethyl-10,15-dihydro-5H-diindeno [1,2-a: 1 ', 2'-c in the same manner as in Synthesis Examples 1 and 2 ] Florene, phthalic anhydride, and bromobenzene were used to obtain the target compound [165] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.83(s, 12H), 1.89(s, 6H), 7.24~7.28(m, 2H), 7.38 ~7.55(m, 16H), 7.76(s, 1H), 7.87~7.91(m, 3H), 8.07~8.09(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.83 (s, 12H), 1.89 (s, 6H), 7.24 ~ 7.28 (m, 2H), 7.38 ~ 7.55 (m, 16H), 7.76 (s, 1H) , 7.87 to 7.91 (m, 3H), 8.07 to 8.09 (m, 2H)

MS/FAB : 678(M+)MS / FAB: 678 (M + )

[합성 예 166] 화합물 [166]의 합성Synthesis Example 166 Synthesis of Compound [166]

Figure pat00181
Figure pat00181

합성예 1, 2와 동일한 방법으로 5,5,10,10,15,15-헥사메틸-10,15-디히드로-5H-디인데노[1,2-a:1',2'-c]플로렌, 나프토[1,2-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색 고체의 목적화합물 [166]을수득하였다.5,5,10,10,15,15-hexamethyl-10,15-dihydro-5H-diindeno [1,2-a: 1 ', 2'-c in the same manner as in Synthesis Examples 1 and 2 ] Plenylene, naphtho [1,2-c] furan-1,3-dione and bromobenzene were used to obtain the target compound [166] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.83(s, 12H), 1.89(s, 6H), 7.24~7.55(m, 17H), 7.76 ~7.91(m, 5H), 8.07~8.12(m, 3H), 8.93(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.83 (s, 12H), 1.89 (s, 6H), 7.24 ~ 7.55 (m, 17H), 7.76 ~ 7.91 (m, 5H), 8.07 ~ 8.12 (m, 3H), 8.93 (d, 1H)

MS/FAB : 728(M+)MS / FAB: 728 (M + )

[합성 예 167] 화합물 [167]의 합성Synthesis Example 167 Synthesis of Compound [167]

Figure pat00182
Figure pat00182

합성예 1, 2와 동일한 방법으로 5,5,10,10,15,15-헥사메틸-10,15-디히드로-5H-디인데노[1,2-a:1',2'-c]플로렌, 퓨로[3,4-b]피라진-5,7-디온, 브로모벤젠을 사용하여 노란색 고체의 목적화합물 [167]을수득하였다.5,5,10,10,15,15-hexamethyl-10,15-dihydro-5H-diindeno [1,2-a: 1 ', 2'-c in the same manner as in Synthesis Examples 1 and 2 ; Florencio, using furo [3,4-b] pyrazine-5,7-dione, bromobenzene to afford the target compound [167] in a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.83(s, 12H), 1.89(s, 6H), 7.24~7.28(m, 2H), 7.38 ~7.55(m, 14H), 7.83~7.87(m, 2H), 8.05~8.09(m, 2H), 8.74(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.83 (s, 12H), 1.89 (s, 6H), 7.24-7.28 (m, 2H), 7.38-7.75 (m, 14H), 7.83-7.87 (m, 2H), 8.05-8.09 (m, 2H), 8.74 (s, 2H)

MS/FAB : 680(M+)MS / FAB: 680 (M + )

[합성 예 168] 화합물 [168]의 합성Synthesis Example 168 Synthesis of Compound [168]

Figure pat00183
Figure pat00183

합성예 1, 2, 22와 동일한 방법으로 5,5,10,10,15,15-헥사메틸-10,15-디히드로-5H-디인데노[1,2-a:1',2'-c]플로렌, 무수푸탈산, 디페닐아민을 사용하여 노란색 고체의 목적화합물 [168]을수득하였다.5,5,10,10,15,15-hexamethyl-10,15-dihydro-5H-diindeno [1,2-a: 1 ', 2' in the same manner as in Synthesis example 1, 2, 22 -c] The desired compound [168] as a yellow solid was obtained using florene, phthalic anhydride, and diphenylamine.

1H NMR (300 MHz, CDCl3):δ 1.83(s, 12H), 1.89(s, 6H), 7.02~7.08(m, 12H), 7.20 ~7.28(m, 10H), 7.38~7.44(m, 4H), 7.55~7.61(m, 2H), 7.61(s, 1H), 7.87~7.91(m, 3H), 8.00(s, 1H), 8.09(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.83 (s, 12H), 1.89 (s, 6H), 7.02 ~ 7.08 (m, 12H), 7.20 ~ 7.28 (m, 10H), 7.38 ~ 7.44 (m, 4H), 7.55-7.61 (m, 2H), 7.61 (s, 1H), 7.87-7.91 (m, 3H), 8.00 (s, 1H), 8.09 (d, 1H)

MS/FAB : 861(M+)MS / FAB: 861 (M + )

[합성 예 169] 화합물 [169]의 합성Synthesis Example 169 Synthesis of Compound

Figure pat00184
Figure pat00184

합성예 1, 2, 19와 동일한 방법으로 5,5,10,10,15,15-헥사메틸-10,15-디히드로-5H-디인데노[1,2-a:1',2'-c]플로렌, 5-브로모무수푸탈산, 브로모벤젠, 페닐보론산을 사용하여 노란색 고체의 목적화합물 [169]을수득하였다.5,5,10,10,15,15-hexamethyl-10,15-dihydro-5H-diindeno [1,2-a: 1 ', 2' in the same manner as in Synthesis example 1, 2, 19 -c] to give the Florencio, 5-bromo-deoxy anhydrous Fu, bromobenzene, the desired compound in a yellow solid using the boronic acid [169].

1H NMR (300 MHz, CDCl3):δ 1.83(s, 12H), 1.89(s, 6H), 7.24~7.28(m, 2H), 7.38 ~7.55(m, 20H), 7.76(s, 1H), 7.87(d, 1H), 7.97(d, 1H), 8.07~8.13(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.83 (s, 12H), 1.89 (s, 6H), 7.24 ~ 7.28 (m, 2H), 7.38 ~ 7.55 (m, 20H), 7.76 (s, 1H) , 7.87 (d, 1H), 7.97 (d, 1H), 8.07-8.13 (m, 3H)

MS/FAB : 755(M+)MS / FAB: 755 (M + )

[합성 예 170] 화합물 [170]의 합성Synthesis Example 170 Synthesis of Compound

Figure pat00185
Figure pat00185

합성예 1, 2, 19와 동일한 방법으로 5,5,10,10,15,15-헥사메틸-10,15-디히드로-5H-디인데노[1,2-a:1',2'-c]플로렌, 5-브로모무수푸탈산, 2-브로모나프탈렌, 페닐보론산을 사용하여 노란색 고체의 목적화합물 [170]을수득하였다.5,5,10,10,15,15-hexamethyl-10,15-dihydro-5H-diindeno [1,2-a: 1 ', 2' in the same manner as in Synthesis example 1, 2, 19 -c] to give the Florencio, 5-bromo anhydrous Fu deoxy, 2-bromo-naphthalene, the desired compound of the yellow solid using the boronic acid [170].

1H NMR (300 MHz, CDCl3):δ 1.83(s, 12H), 1.89(s, 6H), 7.24~7.28(m, 2H), 7.38 ~7.61(m, 16H), 7.73~7.76(m, 3H), 7.87~8.00(m, 8H), 8.07~8.13(m, 3H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.83 (s, 12H), 1.89 (s, 6H), 7.24 ~ 7.28 (m, 2H), 7.38 ~ 7.61 (m, 16H), 7.73 ~ 7.76 (m, 3H), 7.87-8.00 (m, 8H), 8.07-8.13 (m, 3H)

MS/FAB : 855(M+)MS / FAB: 855 (M + )

[합성 예 171] 화합물 [171]의 합성Synthesis Example 171 Synthesis of Compound [171]

Figure pat00186
Figure pat00186

합성예 1, 2, 22와 동일한 방법으로 2-브로모-5,5,10,10,15,15-헥사메틸-10,15-디히드로-5H-디인데노[1,2-a:1',2'-c]플로렌, 5-브로모무수푸탈산, 브로모벤젠, 디페닐아민을 사용하여 노란색 고체의 목적화합물 [171]을수득하였다.2-Bromo-5,5,10,10,15,15-hexamethyl-10,15-dihydro-5H-diindeno [1,2-a: in the same manner as in Synthesis examples 1, 2, 22 : 1 ', to give the 2'-c] Florencio, 5-bromo-deoxy anhydrous Fu, bromobenzene, di target compound as a yellow solid using phenylamine [171].

1H NMR (300 MHz, CDCl3):δ 1.83(s, 12H), 1.89(s, 6H), 7.03~7.08(m, 16H), 7.20 ~7.28(m, 9H), 7.38~7.41(m, 3H), 7.51~7.55(m, 9H), 7.75~7.76(m, 2H), 7.84~7.87(m, 2H), 8.07(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.83 (s, 12H), 1.89 (s, 6H), 7.03 ~ 7.08 (m, 16H), 7.20 ~ 7.28 (m, 9H), 7.38 ~ 7.41 (m, 3H), 7.51-7.55 (m, 9H), 7.75-7.72 (m, 2H), 7.84-7.87 (m, 2H), 8.07 (s, 1H)

MS/FAB : 1013(M+)MS / FAB: 1013 (M + )

[합성 예 172] 화합물 [172]의 합성Synthesis Example 172 Synthesis of Compound

Figure pat00187
Figure pat00187

합성예 1, 2, 22와 동일한 방법으로 2,7-디브로모-5,5,10,10,15,15-헥사메틸-10,15-디히드로-5H-디인데노[1,2-a:1',2'-c]플로렌, 5-브로모무수푸탈산, 브로모벤젠, 디페닐아민을 사용하여 노란색 고체의 목적화합물 [172]을수득하였다.2,7-Dibromo-5,5,10,10,15,15-hexamethyl-10,15-dihydro-5H-diindeno [1,2 in the same manner as in Synthesis examples 1, 2, 22 -a: 1 ', to give the 2'-c] Florencio, 5-bromo-deoxy anhydrous Fu, bromobenzene, di target compound as a yellow solid using phenylamine [172].

1H NMR (300 MHz, CDCl3):δ 1.83(s, 12H), 1.89(s, 6H), 7.03~7.09(m, 24H), 7.20 ~7.24(m, 12H), 7.41~7.52(m, 10H), 7.62(d, 1H), 7.75~7.76(m, 2H), 7.84(d, 1H), 8.07(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.83 (s, 12H), 1.89 (s, 6H), 7.03 ~ 7.09 (m, 24H), 7.20 ~ 7.24 (m, 12H), 7.41 ~ 7.52 (m, 10H), 7.62 (d, 1H), 7.75-7.72 (m, 2H), 7.84 (d, 1H), 8.07 (s, 1H)

MS/FAB : 1180(M+)MS / FAB: 1180 (M + )

[합성 예 173] 화합물 [173]의 합성Synthesis Example 173 Synthesis of Compound [173]

Figure pat00188
Figure pat00188

합성예 1, 2, 18와 동일한 방법으로 5,5,10,10,15,15-헥사메틸-10,15-디히드로-5H-디인데노[1,2-a:1',2'-c]플로렌, 무수푸탈산, 브로모벤젠, 4-브로모피리딘을 사용하여 노란색 고체의 목적화합물 [173]을수득하였다.5,5,10,10,15,15-hexamethyl-10,15-dihydro-5H-diindeno [1,2-a: 1 ', 2' in the same manner as in Synthesis example 1, 2, 18 -c] Florencio, using anhydrous Fu deoxidation, bromobenzene, 4-bromo-pyridine to give the desired compound [173] in a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.83(s, 12H), 1.89(s, 6H), 7.24~7.28(m, 2H), 7.38 ~7.61(m, 11H), 7.76(s, 1H), 7.87~7.91(m, 3H), 7.99(d, 2H), 8.07~8.09(m, 2H), 8.75(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.83 (s, 12H), 1.89 (s, 6H), 7.24 ~ 7.28 (m, 2H), 7.38 ~ 7.61 (m, 11H), 7.76 (s, 1H) , 7.87 to 7.91 (m, 3H), 7.99 (d, 2H), 8.07 to 8.09 (m, 2H), 8.75 (d, 2H)

MS/FAB : 678(M+)MS / FAB: 678 (M + )

[합성 예 174] 화합물 [174]의 합성Synthesis Example 174 Synthesis of Compound

Figure pat00189
Figure pat00189

합성예 1, 2, 18와 동일한 방법으로 5,5,10,10,15,15-헥사메틸-10,15-디히드로-5H-디인데노[1,2-a:1',2'-c]플로렌, 무수푸탈산, 브로모벤젠, 6-브로모-2,2'-비피리딘을 사용하여 노란색 고체의 목적화합물 [174]을수득하였다.5,5,10,10,15,15-hexamethyl-10,15-dihydro-5H-diindeno [1,2-a: 1 ', 2' in the same manner as in Synthesis example 1, 2, 18 -c] Florencio, using anhydrous Fu deoxidation, bromobenzene, 6-bromo-2,2'-bipyridine, to give the desired compound [174] in a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.83(s, 12H), 1.89(s, 6H), 7.12~7.14(m, 2H), 7.24 ~7.28(m, 2H), 7.38~7.76(m, 14H), 7.87~7.91(m, 3H), 8.07~8.09(m, 2H), 8.53(d, 1H), 8.90(d, 1H), 9.30(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.83 (s, 12H), 1.89 (s, 6H), 7.12 ~ 7.14 (m, 2H), 7.24 ~ 7.28 (m, 2H), 7.38 ~ 7.76 (m, 14H), 7.87-7.91 (m, 3H), 8.07-8.09 (m, 2H), 8.53 (d, 1H), 8.90 (d, 1H), 9.30 (d, 1H)

MS/FAB : 756(M+)MS / FAB: 756 (M + )

[합성 예 175] 화합물 [175]의 합성Synthesis Example 175 Synthesis of Compound [175]

Figure pat00190
Figure pat00190

합성예 1과동일한방법으로화합물[175-1], 무수말레인산을 사용하여 노란색 고체의 목적화합물 [175]을수득하였다. Synthesis Example In the same manner as in 1 , compound [175-1] and maleic anhydride were used to obtain the title compound [175] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.84(s, 6H), 1.90(s, 6H), 1.97(s, 6H), 7.01 ~7.03(m, 6H), 7.28(t, 1H), 7.41(t, 1H), 7.67(s, 1H), 7.90~7.96(m, 2H), 1 H NMR (300 MHz, CDCl 3 ): δ 1.84 (s, 6H), 1.90 (s, 6H), 1.97 (s, 6H), 7.01 to 7.03 (m, 6H), 7.28 (t, 1H), 7.41 (t, 1H), 7.67 (s, 1H), 7.90-7.96 (m, 2H),

MS/FAB : 415(M+)MS / FAB: 415 (M + )

[합성 예 176] 화합물 [176]의 합성Synthesis Example 176 Synthesis of Compound [176]

Figure pat00191
Figure pat00191

합성예 1과동일한방법으로화합물[175-1], 무수푸탈산 을 사용하여 노란색 고체의 목적화합물 [176]을수득하였다. Synthesis Example 1 In the same manner as the compound [175-1] , the desired compound of the yellow solid [176] was obtained using anhydrous phthalic anhydride.

1H NMR (300 MHz, CDCl3):δ 1.84(s, 6H), 1.90(s, 6H), 1.97(s, 6H), 7.01 ~7.03(m, 6H), 7.38~7.39(m, 3H), 7.91~7.92(m, 2H), 8.13(s, 1H), 8.19(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.84 (s, 6H), 1.90 (s, 6H), 1.97 (s, 6H), 7.01-7.03 (m, 6H), 7.38-7.39 (m, 3H) , 7.91 ~ 7.92 (m, 2H), 8.13 (s, 1H), 8.19 (s, 1H)

MS/FAB : 465(M+)MS / FAB: 465 (M + )

[합성 예 177] 화합물 [177]의 합성Synthesis Example 177 Synthesis of Compound

Figure pat00192
Figure pat00192

합성예 1과동일한방법으로화합물[175-1], 나프토[2,3-c]퓨란-1,3-디온을 사용하여 노란색 고체의 목적화합물 [177]을수득하였다. Synthesis Example 1 In the same manner as the compound [175-1] and naphtho [2,3-c] furan-1,3-dione to obtain the target compound [177] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.84(s, 6H), 1.90(s, 6H), 1.97(s, 6H), 7.01 ~7.03(m, 6H), 7.38~7.39(m, 3H), 7.91~7.92(m, 4H), 8.13(s, 1H), 8.19(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.84 (s, 6H), 1.90 (s, 6H), 1.97 (s, 6H), 7.01-7.03 (m, 6H), 7.38-7.39 (m, 3H) , 7.91 ~ 7.92 (m, 4H), 8.13 (s, 1H), 8.19 (s, 1H)

MS/FAB : 515(M+)MS / FAB: 515 (M + )

[합성 예 178] 화합물 [178]의 합성Synthesis Example 178 Synthesis of Compound

Figure pat00193
Figure pat00193

합성예 1, 2와동일한방법으로화합물[175-1], 무수푸탈산, 브로모벤젠을 사용하여 노란색 고체의 목적화합물 [178]을수득하였다.Due to Synthesis Example 1, 2 vortex same way using the compound [175-1], anhydrous Fu deoxidation, bromo-benzene, to give the desired compound [178] in a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.84(s, 6H), 1.90(s, 6H), 1.97(s, 6H), 7.01 ~7.03(m, 6H), 7.38~7.52(m, 13H), 7.91~7.92(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.84 (s, 6H), 1.90 (s, 6H), 1.97 (s, 6H), 7.01-7.03 (m, 6H), 7.38-7.52 (m, 13H) , 7.91-7.92 (m, 2H)

MS/FAB : 617(M+)MS / FAB: 617 (M + )

[합성 예 179] 화합물 [179]의 합성Synthesis Example 179 Synthesis of Compound

Figure pat00194
Figure pat00194

합성예 1, 2와동일한방법으로화합물[175-1], 나프토[1,2-c]퓨란-1,3-디온, 브로모벤젠을 사용하여 노란색 고체의 목적화합물 [179]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , compound [175-1] , naphtho [1,2-c] furan-1,3-dione, and bromobenzene were used to obtain the target compound as a yellow solid [179] . .

1H NMR (300 MHz, CDCl3):δ 1.84(s, 6H), 1.90(s, 6H), 1.97(s, 6H), 7.01 ~7.03(m, 6H), 7.38~7.52(m, 12H), 7.82~7.91(m, 3H), 8.12(d, 1H), 8.93(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.84 (s, 6H), 1.90 (s, 6H), 1.97 (s, 6H), 7.01-7.03 (m, 6H), 7.38-7.52 (m, 12H) , 7.82-7.91 (m, 3H), 8.12 (d, 1H), 8.93 (d, 1H)

MS/FAB : 667(M+)MS / FAB: 667 (M + )

[합성 예 180] 화합물 [180]의 합성Synthesis Example 180 Synthesis of Compound

Figure pat00195
Figure pat00195

합성예 1, 2와동일한방법으로화합물[175-1], 퓨로[3,4-b]피리딘-5,7-디온, 브로모벤젠을 사용하여 노란색 고체의 목적화합물 [180]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , compound [175-1] , puro [3,4-b] pyridine-5,7-dione, and bromobenzene were used to obtain the target compound [180] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.84(s, 6H), 1.90(s, 6H), 1.97(s, 6H), 7.01 ~7.03(m, 6H), 7.41~7.58(m, 11H), 7.67(s, 1H), 8.38(d, 1H), 8.83(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.84 (s, 6H), 1.90 (s, 6H), 1.97 (s, 6H), 7.01 to 7.03 (m, 6H), 7.41 ~ 7.58 (m, 11H) , 7.67 (s, 1H), 8.38 (d, 1H), 8.83 (d, 1H)

MS/FAB : 618(M+)MS / FAB: 618 (M + )

[합성 예 181] 화합물 [181]의 합성Synthesis Example 181 Synthesis of Compound [181]

Figure pat00196
Figure pat00196

합성예 1, 2와동일한방법으로화합물[175-1], 퓨로[3,4-b]피라진-5,7-디온, 브로모벤젠을 사용하여 노란색 고체의 목적화합물 [181]을수득하였다. In the same manner as in Synthesis Examples 1 and 2 , compound [175-1] , puro [3,4-b] pyrazine-5,7-dione, and bromobenzene were used to obtain the target compound [181] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.84(s, 6H), 1.90(s, 6H), 1.97(s, 6H), 7.01 ~7.03(m, 6H), 7.41~7.52(m, 10H), 7.67(s, 1H), 8.74(s, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.84 (s, 6H), 1.90 (s, 6H), 1.97 (s, 6H), 7.01-7.03 (m, 6H), 7.41-7.52 (m, 10H) , 7.67 (s, 1H), 8.74 (s, 2H)

MS/FAB : 619(M+)MS / FAB: 619 (M + )

[합성 예 182] 화합물 [182]의 합성Synthesis Example 182 Synthesis of Compound [182]

Figure pat00197
Figure pat00197

합성예 1, 2, 18와동일한방법으로화합물[175-1], 무수푸탈산, 브로모벤젠, 4-브로모피리딘을 사용하여 노란색 고체의 목적화합물 [182]을수득하였다. In the same manner as in Synthesis Examples 1, 2, and 18 , Compound [175-1] , Phthalic anhydride, bromobenzene, and 4-bromopyridine were used to obtain the target compound [182] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.84(s, 6H), 1.90(s, 6H), 1.97(s, 6H), 7.01 ~7.03(m, 6H), 7.38~7.52(m, 8H), 7.91~7.99(m, 4H), 8.75(d, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.84 (s, 6H), 1.90 (s, 6H), 1.97 (s, 6H), 7.01 to 7.03 (m, 6H), 7.38 ~ 7.52 (m, 8H) , 7.91-7.99 (m, 4H), 8.75 (d, 2H)

MS/FAB : 618(M+)MS / FAB: 618 (M + )

[합성 예 183] 화합물 [183]의 합성Synthesis Example 183 Synthesis of Compound [183]

Figure pat00198
Figure pat00198

합성예 1, 2, 18와동일한방법으로화합물[175-1], 무수푸탈산, 브로모벤젠, 2-브로모퀴놀린을 사용하여 노란색 고체의 목적화합물 [183]을수득하였다. In the same manner as in Synthesis Examples 1, 2, and 18 , Compound [175-1] , Phthalic anhydride, bromobenzene, and 2-bromoquinoline were used to obtain the target compound [183] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.84(s, 6H), 1.90(s, 6H), 1.97(s, 6H), 7.01 ~7.03(m, 6H), 7.34~7.41(m, 5H), 7.51~7.60(m, 5H), 7.78(t, 1H), 7.91~7.98(m, 3H), 8.06~8.10(m, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.84 (s, 6H), 1.90 (s, 6H), 1.97 (s, 6H), 7.01-7.03 (m, 6H), 7.34-7.41 (m, 5H) , 7.51 ~ 7.60 (m, 5H), 7.78 (t, 1H), 7.91 ~ 7.98 (m, 3H), 8.06 ~ 8.10 (m, 2H)

MS/FAB : 668(M+)MS / FAB: 668 (M + )

[합성 예 184] 화합물 [184]의 합성Synthesis Example 184 Synthesis of Compound

Figure pat00199
Figure pat00199

합성예 1, 2, 19와동일한방법으로화합물[175-1], 5-브로모무수푸탈산, 브로모벤젠, 페닐보론산을 사용하여 노란색 고체의 목적화합물 [184]을수득하였다. In the same manner as in Synthesis Examples 1, 2, and 19 , Compound [175-1] , 5- bromophthalic anhydride, bromobenzene, and phenylboronic acid were used to obtain the title compound [184] .

1H NMR (300 MHz, CDCl3):δ 1.84(s, 6H), 1.90(s, 6H), 1.97(s, 6H), 7.01 ~7.03(m, 6H), 7.38~7.52(m, 16H), 7.61(d, 1H), 7.97(d, 1H), 8.13(s, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.84 (s, 6H), 1.90 (s, 6H), 1.97 (s, 6H), 7.01-7.03 (m, 6H), 7.38-7.52 (m, 16H) , 7.61 (d, 1H), 7.97 (d, 1H), 8.13 (s, 1H)

MS/FAB : 693(M+)MS / FAB: 693 (M + )

[합성 예 185] 화합물 [185]의 합성Synthesis Example 185 Synthesis of Compound [185]

Figure pat00200
Figure pat00200

합성예 1, 2, 22와동일한방법으로화합물[175-1], 5-브로모무수푸탈산, 브로모벤젠, 디페닐아민을 사용하여 노란색 고체의 목적화합물 [185]을수득하였다. In the same manner as in Synthesis Examples 1, 2 and 22 , compound [175-1] , 5- bromophthalic anhydride, bromobenzene, and diphenylamine were used to obtain the target compound [185] as a yellow solid.

1H NMR (300 MHz, CDCl3):δ 1.84(s, 6H), 1.90(s, 6H), 1.97(s, 6H), 7.01 ~7.08(m, 14H), 7.20~7.22(m, 4H), 7.38~7.52(m, 11H), 7.75(d, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.84 (s, 6H), 1.90 (s, 6H), 1.97 (s, 6H), 7.01 to 7.08 (m, 14H), 7.20 ~ 7.22 (m, 4H) , 7.38-7.52 (m, 11H), 7.75 (d, 1H)

MS/FAB : 785(M+)
MS / FAB: 785 (M + )

비교예 1Comparative Example 1

하기 화학식 a로 표시되는 화합물 a를 발광층 물질로 사용하고, 화학식 b로 표시되는 2-TNATA(4,4',4"-tris(N-naphthalen-2-yl)-N-phenylamino)-triphenylamine)을 정공주입층 물질로 사용하고, 화학식 c로 표시되는 α-NPD(N,N'-di(naphthalene-1-yl)-N,N'-diphenylbenzidine)을 정공수송층 물질로 사용하여, 다음과 같은 구조를 갖는 유기발광소자를 제작하였다: ITO/2-TNATA(80nm)/α-NPD(30nm)/화합물a(30nm)/Alq3(30nm)/LiF(0.5nm) /Al(60nm).2-TNATA (4,4 ', 4 "-tris (N-naphthalen-2-yl) -N-phenylamino) -triphenylamine) represented by Chemical Formula b using Compound a represented by Chemical Formula a below Is used as the hole injection layer material, and α-NPD (N, N'-di (naphthalene-1-yl) -N, N'-diphenylbenzidine) represented by Chemical Formula c is used as the hole transport layer material. An organic light emitting device having a structure was prepared: ITO / 2-TNATA (80 nm) / α-NPD (30 nm) / Compound a (30 nm) / Alq 3 (30 nm) / LiF (0.5 nm) / Al (60 nm).

애노드는 코닝(Corning)사의 15Ω/cm2(1000Å) ITO 유리 기판을 50mm x 50mm x 0.7mm크기로 잘라서 아세톤 이소프로필 알콜과 순수물 속에서 각 15분 동안 초음파 세정한 후, 30분 동안 UV 오존 세정하여 사용하였다. 상기 기판 상부에 2-TANATA를 진공 증착하여 80nm 두께의 정공주입층을 형성하였다. 상기 정공주입층 상부에, α-NPD를 진공 증착하여 30nm 두께의 정공수송층을 형성하였다. 상기 정공수송층 상부에 화학식 a로 표시되는 화합물 a를 진공 증착하여 25nm두께의 발광층을 형성하였다. 이후, 상기 발광층 상부에 Alq3 화합물을 30nm의 두께로 진공증착하여 전자수송층을 형성하였다. 상기 전자수송층 상부에 LiF 0.5nm(전자주입층)과 Al 600nm(캐소드)를 순차적으로 진공증착하여, 도 1b에 도시된 바와 같은 유기발광소자를 제조하였다. 이를 비교샘플 1이라고 한다.Anode cuts Corning's 15Ω / cm 2 (1000Å) ITO glass substrate into 50mm x 50mm x 0.7mm sizes, ultrasonically cleans for 15 minutes in acetone isopropyl alcohol and pure water, and then UV ozone for 30 minutes. It was used by washing. 2-TANATA was vacuum deposited on the substrate to form a hole injection layer having a thickness of 80 nm. On the hole injection layer, α-NPD was vacuum deposited to form a hole transport layer having a thickness of 30 nm. Compound a represented by Chemical Formula a was vacuum deposited on the hole transport layer to form a light emitting layer having a thickness of 25 nm. Thereafter, an Alq3 compound was vacuum-deposited to a thickness of 30 nm on the emission layer to form an electron transport layer. LiF 0.5 nm (electron injection layer) and Al 600 nm (cathode) were sequentially vacuum deposited on the electron transport layer to prepare an organic light emitting device as shown in FIG. 1B. This is called Comparative Sample 1.

본 실시예 및 이하의 실시예들에서는 디오브이사에서 제작한 EL 증착기를 사용하여 소자를 제작하였다.In this embodiment and the following examples, the device was fabricated using an EL deposition machine manufactured by DIOB Corporation.

<화학식 a> <화학식 b><Formula a> <Formula b>

Figure pat00201
Figure pat00202
Figure pat00201
Figure pat00202

<화학식 c> <Formula c>

Figure pat00203

Figure pat00203

실시예 1~117Examples 1 to 117

상기 비교예 1 중, 발광층 화합물로서 화합물 a 대신 상기 합성예에 개시된 화합물 1~117을 EML층 화합물로 각각 이용한 것을 제외하고는 상기 비교예 1과 동일한 방법으로 ITO/DNTPD(80nm)/α-NPD(30nm)/[EML 화합물 1~185](30nm)/Alq3(30nm)/LiF(0.5nm)/Al(60nm)의 구조를 갖는 유기발광소자를 제조하였다. 이를 각각 샘플 1 내지 125라고 한다.ITO / DNTPD (80nm) / α-NPD in the same manner as in Comparative Example 1, except that Compounds 1 to 117 disclosed in Synthesis Example were used as EML layer compounds instead of Compound a as Comparative Example 1, respectively. An organic light emitting diode having a structure of (30 nm) / [EML Compound 1-185] (30 nm) / Alq 3 (30 nm) / LiF (0.5 nm) / Al (60 nm) was manufactured. These are referred to as samples 1 to 125, respectively.

평가예 1 : 비교샘플 1 및 샘플 1~125의 발광 특성 평가Evaluation Example 1 Evaluation of Luminescence Characteristics of Comparative Sample 1 and Samples 1 to 125

비교샘플 1 및 샘플 1~125에 대하여, Keithley SMU 235, PR650를 이용하여 구동전압, 발광 휘도, 발광 효율, 발광피크를 각각 평가하여, 그 결과를 하기 표 1에 나타내었다. 상기 샘플들은 476~522nm 범위에서 청색 발광피크값을 보여주었다.For Comparative Sample 1 and Samples 1 to 125, Keithley SMU 235 and PR650 were used to evaluate driving voltage, emission luminance, emission efficiency, and emission peak, respectively, and the results are shown in Table 1 below. The samples showed blue emission peak values in the range of 476-522 nm.

<표 1>
TABLE 1

Figure pat00204
Figure pat00204

Figure pat00205
Figure pat00205

Figure pat00206
Figure pat00206

Figure pat00207
Figure pat00207

상기 표 1에 보여지는 바와 같이 샘플 1 내지 125은 비교샘플 1에 비하여 향상된 발광 특성을 나타내었다.
As shown in Table 1, Samples 1 to 125 exhibited improved luminescence properties compared to Comparative Sample 1.

이상의 설명에서 통상의 공지된 기술을 생략되어 있으나, 당업자라면 용이하게 이를 추측 및 추론하고 재현할 수 있다.
Although the well-known techniques are omitted in the above description, those skilled in the art can easily infer, infer, and reproduce them.

Claims (10)

제1전극; 제2전극; 및 상기 제1전극과 상기 제2전극 사이에 적어도 한 층의 유기막을 포함하는 유기 광소자로서, 상기 유기막이 하기 화학식 A의 유기 광화합물을 포함하는 것을 특징으로 하는 유기 광소자:
<화학식 A>
Figure pat00208


상기 식에서 A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 및 C2는 서로 독립적 또는 유관하게, 수소, 치환 또는 비치환된 C6-C50아릴기, 치환 또는 비치환된 C2-C50헤테로아릴기, 치환 또는 비치환된 C2-C50사이클로알킬기, 치환 또는 비치환된 C2-C50헤테로사이클로알킬기, 또는 치환 또는 비치환된 포화 또는 불포화 탄화수소이고,
X1, X2, X3, X4는 각각 0(zero), Si, S, Se, O, C 또는 N이고,
X1과 X2 중 어느 하나가 0(zero)이면 다른 하나는 0(zero)이 아니며,
X3과 X4중 어느 하나가 0(zero)이면 다른 하나는 0(zero)이 아니고,
X1, X2, X3 또는 X4가 0(zero)이면 이에 상응하는 C2, C1, A1d 또는 A1c가 0(zero)이고,
X1 및 X2이 포함된 고리는 공명 또는 비공명구조이다.
A first electrode; A second electrode; And an organic optical device comprising at least one organic film between the first electrode and the second electrode, wherein the organic film comprises an organic optical compound represented by Formula A:
<Formula A>
Figure pat00208


Wherein A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 and C2 are each independently or related to hydrogen, a substituted or unsubstituted C6-C50 aryl group, a substituted or unsubstituted C2-C50 hetero An aryl group, a substituted or unsubstituted C2-C50 cycloalkyl group, a substituted or unsubstituted C2-C50 heterocycloalkyl group, or a substituted or unsubstituted saturated or unsaturated hydrocarbon,
X1, X2, X3, X4 are each 0 (zero), Si, S, Se, O, C or N,
If one of X1 and X2 is zero, the other is not zero.
If one of X3 and X4 is zero, the other is not zero.
If X1, X2, X3 or X4 is zero, the corresponding C2, C1, A1d or A1c is zero
Rings containing X1 and X2 are either resonance or non-resonant.
제 1 항에 있어서,
A1a와 A1b, A1a와 A1c, A1b와 A1d, B1과 C1, B2와 C2 및 A2a와 A2b의 일부는 유관하게 작용기를 구성할 수 있으며,
이 작용기는 치환 또는 비치환된 C2-C50사이클로알킬기, 치환 또는 비치환된 C2-C50헤테로사이클로알킬기, 치환 또는 비치환된 C6-C50아릴기, 또는 치환 또는 비치환된 C2-C50헤테로아릴기인 것을 특징으로 하는 유기 광소자.
The method of claim 1,
A1a and A1b, A1a and A1c, A1b and A1d, B1 and C1, B2 and C2, and some of A2a and A2b may be related groups,
The functional group is a substituted or unsubstituted C2-C50 cycloalkyl group, a substituted or unsubstituted C2-C50 heterocycloalkyl group, a substituted or unsubstituted C6-C50 aryl group, or a substituted or unsubstituted C2-C50 heteroaryl group. An organic optical device characterized by the above-mentioned.
제 1 항에 있어서,
상기 A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 및 C2 중 하나 이상이 페닐기인 것을 특징으로 하는 유기 광소자.
The method of claim 1,
At least one of A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 and C2 is a phenyl group.
제 1 항에 있어서,
상기 아릴기, 헤테로아릴기, 사이클로알킬기 및 헤테로사이클로알킬기의 치환기가,
C1-C50알킬기; C1-C50알콕시기; 비치환 또는 C1-C50알킬기 또는 C1-C50알콕시기로 치환된 C6-C50아릴기; 비치환 또는 C1-C50알킬기 또는 C1-C50알콕시기로 치환된 C2-C50헤테로아릴기; 비치환 또는 C1-C50알킬기 또는 C1-C50알콕시기로 치환된 C5-C50사이클로알킬기; 비치환 또는 C1-C20알킬기 또는 C1-C20알콕시기로 치환된 C5-C50헤테로사이클로알킬기; 또는 실레인기로 이루어진 군으로부터 선택된 하나 이상의 치환기인 것을 특징으로 하는 유기 광소자.
The method of claim 1,
Substituents of the aryl group, heteroaryl group, cycloalkyl group and heterocycloalkyl group,
C1-C50 alkyl group; C1-C50 alkoxy group; C 6 -C 50 aryl groups which are unsubstituted or substituted with C 1 -C 50 alkyl groups or C 1 -C 50 alkoxy groups; C2-C50 heteroaryl group unsubstituted or substituted with a C1-C50 alkyl group or a C1-C50 alkoxy group; A C5-C50 cycloalkyl group unsubstituted or substituted with a C1-C50 alkyl group or a C1-C50 alkoxy group; C5-C50 heterocycloalkyl group which is unsubstituted or substituted with a C1-C20 alkyl group or a C1-C20 alkoxy group; Or one or more substituents selected from the group consisting of a silane group.
제 1 항에 있어서,
상기 A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 및 C2는 서로 독립적으로 또는 유관하게,
수소, 페닐기, 톨일기, 비페닐기, 펜타레닐기, 인데닐기, 나프틸기, 비페닐레닐기, 안트라세닐기, 벤조안트라세닐기, 아즈레닐기, 헵타레닐기, 아세나프틸레닐기, 페나레닐기, 메틸안트릴기, 페난트레닐기, 트리페닐레닐기, 피레닐기, 크리세닐기, 피세닐기, 페릴레닐기, 클로로페릴레닐기, 펜타페닐기, 펜타세닐기, 테트라페닐레닐기, 헥사페닐기, 헥사세닐기, 루비세닐기, 코로네닐기, 트리나프틸레닐기, 헵타페닐기, 헵타세닐기, 플루오레닐기, 피란트레닐기, 오바레닐기, 카르바졸릴기, 디벤조퓨라닐기, 디벤조티오페닐기, 티오페닐기, 인돌일기, 푸리닐기, 벤즈이미다졸일기, 퀴놀리닐기, 벤조티오페닐기, 파라티아지닐기, 피롤일기, 피라졸릴기, 이미다졸릴기, 이미다졸리닐기, 옥사졸릴기, 티아졸릴기, 트리아졸릴기, 테트라졸일기, 옥사디아졸릴기, 피리디닐기, 피리다지닐기, 피리미디닐기, 피라지닐기, 티안트레닐기(thianthrenyl), 사이클로펜틸기, 사이클로헥실기, 옥시라닐기, 피롤리디닐기, 피라졸리디닐기, 이미다졸리디닐기, 피페리디닐기, 피페라지닐기, 모르폴리닐기, 디(C6-C50아릴)아미노기, 실레인기 및 이들의 유도체로 이루어진 군으로부터 선택된 것을 특징으로 하는 유기 광소자.
The method of claim 1,
A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1, and C2 are independent or related to each other,
Hydrogen, phenyl group, tolyl group, biphenyl group, pentarenyl group, indenyl group, naphthyl group, biphenylenyl group, anthracenyl group, benzoanthracenyl group, azurenyl group, heptarenyl group, acenaphthylenyl group, phenenalenyl group , Methyl anthryl group, phenanthrenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pisenyl group, perylenyl group, chloroperylenyl group, pentaphenyl group, pentaxenyl group, tetraphenylenyl group, hexaphenyl group, Hexenyl group, rubisenyl group, coronyl group, trinaphthylenyl group, heptaphenyl group, heptasenyl group, fluorenyl group, pyrantrenyl group, obarenyl group, carbazolyl group, dibenzofuranyl group, dibenzothiophenyl group , Thiophenyl group, indolyl group, furinyl group, benzimidazolyl group, quinolinyl group, benzothiophenyl group, parathiazinyl group, pyrrolyl group, pyrazolyl group, imidazolyl group, imidazolinyl group, oxazolyl group, thia Zolyl group, triazolyl group, tetrazolyl group, oxadiazolyl group , Pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, thianthrenyl, cyclopentyl, cyclohexyl, oxiranyl, pyrrolidinyl, pyrazolidinyl, imidazoli An organic optical device, characterized in that selected from the group consisting of a diyl group, a piperidinyl group, a piperazinyl group, a morpholinyl group, a di (C6-C50 aryl) amino group, a silane group and derivatives thereof.
제 1 항에 있어서,
상기 화합물이 하기 화학식 1 내지 185로 표시되는 것을 특징으로 하는 유기 광소자:


Figure pat00209

Figure pat00210

Figure pat00211

Figure pat00212

Figure pat00213

Figure pat00214

Figure pat00215

Figure pat00216



Figure pat00217

Figure pat00218

Figure pat00219

Figure pat00220

Figure pat00221
The method of claim 1,
An organic optical device characterized in that the compound is represented by the formula 1 to 185:


Figure pat00209

Figure pat00210

Figure pat00211

Figure pat00212

Figure pat00213

Figure pat00214

Figure pat00215

Figure pat00216



Figure pat00217

Figure pat00218

Figure pat00219

Figure pat00220

Figure pat00221
하기 화학식 A로 표시되는 유기 광화합물:
<화학식 A>
Figure pat00222


상기 식에서 A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 및 C2는 서로 독립적 또는 유관하게, 수소, 치환 또는 비치환된 C6-C50아릴기, 치환 또는 비치환된 C2-C50헤테로아릴기, 치환 또는 비치환된 C2-C50사이클로알킬기, 치환 또는 비치환된 C2-C50헤테로사이클로알킬기, 또는 치환 또는 비치환된 포화 또는 불포화 탄화수소이고,
X1, X2, X3, X4는 각각 0(zero), Si, S, Se, O, C 또는 N이고,
X1과 X2 중 어느 하나가 0(zero)이면 다른 하나는 0(zero)이 아니며,
X3과 X4중 어느 하나가 0(zero)이면 다른 하나는 0(zero)이 아니고,
X1, X2, X3 또는 X4가 0(zero)이면 이에 상응하는 C2, C1, A1d 또는 A1c가 0(zero)이고,
X1 및 X2이 포함된 고리는 공명 또는 비공명구조이다.
An organic photo compound represented by the following formula (A):
<Formula A>
Figure pat00222


Wherein A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 and C2 are each independently or related to hydrogen, a substituted or unsubstituted C6-C50 aryl group, a substituted or unsubstituted C2-C50 hetero An aryl group, a substituted or unsubstituted C2-C50 cycloalkyl group, a substituted or unsubstituted C2-C50 heterocycloalkyl group, or a substituted or unsubstituted saturated or unsaturated hydrocarbon,
X1, X2, X3, X4 are each 0 (zero), Si, S, Se, O, C or N,
If one of X1 and X2 is zero, the other is not zero.
If one of X3 and X4 is zero, the other is not zero.
If X1, X2, X3 or X4 is zero, the corresponding C2, C1, A1d or A1c is zero
Rings containing X1 and X2 are either resonance or non-resonant.
제 7 항에 있어서,
A1a와 A1b, A1a와 A1c, A1b와 A1d, B1과 C1, B2와 C2 및 A2a와 A2b의 일부는 유관하게 작용기를 구성할 수 있으며,
이 작용기는 치환 또는 비치환된 C2-C50사이클로알킬기, 치환 또는 비치환된 C2-C50헤테로사이클로알킬기, 치환 또는 비치환된 C6-C50아릴기, 또는 치환 또는 비치환된 C2-C50헤테로아릴기인 것을 특징으로 하는 유기 광소자.
The method of claim 7, wherein
A1a and A1b, A1a and A1c, A1b and A1d, B1 and C1, B2 and C2, and some of A2a and A2b may be related groups,
The functional group is a substituted or unsubstituted C2-C50 cycloalkyl group, a substituted or unsubstituted C2-C50 heterocycloalkyl group, a substituted or unsubstituted C6-C50 aryl group, or a substituted or unsubstituted C2-C50 heteroaryl group. An organic optical device characterized by the above-mentioned.
제 7 항에 있어서,
상기 A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 및 C2 중 하나 이상이 페닐기인 것을 특징으로 하는 유기 광화합물.
The method of claim 7, wherein
At least one of A1a, A1b, A1c, A1d, A2a, A2b, B1, B2, C1 and C2 is a phenyl group.
제 7 항에 있어서,
상기 화합물이 하기 화학식 1 내지 185로 표시되는 것을 특징으로 하는 유기 광화합물:
Figure pat00223

Figure pat00224

Figure pat00225

Figure pat00226

Figure pat00227

Figure pat00228

Figure pat00229

Figure pat00230



Figure pat00231

Figure pat00232

Figure pat00233

Figure pat00234

Figure pat00235
The method of claim 7, wherein
An organic photo compound, characterized in that the compound is represented by the formula 1 to 185:
Figure pat00223

Figure pat00224

Figure pat00225

Figure pat00226

Figure pat00227

Figure pat00228

Figure pat00229

Figure pat00230



Figure pat00231

Figure pat00232

Figure pat00233

Figure pat00234

Figure pat00235
KR1020100006378A 2010-01-14 2010-01-25 Organic light device and organic light compound for the same KR101324782B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20100003629 2010-01-14
KR1020100003629 2010-01-14

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020110140987A Division KR101612069B1 (en) 2010-01-14 2011-12-23 Organic light device and organic light compound for the same

Publications (2)

Publication Number Publication Date
KR20110083442A true KR20110083442A (en) 2011-07-20
KR101324782B1 KR101324782B1 (en) 2013-10-31

Family

ID=44921187

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020100006378A KR101324782B1 (en) 2010-01-14 2010-01-25 Organic light device and organic light compound for the same
KR1020110140987A KR101612069B1 (en) 2010-01-14 2011-12-23 Organic light device and organic light compound for the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020110140987A KR101612069B1 (en) 2010-01-14 2011-12-23 Organic light device and organic light compound for the same

Country Status (1)

Country Link
KR (2) KR101324782B1 (en)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103173211A (en) * 2012-11-09 2013-06-26 吉林奥来德光电材料股份有限公司 Dihydropentacene-containing organic luminous material and preparation method thereof
KR20130093460A (en) * 2012-02-14 2013-08-22 덕산하이메탈(주) Compound for organic electronic element, organic electronic element using the same, and a electronic device thereof
KR20130093541A (en) * 2012-02-14 2013-08-22 덕산하이메탈(주) Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
WO2013122364A2 (en) * 2012-02-13 2013-08-22 덕산하이메탈(주) Compound for organic electrical element, organic electrical element comprising same, and electronic device therewith
WO2013149001A3 (en) * 2012-03-29 2013-11-21 Corning Incorporated Novel fused naphthalene cyclohetero ring compounds, and methods and uses thereof
WO2014027822A1 (en) * 2012-08-17 2014-02-20 주식회사 두산 Novel compound and organic electroluminescent device comprising same
KR20140064463A (en) * 2012-11-20 2014-05-28 덕산하이메탈(주) Compound for organic electronic element, organic electronic element using the same, and a electronic device thereof
EP2772493A1 (en) * 2013-02-28 2014-09-03 Samsung Display Co., Ltd. Condensed benzoindoles and organic light emitting device comprising the same
WO2015008940A1 (en) * 2013-07-16 2015-01-22 주식회사 두산 Organic electroluminescent device
WO2015046982A2 (en) * 2013-09-30 2015-04-02 주식회사 두산 Organic compound and organic electroluminescent element comprising same
TWI494315B (en) * 2012-02-13 2015-08-01 Duk San Neolux Co Ltd Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
JP2015534543A (en) * 2012-09-04 2015-12-03 メルク パテント ゲーエムベーハー Compounds for electronic devices
JP2016001659A (en) * 2014-06-11 2016-01-07 株式会社東海理化電機製作所 Organic semiconductor material
JP2016502500A (en) * 2012-09-28 2016-01-28 チェイル インダストリーズ インコーポレイテッド Compound for organic optoelectronic device, organic light emitting device including the same, and display device including the organic light emitting device
KR20160017393A (en) * 2014-08-05 2016-02-16 삼성디스플레이 주식회사 Condensed-cyclic compound and organic light emitting diode comprising the same
JP2016040292A (en) * 2011-12-07 2016-03-24 ドゥーサン コーポレイション Organic light-emitting compound and organic electroluminescent element using the same
WO2016192329A1 (en) * 2015-06-02 2016-12-08 吉林奥来德光电材料股份有限公司 Aromatic heterocyclic compound, preparation method therefor, and organic electroluminescent component
KR20170018743A (en) * 2015-08-10 2017-02-20 희성소재 (주) Hetero-cyclic compound and organic light emitting device using the same
CN106854218A (en) * 2016-12-30 2017-06-16 上海升翕光电科技有限公司 A kind of silicon anthracene derivative and preparation method thereof and organic luminescent device
WO2017188598A1 (en) * 2016-04-29 2017-11-02 주식회사 두산 Organic compound and organic electroluminescent element
WO2017221999A1 (en) 2016-06-22 2017-12-28 Idemitsu Kosan Co., Ltd. Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes
JP2019520349A (en) * 2016-06-03 2019-07-18 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company Electroactive compound
KR20200072440A (en) * 2018-12-12 2020-06-22 주식회사 엘지화학 Multicyclic compound and organic electronic device comprising same
CN113105493A (en) * 2021-03-12 2021-07-13 华南理工大学 Naphthosilole compound and synthesis method for preparing naphthosilole compound through photocatalysis
CN114853702A (en) * 2022-06-07 2022-08-05 阜阳欣奕华材料科技有限公司 Naphthalene heteroaromatic compound, organic electroluminescent device and display device
KR102581525B1 (en) * 2022-04-11 2023-09-21 아주대학교산학협력단 In vivo lipid droplet selective two-photon fluorescence tracker and uses thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106543214B (en) * 2016-10-27 2019-04-16 天津大学 A kind of benzene, anthra thiophene cough up derivative organic photoelectrical material and its synthetic method
CN106543216B (en) * 2016-10-27 2019-06-25 天津大学 A kind of benzene, naphtho- thiophene cough up derivative organic photoelectrical material and preparation method thereof
WO2020159135A1 (en) * 2019-01-30 2020-08-06 덕산네오룩스 주식회사 Compound for organic electric element, organic electric element using same, and electronic device therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101003851B1 (en) * 2008-06-18 2010-12-23 (주)씨에스엘쏠라 Organic light emitting compound and organic light emitting device comprising the same

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10038146B2 (en) 2011-12-07 2018-07-31 Doosan Corporation Organic light-emitting compound and organic electroluminescent device using same
JP2016040292A (en) * 2011-12-07 2016-03-24 ドゥーサン コーポレイション Organic light-emitting compound and organic electroluminescent element using the same
TWI494315B (en) * 2012-02-13 2015-08-01 Duk San Neolux Co Ltd Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
WO2013122364A2 (en) * 2012-02-13 2013-08-22 덕산하이메탈(주) Compound for organic electrical element, organic electrical element comprising same, and electronic device therewith
WO2013122364A3 (en) * 2012-02-13 2013-10-10 덕산하이메탈(주) Compound for organic electrical element, organic electrical element comprising same, and electronic device therewith
KR20130093460A (en) * 2012-02-14 2013-08-22 덕산하이메탈(주) Compound for organic electronic element, organic electronic element using the same, and a electronic device thereof
KR20130093541A (en) * 2012-02-14 2013-08-22 덕산하이메탈(주) Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
US20150045560A1 (en) * 2012-03-29 2015-02-12 Corning Incorporated Novel fused naphthalene cyclohetero ring compounds, and methods and uses thereof
WO2013149001A3 (en) * 2012-03-29 2013-11-21 Corning Incorporated Novel fused naphthalene cyclohetero ring compounds, and methods and uses thereof
CN104797583A (en) * 2012-03-29 2015-07-22 康宁公司 Novel fused naphthalene cyclohetero ring compounds, and methods and uses thereof
CN104736541A (en) * 2012-08-17 2015-06-24 株式会社斗山 Novel compound and organic electroluminescent device comprising same
US9837618B2 (en) 2012-08-17 2017-12-05 Doosan Corporation Compound and organic electroluminescence device including thesame
WO2014027822A1 (en) * 2012-08-17 2014-02-20 주식회사 두산 Novel compound and organic electroluminescent device comprising same
JP2015534543A (en) * 2012-09-04 2015-12-03 メルク パテント ゲーエムベーハー Compounds for electronic devices
US10439145B2 (en) 2012-09-04 2019-10-08 Merck Patent Gmbh Compounds for electronic devices
JP2016502500A (en) * 2012-09-28 2016-01-28 チェイル インダストリーズ インコーポレイテッド Compound for organic optoelectronic device, organic light emitting device including the same, and display device including the organic light emitting device
CN103173211A (en) * 2012-11-09 2013-06-26 吉林奥来德光电材料股份有限公司 Dihydropentacene-containing organic luminous material and preparation method thereof
KR20140064463A (en) * 2012-11-20 2014-05-28 덕산하이메탈(주) Compound for organic electronic element, organic electronic element using the same, and a electronic device thereof
EP2772493A1 (en) * 2013-02-28 2014-09-03 Samsung Display Co., Ltd. Condensed benzoindoles and organic light emitting device comprising the same
KR101506793B1 (en) * 2013-07-16 2015-03-27 주식회사 두산 Organic electro luminescence device
WO2015008940A1 (en) * 2013-07-16 2015-01-22 주식회사 두산 Organic electroluminescent device
WO2015046982A3 (en) * 2013-09-30 2015-05-07 주식회사 두산 Organic compound and organic electroluminescent element comprising same
WO2015046982A2 (en) * 2013-09-30 2015-04-02 주식회사 두산 Organic compound and organic electroluminescent element comprising same
JP2016001659A (en) * 2014-06-11 2016-01-07 株式会社東海理化電機製作所 Organic semiconductor material
KR20160017393A (en) * 2014-08-05 2016-02-16 삼성디스플레이 주식회사 Condensed-cyclic compound and organic light emitting diode comprising the same
WO2016192329A1 (en) * 2015-06-02 2016-12-08 吉林奥来德光电材料股份有限公司 Aromatic heterocyclic compound, preparation method therefor, and organic electroluminescent component
KR20170018743A (en) * 2015-08-10 2017-02-20 희성소재 (주) Hetero-cyclic compound and organic light emitting device using the same
WO2017188598A1 (en) * 2016-04-29 2017-11-02 주식회사 두산 Organic compound and organic electroluminescent element
JP2019520349A (en) * 2016-06-03 2019-07-18 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company Electroactive compound
WO2017221999A1 (en) 2016-06-22 2017-12-28 Idemitsu Kosan Co., Ltd. Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes
US11691983B2 (en) 2016-06-22 2023-07-04 Idemitsu Kosan Co., Ltd. Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes
CN106854218B (en) * 2016-12-30 2019-03-05 上海升翕光电科技有限公司 A kind of silicon anthracene derivative and preparation method thereof and organic luminescent device
CN106854218A (en) * 2016-12-30 2017-06-16 上海升翕光电科技有限公司 A kind of silicon anthracene derivative and preparation method thereof and organic luminescent device
KR20200072440A (en) * 2018-12-12 2020-06-22 주식회사 엘지화학 Multicyclic compound and organic electronic device comprising same
CN113105493A (en) * 2021-03-12 2021-07-13 华南理工大学 Naphthosilole compound and synthesis method for preparing naphthosilole compound through photocatalysis
CN113105493B (en) * 2021-03-12 2022-03-29 华南理工大学 Naphthosilole compound and synthesis method for preparing naphthosilole compound through photocatalysis
KR102581525B1 (en) * 2022-04-11 2023-09-21 아주대학교산학협력단 In vivo lipid droplet selective two-photon fluorescence tracker and uses thereof
CN114853702A (en) * 2022-06-07 2022-08-05 阜阳欣奕华材料科技有限公司 Naphthalene heteroaromatic compound, organic electroluminescent device and display device

Also Published As

Publication number Publication date
KR101612069B1 (en) 2016-04-15
KR101324782B1 (en) 2013-10-31
KR20120013279A (en) 2012-02-14

Similar Documents

Publication Publication Date Title
KR101324782B1 (en) Organic light device and organic light compound for the same
KR101324788B1 (en) Organic light device and organic light compound for the same
KR101536167B1 (en) Organic light compound and organic light device using the same
KR101399636B1 (en) Organic light compound and organic light device using the same
KR101430589B1 (en) Organic light compound and organic light device using the same
KR100987822B1 (en) Organic light emitting compound and organic light emitting device comprising the same
KR101247956B1 (en) Organic light emitting device and organic light emitting compound for the same
KR101790552B1 (en) Organic light compound and organic light device using the same
KR20130021431A (en) Organic light compound and organic light device using the same
KR100984341B1 (en) Organic light emitting device and organic light emitting compound used therein
KR101324785B1 (en) Organic light compound and organic light device using the same
KR101375361B1 (en) Organic light compound and organic light device using the same
KR101395607B1 (en) Organic light compound and organic light device using the same
KR101520350B1 (en) Organic light compound and organic light device using the same
KR20120070468A (en) Organic light compound and organic light device using the same
KR20120120886A (en) Organic light compound and organic light device using the same
KR20140058017A (en) Novel heterocyclic compound for organic light emitting device and organic light emitting device comprising the same
KR101324786B1 (en) Organic light compound and organic light device using the same
KR101501239B1 (en) Organic light device and organic light compound for the same
KR20130084952A (en) Organic light emiiting compound and organic light emitting device comprising the same
KR101375358B1 (en) Organic light compound and organic light device using the same
KR20130100079A (en) Organic light compound and organic light device using the same
KR20120120885A (en) Organic light compound and organic light device using the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
A107 Divisional application of patent
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20161007

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20181004

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20191002

Year of fee payment: 7